| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600200 | 66756 | ELECOR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ELECOR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 200 comprimidos | 25 mg | 5 | 200 | 10 | 200 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66756/66756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66756/66756_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600201 | 66757 | ELECOR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ELECOR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 200 comprimidos | 50 mg | 5 | 200 | 10 | 200 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66757/66757_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66757/66757_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 603239 | 09590004 | PREVENAR 13 SUSPENSION INYECTABLE | PREVENAR 13 SUSPENSION INYECTABLE, 10 jeringas precargadas de 0,5 ml + 10 AGUJAS | N/A (vacuna) | 33 | 10 | 61 | 10 jeringas precargadas de 0,5 ml + 10 AGUJAS | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09590004/09590004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09590004/09590004_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2009-12-29 | 1 | 1 | 1 | 2009-12-29 | 2009-12-29 | 1 | 2023-11-06 | View Edit Delete | ||||||||||||
| 603383 | 72280 | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 80 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72280/72280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72280/72280_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2010-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 606216 | 63437 | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES , 50 comprimidos | 40 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63437/63437_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63437/63437_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2013-07-09 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 606217 | 63436 | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES , 50 comprimidos | 20 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63436/63436_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63436/63436_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2013-07-09 | 1 | 2013-12-05 | View Edit Delete | ||||||||||||
| 607110 | 62825 | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG,100 comprimidos | 100 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62825/62825_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62825/62825_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 11424 | 11424 | 1999-12-10 | 1 | 1 | 1 | 2012-08-07 | 2018-11-29 | 1 | 2019-06-13 | View Edit Delete | ||||||||||||
| 607370 | 1181272001 | SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 10 viales (polvo) y 10 viales (suspensión) | N/A (vacuna) | 83 | 10 | 34 | 10 viales (polvo) y 10 viales (suspensión) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181272001/1181272001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181272001/1181272001_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | 3732 | 2020-10-16 | 1 | 1 | 1 | 2020-10-17 | 2020-10-16 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 607476 | 1211612002 | PREVENAR 20 SUSPENSION INYECTABLE EN JERINGA PRECARGADA | PREVENAR 20 SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas precargadas | N/A (más de 4 PA) | 33 | 10 | 61 | 10 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211612002/1211612002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211612002/1211612002_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2022-03-23 | 1 | 1 | 1 | 2022-03-24 | 2022-03-23 | 1 | 2022-08-01 | View Edit Delete | ||||||||||||
| 607491 | 86793 | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 80 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86793/86793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86793/86793_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 607492 | 86794 | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86794/86794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86794/86794_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 607493 | 86795 | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86795/86795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86795/86795_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 607494 | 86796 | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimdos | 10 mg | 5 | 500 | 10 | 500 comprimdos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86796/86796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86796/86796_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 607554 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 36 frascos de 50 ml | 20 mg/ml + 0,7 mg/ml | 6 | 1800 | 26 | 36 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2022-11-21 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607555 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 15 frascos de 250 ml | 20 mg/ml + 0,7 mg/ml | 6 | 3750 | 26 | 15 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2022-11-21 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607602 | 88384 | AQUASEPTIC PHARMA 20 MG/ML SOLUCIÓN CUTÁNEA | AQUASEPTIC PHARMA 20 MG/ML SOLUCIÓN CUTÁNEA, 36 frascos de 50 ml | 20 mg/ml | 6 | 1800 | 26 | 36 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88384/88384_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88384/88384_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-12-12 | 1 | 1 | 1 | 2022-12-13 | 2022-12-12 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607605 | 88409 | AQUASEPTIC PHARMA ORANGE 20 MG/ML SOLUCIÓN CUTÁNEA | AQUASEPTIC PHARMA ORANGE 20 MG/ML SOLUCIÓN CUTÁNEA, 36 frascos de 50 ml | 20 mg/ml | 6 | 1800 | 26 | 36 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88409/88409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88409/88409_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607639 | 3400935557506IP1 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 80 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506IP1/3400935557506IP1_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38087 | 26669 | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2023-06-21 | View Edit Delete | ||||||||||||
| 607675 | 1231740001 | AREXVY POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | AREXVY POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 10 viales de polvo + 10 viales con suspensión | N/A (vacuna) | 83 | 10 | 34 | 10 viales de polvo + 10 viales con suspensión | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231740001/1231740001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231740001/1231740001_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | 3732 | 2023-06-12 | 1 | 1 | 1 | 2023-06-13 | 2023-06-12 | 1 | 2024-08-08 | View Edit Delete | ||||||||||||
| 607692 | 1231752001 | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales (polvo) + 10 jeringas precargadas (disolvente) + 10 adaptadores del vial + 10 agujas | N/A (vacuna) | 80 | 10 | 76 | 10 viales (polvo) + 10 jeringas precargadas (disolvente) + 10 adaptadores del vial + 10 agujas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231752001/1231752001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231752001/1231752001_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2023-09-01 | 1 | 1 | 1 | 2023-09-02 | 2023-09-01 | 1 | 2023-11-10 | View Edit Delete | ||||||||||||
| 607827 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 15 frascos de 500 ml | 20 mg/ml + 0,7 mg/ml | 6 | 7500 | 26 | 15 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2024-09-13 | 1 | 2024-10-09 | View Edit Delete | ||||||||||||
| 607832 | 1231752001 | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales de polvo (antígenos) + 10 viales (disolvente) | N/A (vacuna) | 45 | 10 | 34 | 10 viales de polvo (antígenos) + 10 viales (disolvente) | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231752001/1231752001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231752001/1231752001_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2023-09-01 | 1 | 1 | 1 | 2023-09-02 | 2024-09-30 | 1 | 2025-03-11 | View Edit Delete | ||||||||||||
| 607861 | 90137 | FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA | FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas precargadas de 0,5 ml | N/A (Vacuna) | 33 | 1 | 61 | 10 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90137/90137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90137/90137_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 2025-02-13 | 1 | 1 | 1 | 2025-02-14 | 2025-02-13 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 612283 | 61717 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61717/61717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61717/61717_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-01-09 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 615435 | 61718 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61718/61718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61718/61718_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-03-28 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 641084 | 58839 | TRIALMIN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TRIALMIN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 600 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58839/58839_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58839/58839_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1803 | 1803 | 1991-02-01 | 1 | 1 | 1 | 1991-02-01 | 1991-04-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 644948 | 59468 | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59468/59468_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59468/59468_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1994-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 649251 | 61513 | CLORXIL 5 mg/g CREMA | CLORXIL 5 mg/g CREMA , 1 tubo de 200 g | 5 mg/g | 44 | 200 | 21 | 1 tubo de 200 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61513/61513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61513/61513_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-03-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 650179 | 66355 | INSPRA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | INSPRA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66355/66355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66355/66355_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2004-09-21 | 1 | 1 | 1 | 2004-09-21 | 2004-09-21 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 650181 | 66356 | INSPRA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | INSPRA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66356/66356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66356/66356_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2004-09-21 | 1 | 1 | 1 | 2004-09-21 | 2004-09-21 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 650256 | 66388 | CLARITROMICINA SANDOZ 25 mg/ml GRANULADO PARA SUSPENSION ORAL | CLARITROMICINA SANDOZ 25 mg/ml GRANULADO PARA SUSPENSION ORAL , 1 frasco de 100 ml | 25 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66388/66388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66388/66388_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2004-09-28 | 1 | 1 | 1 | 2004-09-28 | 2004-09-28 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 650362 | 66428 | LANSOPRAZOL NORMON 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL NORMON 15 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66428/66428_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66428/66428_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2004-11-03 | 1 | 1 | 1 | 2004-11-03 | 2004-11-03 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 650393 | 65569 | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65569/65569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65569/65569_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2003-09-05 | 1 | 1 | 1 | 2003-09-05 | 2011-08-18 | 1 | 2011-09-28 | 709469, 999743 | View Edit Delete | |||||||||||
| 650403 | 04298002 | KIVEXA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | KIVEXA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 600 mg/300 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04298002/04298002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04298002/04298002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | 3776 | 2004-12-30 | 1 | 1 | 1 | 2004-12-30 | 2004-12-30 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 650414 | 66453 | SUMATRIPTAN SANDOZ 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SUMATRIPTAN SANDOZ 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 4 comprimidos | 50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66453/66453_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66453/66453_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2004-11-23 | 1 | 1 | 1 | 2004-11-23 | 2004-11-23 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 650433 | 66462 | BOOSTRIX POLIO SUSPENSION INYECTABLE EN JERINGA PRECARGADA | BOOSTRIX POLIO SUSPENSION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66462/66462_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66462/66462_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 2004-11-18 | 1 | 1 | 1 | 2014-02-28 | 2014-02-28 | 1 | 2014-09-30 | View Edit Delete | ||||||||||||
| 650479 | 66486 | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG, 14 cápsulas | 30 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66486/66486_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66486/66486_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2004-11-23 | 1 | 1 | 1 | 2004-11-23 | 2004-11-23 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 650480 | 66486 | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66486/66486_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66486/66486_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2004-11-23 | 1 | 1 | 1 | 2004-11-23 | 2004-11-23 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 651003 | 01185052 | ARANESP 80 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA | ARANESP 80 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,4 ml | 80 microgramos | 66 | 1 | 49 | 1 pluma precargada de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185052/01185052_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185052/01185052_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 651005 | 01185054 | ARANESP 150 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA | ARANESP 150 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,3 ml | 150 microgramos | 66 | 1 | 49 | 1 pluma precargada de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185054/01185054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185054/01185054_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 651006 | 01185055 | ARANESP 300 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA | ARANESP 300 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,6 ml | 300 microgramos | 66 | 1 | 49 | 1 pluma precargada de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185055/01185055_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185055/01185055_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 651007 | 01185056 | ARANESP 500 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA | ARANESP 500 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 500 microgramos | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185056/01185056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185056/01185056_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 651009 | 01185049 | ARANESP 40 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA | ARANESP 40 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,4 ml | 40 microgramos | 66 | 1 | 49 | 1 pluma precargada de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185049/01185049_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185049/01185049_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 651175 | 65517 | OMEPRAZOL SANDOZ FARMACEUTICA 10 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL SANDOZ FARMACEUTICA 10 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65517/65517_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65517/65517_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2003-09-04 | 1 | 1 | 1 | 2003-09-05 | 2011-08-18 | 1 | 2011-09-28 | 929620, 999741 | View Edit Delete | |||||||||||
| 651231 | 66756 | ELECOR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ELECOR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66756/66756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66756/66756_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 651235 | 66757 | ELECOR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ELECOR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66757/66757_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66757/66757_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2005-04-28 | 1 | 1 | 1 | 2005-04-28 | 2005-04-28 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 651300 | 64186 | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas (blister) | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64186/64186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64186/64186_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-08-17 | 1 | 1 | 1 | 2001-08-17 | 2011-08-16 | 1 | 2011-09-28 | 926303 | View Edit Delete | |||||||||||
| 651514 | 70025 | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70025/70025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70025/70025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2011-07-19 | 1 | 2011-11-23 | 661394, 672229 | View Edit Delete | |||||||||||
| 651522 | 70026 | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 14 comprimidos | 40 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70026/70026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70026/70026_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2011-07-19 | 1 | 2011-11-23 | 661395 | View Edit Delete | |||||||||||
| 651626 | 66942 | BUDESONIDA ALDO-UNION 0,5 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR | BUDESONIDA ALDO-UNION 0,5 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR , 20 ampollas de 2 ml | 1 mg | 1 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66942/66942_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66942/66942_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | 16620 | 2005-07-18 | 1 | 1 | 1 | 2005-07-18 | 2005-07-18 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 651628 | 66943 | BUDESONIDA ALDO-UNION 0,25 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR | BUDESONIDA ALDO-UNION 0,25 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR , 20 ampollas de 2 ml | 0,5 mg | 1 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66943/66943_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66943/66943_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | 16620 | 2005-07-18 | 1 | 1 | 1 | 2005-07-18 | 2005-07-18 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 652002 | 04285008 | APIDRA 100 UNIDADES/ML SOLUCION INYECTABLE EN CARTUCHO | APIDRA 100 UNIDADES/ML SOLUCION INYECTABLE EN CARTUCHO, 5 cartuchos de 3 ml | 100 U/ml | 12 | 5 | 57 | 5 cartuchos de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04285008/04285008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04285008/04285008_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42153 | 40842 | 2006-05-11 | 1 | 1 | 1 | 2006-05-11 | 2006-05-11 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 652100 | 70026 | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70026/70026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70026/70026_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2011-07-19 | 1 | 2011-11-23 | 661396 | View Edit Delete | |||||||||||
| 652237 | 63625 | ETOPÓSIDO SANDOZ 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG | ETOPÓSIDO SANDOZ 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG , 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63625/63625_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63625/63625_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2005-09-30 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 652433 | 05320001 | NOXAFIL 40 MG/ML SUSPENSION ORAL | NOXAFIL 40 MG/ML SUSPENSION ORAL, 1 frasco de 105 ml | 40 mg/ml | 6 | 105 | 26 | 1 frasco de 105 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05320001/05320001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05320001/05320001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 69623 | 2005-12-15 | 1 | 1 | 1 | 2005-12-15 | 2005-12-15 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 652480 | 67233 | TAMSULOSINA SANDOZ 0,4 mg CAPSULAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA SANDOZ 0,4 mg CAPSULAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67233/67233_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67233/67233_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2011-08-22 | 1 | 2011-09-27 | 652691 | View Edit Delete | |||||||||||
| 652661 | 67217 | TAMSULOSINA TEVA-RATIOPHARM 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA TEVA-RATIOPHARM 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67217/67217_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67217/67217_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2005-11-16 | 1 | 1 | 1 | 2005-11-16 | 2005-11-16 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 652665 | 67220 | TAMSULOSINA MABO 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA MABO 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG , 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67220/67220_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67220/67220_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2005-11-16 | 1 | 1 | 1 | 2005-11-16 | 2005-11-16 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 652672 | 67222 | PARIZAC 40 mg CAPSULAS DURAS GASTRORRESISTENTES | PARIZAC 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67222/67222_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67222/67222_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | 4840 | 2005-11-18 | 1 | 1 | 1 | 2005-11-18 | 2005-11-18 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 652890 | 67335 | AZITROMICINA TEVA 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AZITROMICINA TEVA 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 6 comprimidos | 250 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67335/67335_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67335/67335_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2005-12-12 | 1 | 1 | 1 | 2005-12-12 | 2005-12-12 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 652900 | 67340 | AZITROMICINA TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AZITROMICINA TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 comprimidos | 500 mg | 5 | 3 | 10 | 3 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67340/67340_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67340/67340_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2005-12-12 | 1 | 1 | 1 | 2005-12-12 | 2005-12-12 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 653190 | 64606 | CLARITROMICINA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLARITROMICINA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 500 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64606/64606_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64606/64606_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2002-03-06 | 1 | 1 | 1 | 2002-03-06 | 2006-04-06 | 1 | 2011-11-11 | 838631 | View Edit Delete | |||||||||||
| 653191 | 64606 | CLARITROMICINA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLARITROMICINA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 500 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64606/64606_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64606/64606_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2002-03-06 | 1 | 1 | 1 | 2002-03-06 | 2006-04-06 | 1 | 2011-11-11 | 838904 | View Edit Delete | |||||||||||
| 653233 | 66091 | LANSOPRAZOL ALTER 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL ALTER 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66091/66091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66091/66091_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2004-05-20 | 1 | 1 | 1 | 2004-05-20 | 2006-06-19 | 1 | 2011-11-11 | 817668 | View Edit Delete | |||||||||||
| 653404 | 65956 | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG, 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65956/65956_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65956/65956_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2004-03-09 | 1 | 1 | 1 | 2004-03-09 | 2006-09-14 | 1 | 2011-07-14 | 835439 | View Edit Delete | |||||||||||
| 653502 | 42666 | MAXIDEX 1 MG/ML COLIRIO EN SUSPENSIÓN | MAXIDEX 1 MG/ML COLIRIO EN SUSPENSIÓN , 1 frasco de 5 ml | 1 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42666/42666_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42666/42666_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | 1945 | 1966-03-01 | 1 | 1 | 1 | 1966-03-01 | 2012-02-27 | 1 | 2013-01-03 | 784157, 672093 | View Edit Delete | |||||||||||
| 653619 | 47546 | ESTILSONA 7 mg/ml GOTAS ORALES EN SUSPENSIÓN | ESTILSONA 7 mg/ml GOTAS ORALES EN SUSPENSIÓN, 1 frasco de 10 ml | 13,3 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/47546/47546_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/47546/47546_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 88185 | 945 | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2011-11-30 | 1 | 2012-01-02 | 735092, 734954, 999800, 653431, 656762 | View Edit Delete | |||||||||||
| 653630 | 67487 | ACECLOFENACO KERN PHARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ACECLOFENACO KERN PHARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 20 comprimidos | 100 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67487/67487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67487/67487_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2006-01-23 | 1 | 1 | 1 | 2013-11-26 | 2013-11-26 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 653631 | 67487 | ACECLOFENACO KERN PHARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ACECLOFENACO KERN PHARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 40 comprimidos | 100 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67487/67487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67487/67487_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2006-01-23 | 1 | 1 | 1 | 2013-11-26 | 2013-11-26 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 653739 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2006-02-02 | 1 | 2011-02-25 | View Edit Delete | ||||||||||||
| 653740 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2006-02-02 | 1 | 2011-02-25 | 656559 | View Edit Delete | |||||||||||
| 653743 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2006-02-02 | 1 | 2015-07-06 | View Edit Delete | ||||||||||||
| 653906 | 67589 | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 4 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67589/67589_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67589/67589_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2006-03-01 | 1 | 1 | 1 | 2006-03-01 | 2006-03-01 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 653909 | 67590 | EBASTINA ALTER 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA ALTER 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67590/67590_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67590/67590_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2006-03-01 | 1 | 1 | 1 | 2006-03-01 | 2006-03-01 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 653967 | 67606 | EBASTINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67606/67606_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67606/67606_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2006-03-28 | 1 | 1 | 1 | 2006-03-28 | 2006-03-28 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 653982 | 67614 | EBASTINA TEVA GROUP 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EBASTINA TEVA GROUP 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67614/67614_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67614/67614_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2023-12-26 | View Edit Delete | ||||||||||||
| 653983 | 67615 | EBASTINA TEVA GROUP 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EBASTINA TEVA GROUP 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67615/67615_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67615/67615_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2023-12-26 | View Edit Delete | ||||||||||||
| 654209 | 67708 | EBASTINA VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67708/67708_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67708/67708_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2006-04-11 | 1 | 1 | 1 | 2006-04-20 | 2006-04-11 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 654212 | 67709 | EBASTINA VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67709/67709_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67709/67709_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2006-04-11 | 1 | 1 | 1 | 2006-04-11 | 2006-04-11 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 654213 | 06333001 | MYOZYME 50 MG POLVO CONCENTRADO PARA SOLUCION PARA PERFUSION | MYOZYME 50 MG POLVO CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06333001/06333001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06333001/06333001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42448 | 40842 | 2006-04-26 | 1 | 1 | 1 | 2006-04-26 | 2006-04-26 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 654269 | 59785 | OPIREN 30 mg CAPSULAS | OPIREN 30 mg CAPSULAS , 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59785/59785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59785/59785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 1993-06-01 | 1 | 1 | 1 | 1993-06-01 | 1998-01-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654285 | 61219 | PRO ULCO 30 mg CAPSULAS GASTRORRESISTENTES | PRO ULCO 30 mg CAPSULAS GASTRORRESISTENTES , 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61219/61219_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61219/61219_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 1997-04-01 | 1 | 1 | 1 | 1997-04-01 | 1998-02-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 654405 | 67810 | EBASTINA TEVA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TEVA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67810/67810_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67810/67810_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2006-05-17 | 1 | 1 | 1 | 2006-05-17 | 2006-05-17 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 654406 | 67811 | EBASTINA TEVA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TEVA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67811/67811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67811/67811_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2006-05-17 | 1 | 1 | 1 | 2006-05-17 | 2006-05-17 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 654443 | 09590002 | PREVENAR 13 SUSPENSION INYECTABLE | PREVENAR 13 SUSPENSION INYECTABLE, 1 jeringa precargada de 0,5 ml + 1 AGUJAS | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml + 1 AGUJAS | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09590002/09590002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09590002/09590002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2009-12-29 | 1 | 1 | 1 | 2009-12-29 | 2012-07-17 | 1 | 2023-11-06 | 664470 | View Edit Delete | |||||||||||
| 654514 | 67852 | FLUTICASONA TEVA 50 microgramos SUSPENSION PARA PULVERIZACION NASAL | FLUTICASONA TEVA 50 microgramos SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 envase pulverizador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67852/67852_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67852/67852_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2006-06-13 | 1 | 1 | 1 | 2006-06-13 | 2006-06-13 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 654532 | 67861 | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS, 1 jeringa precargada de 1 ml | 40.000 UI | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67861/67861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67861/67861_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2006-06-06 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654535 | 67861 | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS, 1 jeringa precargada de 0,5 ml | 20.000 UI | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67861/67861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67861/67861_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2006-06-06 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654549 | 60583 | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,5 ml | 5.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60583/60583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60583/60583_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 2006-06-08 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654550 | 60583 | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,6 ml | 6.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60583/60583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60583/60583_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 2006-06-08 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654552 | 60583 | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,8 ml | 8.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60583/60583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60583/60583_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 2006-06-08 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654557 | 67869 | FINASTERIDA ALTER 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FINASTERIDA ALTER 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67869/67869_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67869/67869_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2006-06-12 | 1 | 1 | 1 | 2006-06-12 | 2006-06-12 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 654562 | 05324001 | NAGLAZYME 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | NAGLAZYME 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 1 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05324001/05324001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05324001/05324001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20700 | 28157 | 2006-06-19 | 1 | 1 | 1 | 2006-06-19 | 2006-06-19 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 654599 | 67885 | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS, 105 chicles | 2 mg | 5 | 105 | 9 | 105 chicles | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67885/67885_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67885/67885_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2006-06-26 | 1 | 1 | 1 | 2006-06-26 | 2006-06-26 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 654647 | 67904 | SEBRANE 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | SEBRANE 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67904/67904_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67904/67904_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28152 | 28152 | 2006-07-27 | 1 | 1 | 1 | 2006-07-27 | 2006-07-27 | 1 | 2011-03-01 | View Edit Delete | ||||||||||||
| 655134 | 62024 | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 40 comprimidos | 75 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62024/62024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62024/62024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | 1945 | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 656012 | 66020 | IBUPROFENO CINFA 20 MG/ML SUSPENSIÓN ORAL EFG | IBUPROFENO CINFA 20 MG/ML SUSPENSIÓN ORAL EFG 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66020/66020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66020/66020_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-04-06 | 1 | 1 | 1 | 2004-04-06 | 2006-09-20 | 1 | 2011-10-19 | 890863 | View Edit Delete | |||||||||||
| 656036 | 06346001 | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 300 mg | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06346001/06346001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06346001/06346001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | 19066 | 2006-09-26 | 1 | 1 | 1 | 2006-09-26 | 2006-09-26 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 656185 | 68086 | IBUDOL PEDIÁTRICO 200 MG SUSPENSIÓN ORAL | IBUDOL PEDIÁTRICO 200 MG SUSPENSIÓN ORAL , 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68086/68086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68086/68086_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2006-10-19 | 1 | 1 | 1 | 2006-10-19 | 2006-10-19 | 1 | 2015-09-15 | View Edit Delete | ||||||||||||
| 656526 | 65301 | BARNIX 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | BARNIX 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65301/65301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65301/65301_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31982 | 31982 | 2003-03-20 | 1 | 1 | 1 | 2003-03-20 | 2007-04-26 | 1 | 2011-10-28 | 781062 | View Edit Delete | |||||||||||
| 656527 | 65301 | BARNIX 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | BARNIX 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65301/65301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65301/65301_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31982 | 31982 | 2003-03-20 | 1 | 1 | 1 | 2003-03-20 | 2007-04-26 | 1 | 2012-02-06 | 781021 | View Edit Delete | |||||||||||
| 656528 | 65300 | BARNIX 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | BARNIX 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 56 cápsulas | 10 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65300/65300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65300/65300_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31982 | 31982 | 2003-03-25 | 1 | 1 | 1 | 2003-03-25 | 2007-04-26 | 1 | 2011-10-28 | 780916 | View Edit Delete | |||||||||||
| 656529 | 65300 | BARNIX 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | BARNIX 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 28 cápsulas | 10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65300/65300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65300/65300_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31982 | 31982 | 2003-03-25 | 1 | 1 | 1 | 2003-03-25 | 2007-04-26 | 1 | 2011-10-28 | 780908 | View Edit Delete | |||||||||||
| 656899 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2009-05-26 | 1 | 2011-10-21 | 701490 | View Edit Delete | |||||||||||
| 656902 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2009-05-26 | 1 | 2011-10-21 | 701508 | View Edit Delete | |||||||||||
| 656972 | 70296 | PANTOPRAZOL ALMUS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL ALMUS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70296/70296_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70296/70296_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 10245 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2009-07-24 | 1 | 2011-02-25 | 662000 | View Edit Delete | |||||||||||
| 656974 | 70297 | PANTOPRAZOL ALMUS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL ALMUS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70297/70297_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70297/70297_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 10245 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2009-07-24 | 1 | 2012-01-09 | 662002 | View Edit Delete | |||||||||||
| 657882 | 98067002 | MABTHERA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | MABTHERA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98067002/98067002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98067002/98067002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 657890 | 98067001 | MABTHERA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | MABTHERA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 2 | 34 | 2 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98067001/98067001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98067001/98067001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 658622 | 68542 | MEDIKINET 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 10 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68542/68542_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68542/68542_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 658623 | 68543 | MEDIKINET 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 20 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68543/68543_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68543/68543_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 658624 | 68544 | MEDIKINET 30 MG CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 30 MG CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 30 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68544/68544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68544/68544_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 658626 | 68545 | MEDIKINET 40 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 40 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 40 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68545/68545_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68545/68545_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 658752 | 04281003 | ERBITUX 5 MG/ML SOLUCION PARA PERFUSION | ERBITUX 5 MG/ML SOLUCION PARA PERFUSION, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04281003/04281003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04281003/04281003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29251 | 88146 | 2007-05-17 | 1 | 1 | 1 | 2007-05-17 | 2007-05-17 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 659012 | 68776 | OMEPRAZOL KRKA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL KRKA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68776/68776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68776/68776_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2007-05-09 | 1 | 1 | 1 | 2007-05-09 | 2007-05-09 | 1 | 2014-05-31 | View Edit Delete | ||||||||||||
| 659064 | 68801 | TAMSULOSINA ALTER 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA ALTER 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68801/68801_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68801/68801_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2007-05-21 | 1 | 1 | 1 | 2007-05-21 | 2007-05-21 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 659171 | 97047004 | BENEFIX 250 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | BENEFIX 250 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 250 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97047004/97047004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97047004/97047004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2007-09-04 | 1 | 1 | 1 | 2007-09-04 | 2007-09-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 659172 | 97047005 | BENEFIX 500 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | BENEFIX 500 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 500 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97047005/97047005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97047005/97047005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2007-09-04 | 1 | 1 | 1 | 2007-09-04 | 2007-09-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 659173 | 97047006 | BENEFIX 1000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | BENEFIX 1000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 1.000 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97047006/97047006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97047006/97047006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2007-09-04 | 1 | 1 | 1 | 2007-09-04 | 2007-09-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 659174 | 97047007 | BENEFIX 2000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | BENEFIX 2000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 2.000 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97047007/97047007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97047007/97047007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2007-09-04 | 1 | 1 | 1 | 2007-09-04 | 2007-09-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 659430 | 69034 | TOPIRAMATO VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TOPIRAMATO VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 25 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69034/69034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69034/69034_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2007-06-26 | 1 | 1 | 1 | 2007-06-26 | 2007-06-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659622 | 69139 | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69139/69139_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69139/69139_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659702 | 07393001 | SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 30 ml | 300 mg | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07393001/07393001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07393001/07393001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31986 | 71490 | 2007-08-07 | 1 | 1 | 1 | 2007-08-07 | 2007-08-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 659777 | 69223 | ACECLOFENACO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACECLOFENACO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 100 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69223/69223_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69223/69223_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2007-08-09 | 1 | 1 | 1 | 2007-08-09 | 2007-08-09 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659778 | 69223 | ACECLOFENACO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACECLOFENACO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 40 comprimidos | 100 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69223/69223_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69223/69223_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2007-08-09 | 1 | 1 | 1 | 2007-08-09 | 2007-08-09 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659917 | 07424001 | TORISEL 30 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | TORISEL 30 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial de 1,2 ml + 1 vial de disolvente | 25 mg/ml inyectable 1,2 ml | 45 | 1 | 34 | 1 vial de 1,2 ml + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07424001/07424001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07424001/07424001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2007-12-12 | 1 | 1 | 1 | 2007-12-12 | 2007-12-12 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 659988 | 69328 | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL , 1 envase pulverizador de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69328/69328_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69328/69328_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | 9180 | 2007-10-18 | 1 | 1 | 1 | 2007-11-05 | 2007-10-18 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660201 | 67861 | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 40000 UI/ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS, 1 jeringa precargada de 0,75 ml | 30.000 UI | 33 | 1 | 61 | 1 jeringa precargada de 0,75 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67861/67861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67861/67861_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2007-12-04 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660250 | 07434003 | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07434003/07434003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07434003/07434003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2008-01-24 | 1 | 1 | 1 | 2008-01-24 | 2008-01-24 | 1 | 2011-09-19 | View Edit Delete | ||||||||||||
| 660281 | 69487 | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas (BLISTER) | 40 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69487/69487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69487/69487_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2007-12-21 | 1 | 1 | 1 | 2007-12-21 | 2007-12-21 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 660285 | 69487 | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas (FRASCO) | 40 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69487/69487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69487/69487_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2007-12-21 | 1 | 1 | 1 | 2007-12-21 | 2007-12-21 | 1 | 2012-10-25 | View Edit Delete | ||||||||||||
| 660307 | 69497 | ATORVASTATINA TECNIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TECNIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69497/69497_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69497/69497_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-01-22 | 1 | 1 | 1 | 2008-01-22 | 2008-01-22 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 660309 | 69498 | ATORVASTATINA TECNIGEN 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TECNIGEN 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69498/69498_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69498/69498_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-01-22 | 1 | 1 | 1 | 2008-01-22 | 2008-01-22 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 660310 | 69499 | ATORVASTATINA TECNIGEN 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TECNIGEN 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69499/69499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69499/69499_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-01-22 | 1 | 1 | 1 | 2008-01-22 | 2008-01-22 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 660347 | 69521 | EBASTINA TECNIGEN 20 mg COMPRIMIDOS EFG | EBASTINA TECNIGEN 20 mg COMPRIMIDOS EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69521/69521_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69521/69521_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-01-11 | 1 | 1 | 1 | 2008-01-11 | 2008-01-11 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 660648 | 69667 | BISOPROLOL/HIDROCLOROTIAZIDA TEVA 10/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BISOPROLOL/HIDROCLOROTIAZIDA TEVA 10/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69667/69667_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69667/69667_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-03-04 | 1 | 1 | 1 | 2008-03-04 | 2008-03-04 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660649 | 69667 | BISOPROLOL/HIDROCLOROTIAZIDA TEVA 10/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BISOPROLOL/HIDROCLOROTIAZIDA TEVA 10/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg/25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69667/69667_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69667/69667_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-03-04 | 1 | 1 | 1 | 2008-03-04 | 2008-03-04 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660854 | 68869 | TAMSULOSINA TARBIS 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TAMSULOSINA TARBIS 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68869/68869_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68869/68869_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2007-06-01 | 1 | 1 | 1 | 2007-06-01 | 2008-04-21 | 1 | 2011-10-21 | 659161 | View Edit Delete | |||||||||||
| 660878 | 63506 | TEVETENS 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TEVETENS 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 600 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63506/63506_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63506/63506_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2000-12-04 | 1 | 1 | 1 | 2000-12-04 | 2000-12-04 | 1 | 2014-04-23 | View Edit Delete | ||||||||||||
| 660894 | 63508 | NAVIXEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | NAVIXEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 600 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63508/63508_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63508/63508_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2000-12-04 | 1 | 1 | 1 | 2000-12-04 | 2000-12-04 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 660933 | 69789 | LAMBDALINA 40 mg/g CREMA | LAMBDALINA 40 mg/g CREMA, 1 tubo de 5 g | 40 mg/g | 44 | 5 | 21 | 1 tubo de 5 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69789/69789_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69789/69789_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 2008-05-06 | 1 | 1 | 1 | 2008-05-06 | 2008-05-06 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 660937 | 69789 | LAMBDALINA 40 mg/g CREMA | LAMBDALINA 40 mg/g CREMA, 1 tubo de 30 g | 40 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69789/69789_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69789/69789_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 2008-05-06 | 1 | 1 | 1 | 2008-05-06 | 2008-05-06 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 660944 | 63509 | REGULATEN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | REGULATEN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 600 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63509/63509_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63509/63509_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2000-12-04 | 1 | 1 | 1 | 2000-12-04 | 2000-12-04 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 661058 | 62038 | PRED FORTE 10 MG/ML COLIRIO EN SUSPENSION | PRED FORTE 10 MG/ML COLIRIO EN SUSPENSION , 1 frasco de 5 ml | 10 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62038/62038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62038/62038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16052 | 16052 | 1999-03-01 | 1 | 1 | 1 | 1999-03-01 | 1999-03-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 661130 | 69893 | SUMATRIPTAN AUROVITAS 50 mg COMPRIMIDOS EFG | SUMATRIPTAN AUROVITAS 50 mg COMPRIMIDOS EFG , 4 comprimidos | 50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69893/69893_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69893/69893_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2008-06-17 | 1 | 1 | 1 | 2008-06-17 | 2008-06-17 | 1 | 2020-10-21 | View Edit Delete | ||||||||||||
| 661321 | 69980 | NEXIUM 10 mg GRANULADO GASTRORRESISTENTE PARA SUSPENSION ORAL, SOBRE | NEXIUM 10 mg GRANULADO GASTRORRESISTENTE PARA SUSPENSION ORAL, SOBRE , 28 sobres | 10 mg | 35 | 28 | 64 | 28 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69980/69980_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69980/69980_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2008-07-23 | 1 | 1 | 1 | 2008-07-23 | 2008-07-23 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661400 | 70027 | VALACICLOVIR TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 10 comprimidos | 500 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70027/70027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70027/70027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-09-19 | 1 | 1 | 1 | 2008-09-19 | 2008-09-19 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661401 | 70027 | VALACICLOVIR TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 42 comprimidos | 500 mg | 5 | 42 | 10 | 42 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70027/70027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70027/70027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-09-19 | 1 | 1 | 1 | 2008-09-19 | 2008-09-19 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661476 | 70063 | SAFLUTAN 15 microgramos/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | SAFLUTAN 15 microgramos/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS , 30 envases unidosis de 0,3 ml | 15 microgramos/ml | 3 | 30 | 16 | 30 envases unidosis de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70063/70063_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70063/70063_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2008-09-17 | 1 | 1 | 1 | 2008-09-17 | 2008-09-17 | 1 | 2011-09-28 | View Edit Delete | ||||||||||||
| 661587 | 98058001 | COMBIVIR 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | COMBIVIR 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 150 mg/300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98058001/98058001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98058001/98058001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | 3776 | 1998-11-01 | 1 | 1 | 1 | 1998-11-01 | 1998-11-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661935 | 08492001 | ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION | ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08492001/08492001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08492001/08492001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 2009-01-27 | 1 | 1 | 1 | 2009-01-27 | 2009-01-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661936 | 08492003 | ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION | ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08492003/08492003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08492003/08492003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 2009-01-27 | 1 | 1 | 1 | 2009-01-27 | 2009-01-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661950 | 62169 | ETOPOSIDO TEVAGEN 20mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ETOPOSIDO TEVAGEN 20mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62169/62169_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62169/62169_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 2008-11-26 | 1 | 2011-11-21 | View Edit Delete | ||||||||||||
| 661966 | 70313 | IRBESARTAN ALTER 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN ALTER 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70313/70313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70313/70313_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2008-12-12 | 1 | 1 | 1 | 2008-12-12 | 2008-12-12 | 1 | 2011-06-13 | View Edit Delete | ||||||||||||
| 661968 | 70314 | IRBESARTAN ALTER 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN ALTER 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70314/70314_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70314/70314_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2008-12-12 | 1 | 1 | 1 | 2008-12-12 | 2008-12-12 | 1 | 2011-06-13 | View Edit Delete | ||||||||||||
| 662003 | 70295 | PANTOPRAZOL TECNIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TECNIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70295/70295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70295/70295_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2008-12-10 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 662004 | 70298 | PANTOPRAZOL TECNIGEN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TECNIGEN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70298/70298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70298/70298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2008-12-10 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 662133 | 08494001 | STELARA 45 mg SOLUCION INYECTABLE | STELARA 45 mg SOLUCION INYECTABLE, 1 vial de 0,5 ml | 45 mg | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08494001/08494001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08494001/08494001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2009-02-04 | 1 | 1 | 1 | 2009-02-04 | 2009-02-04 | 1 | 2015-11-10 | View Edit Delete | ||||||||||||
| 662197 | 56562 | VOLTAREN RETARD 100 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 100 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 20 comprimidos | 100 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56562/56562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56562/56562_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | 1945 | 1985-04-01 | 1 | 1 | 1 | 1985-04-01 | 1998-02-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 662347 | 07401009 | ALLI 60 MG CAPSULAS DURAS | ALLI 60 MG CAPSULAS DURAS, 84 cápsulas | 60 mg | 6 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07401009/07401009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07401009/07401009_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71084 | 3783 | 2009-03-30 | 1 | 1 | 1 | 2009-03-30 | 2009-03-30 | 1 | 2011-09-19 | View Edit Delete | ||||||||||||
| 662379 | 61970 | NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL | NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 120 dosis | 55 microgramos/dosis | 25 | 120 | 31 | 1 envase pulverizador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61970/61970_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61970/61970_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41334 | 41334 | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 662497 | 08495001 | ZARZIO 30 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA | ZARZIO 30 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 30 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08495001/08495001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08495001/08495001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2009-03-31 | 1 | 1 | 1 | 2009-03-31 | 2009-03-31 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662499 | 08495003 | ZARZIO 30 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA | ZARZIO 30 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA, 5 jeringas precargadas de 0,5 ml | 30 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08495003/08495003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08495003/08495003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2009-03-31 | 1 | 1 | 1 | 2009-03-31 | 2009-03-31 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662500 | 08495005 | ZARZIO 48 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA | ZARZIO 48 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 48 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08495005/08495005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08495005/08495005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2009-03-31 | 1 | 1 | 1 | 2009-03-31 | 2009-03-31 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662503 | 08495007 | ZARZIO 48 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA | ZARZIO 48 MU/0,5 ml SOL. INY. O PARA PERFUSION EN JERINGA PRECARGADA, 5 jeringas precargadas de 0,5 ml | 48 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08495007/08495007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08495007/08495007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2009-03-31 | 1 | 1 | 1 | 2009-03-31 | 2009-03-31 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662711 | 08462001 | RANEXA 375 mg COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 375 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 375 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462001/08462001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462001/08462001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1803 | 2009-05-07 | 1 | 1 | 1 | 2009-05-07 | 2009-05-07 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 662846 | 03260026 | STALEVO 75 mg/18,75 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 75 mg/18,75 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 75 mg/18,75 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260026/03260026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260026/03260026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2009-04-23 | 1 | 1 | 1 | 2009-04-23 | 2009-04-23 | 1 | 2014-04-25 | View Edit Delete | ||||||||||||
| 662847 | 03260031 | STALEVO 125 mg/31,25 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 125 mg/31,25 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 125 mg/31,25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260031/03260031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260031/03260031_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2009-04-23 | 1 | 1 | 1 | 2009-04-23 | 2009-04-23 | 1 | 2014-04-25 | View Edit Delete | ||||||||||||
| 663006 | 01185081 | ARANESP 30 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 30 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,3 ml | 30 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185081/01185081_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185081/01185081_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663007 | 01185083 | ARANESP 40 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 40 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,4 ml | 40 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185083/01185083_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185083/01185083_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663008 | 01185085 | ARANESP 50 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 50 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,5 ml | 50 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185085/01185085_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185085/01185085_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663009 | 01185087 | ARANESP 60 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 60 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,3 ml | 60 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185087/01185087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185087/01185087_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-11-10 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663010 | 01185089 | ARANESP 80 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 80 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,4 ml | 80 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185089/01185089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185089/01185089_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663011 | 01185091 | ARANESP 100 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 100 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA , 4 jeringas precargadas de 0,5 ml | 100 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185091/01185091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185091/01185091_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663012 | 01185093 | ARANESP 130 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 130 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA , 4 jeringas precargadas de 0,65 ml | 130 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,65 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185093/01185093_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185093/01185093_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 663014 | 01185095 | ARANESP 150 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 150 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,3 ml | 150 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185095/01185095_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185095/01185095_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663015 | 01185096 | ARANESP 300 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 300 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,6 ml | 300 microgramos | 33 | 1 | 61 | 1 jeringa precargada de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185096/01185096_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185096/01185096_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663016 | 01185098 | ARANESP 500 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 500 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 500 microgramos | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185098/01185098_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185098/01185098_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 663114 | 70761 | LANSOPRAZOL ALMUS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL ALMUS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70761/70761_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70761/70761_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2009-06-05 | 1 | 1 | 1 | 2009-06-05 | 2009-06-05 | 1 | 2011-02-25 | View Edit Delete | ||||||||||||
| 663116 | 70762 | LANSOPRAZOL ALMUS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL ALMUS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70762/70762_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70762/70762_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2009-06-05 | 1 | 1 | 1 | 2009-06-05 | 2009-06-05 | 1 | 2011-02-25 | View Edit Delete | ||||||||||||
| 663162 | 06366018 | TANDEMACT 30 mg/2 mg COMPRIMIDOS | TANDEMACT 30 mg/2 mg COMPRIMIDOS, 28 comprimidos | 2 mg/30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06366018/06366018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06366018/06366018_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | 2495 | 2009-09-29 | 1 | 1 | 1 | 2009-09-29 | 2009-09-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 663163 | 06366006 | TANDEMACT 30 mg/4 mg COMPRIMIDOS | TANDEMACT 30 mg/4 mg COMPRIMIDOS, 28 comprimidos | 4 mg/30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06366006/06366006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06366006/06366006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | 2495 | 2009-09-29 | 1 | 1 | 1 | 2009-09-29 | 2009-09-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 663421 | 67326 | CADUET 10 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CADUET 10 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67326/67326_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67326/67326_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2005-12-12 | 1 | 1 | 1 | 2005-12-12 | 2011-02-14 | 1 | 2011-10-28 | 652877 | View Edit Delete | |||||||||||
| 663422 | 67593 | ASTUCOR 10 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ASTUCOR 10 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67593/67593_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67593/67593_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2006-03-15 | 1 | 1 | 1 | 2006-03-15 | 2011-02-14 | 1 | 2012-04-19 | 653929 | View Edit Delete | |||||||||||
| 663425 | 67325 | CADUET 5 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CADUET 5 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67325/67325_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67325/67325_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2005-12-02 | 1 | 1 | 1 | 2005-12-12 | 2011-02-14 | 1 | 2011-10-28 | 652874 | View Edit Delete | |||||||||||
| 663426 | 67594 | ASTUCOR 5 mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ASTUCOR 5 mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67594/67594_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67594/67594_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2006-03-15 | 1 | 1 | 1 | 2006-03-15 | 2011-02-14 | 1 | 2012-04-19 | 653930 | View Edit Delete | |||||||||||
| 663526 | 61905 | NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL | NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL , 1 envase pulverizador de 140 dosis | 50 microgramos/dosis | 6 | 140 | 31 | 1 envase pulverizador de 140 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61905/61905_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61905/61905_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 35083 | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2011-09-28 | View Edit Delete | ||||||||||||
| 663830 | 71369 | LANSOPRAZOL FLAS QUALIGEN 30 mg COMPRIMIDOS BUCODISPERSABLES | LANSOPRAZOL FLAS QUALIGEN 30 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71369/71369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71369/71369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | 45332 | 2009-09-10 | 1 | 1 | 1 | 2009-09-10 | 2009-09-10 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 663833 | 71368 | LANSOPRAZOL FLAS QUALIGEN 15 mg COMPRIMIDOS BUCODISPERSABLES | LANSOPRAZOL FLAS QUALIGEN 15 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71368/71368_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71368/71368_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | 45332 | 2009-09-10 | 1 | 1 | 1 | 2009-09-10 | 2009-09-10 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 663835 | 71367 | MONOLITUM FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES | MONOLITUM FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71367/71367_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71367/71367_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2009-09-09 | 1 | 1 | 1 | 2009-09-09 | 2009-09-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 663836 | 71367 | MONOLITUM FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES | MONOLITUM FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES, 56 comprimidos | 15 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71367/71367_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71367/71367_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2009-09-09 | 1 | 1 | 1 | 2009-09-09 | 2009-09-09 | 1 | 2019-02-01 | View Edit Delete | ||||||||||||
| 663837 | 71366 | MONOLITUM FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | MONOLITUM FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71366/71366_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71366/71366_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2009-09-09 | 1 | 1 | 1 | 2009-09-09 | 2009-09-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 663838 | 71366 | MONOLITUM FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | MONOLITUM FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES, 56 comprimidos | 30 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71366/71366_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71366/71366_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2009-09-09 | 1 | 1 | 1 | 2009-09-09 | 2009-09-09 | 1 | 2019-02-01 | View Edit Delete | ||||||||||||
| 663854 | 71377 | ESTOMIL FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES | ESTOMIL FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71377/71377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71377/71377_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88146 | 88146 | 2009-09-16 | 1 | 1 | 1 | 2009-09-16 | 2009-09-16 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 663857 | 71378 | ESTOMIL FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | ESTOMIL FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71378/71378_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71378/71378_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88146 | 88146 | 2009-09-16 | 1 | 1 | 1 | 2009-09-16 | 2009-09-16 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 663870 | 07416002 | ECALTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ECALTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07416002/07416002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07416002/07416002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2009-10-27 | 1 | 1 | 1 | 2009-10-27 | 2009-10-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 663962 | 61469 | REQUIP 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | REQUIP 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 84 comprimidos | 5 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61469/61469_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61469/61469_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2009-09-28 | 1 | 2011-05-05 | View Edit Delete | ||||||||||||
| 664038 | 71492 | NORCOLESTEROL IODADO (131 I) CIS BIO INTERNATIONAL 7,5-15 MBq/ml SOLUCION INYECTABLE | NORCOLESTEROL IODADO (131 I) CIS BIO INTERNATIONAL 7,5-15 MBq/ml SOLUCION INYECTABLE, 1 vial de 15 ml | 7,5-15 MBq/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71492/71492_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71492/71492_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | 28969 | 2009-10-08 | 1 | 1 | 1 | 2009-10-08 | 2009-10-08 | 1 | 2012-02-23 | View Edit Delete | ||||||||||||
| 664093 | 01185079 | ARANESP 20 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 20 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,5 ml | 20 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185079/01185079_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185079/01185079_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2009-09-18 | 1 | 1 | 1 | 2009-09-18 | 2009-09-18 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 664222 | 71288 | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71288/71288_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71288/71288_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2009-11-10 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 664223 | 71288 | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71288/71288_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71288/71288_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2009-11-10 | 1 | 2020-01-09 | View Edit Delete | ||||||||||||
| 664225 | 71289 | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71289/71289_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71289/71289_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2009-11-10 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 664240 | 09546001 | SIMPONI 50 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | SIMPONI 50 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,5 ml | 50 mg inyectable 0,5 ml | 66 | 1 | 49 | 1 pluma precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09546001/09546001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09546001/09546001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2009-11-19 | 1 | 1 | 1 | 2009-11-19 | 2009-11-19 | 1 | 2011-02-28 | View Edit Delete | ||||||||||||
| 664450 | 95002004 | TAXOTERE 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | TAXOTERE 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/95002004/95002004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/95002004/95002004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2009-12-22 | 1 | 1 | 1 | 2009-12-22 | 2009-12-22 | 1 | 2011-06-13 | View Edit Delete | ||||||||||||
| 664516 | 52190 | LEGALON 150 mg CAPSULAS | LEGALON 150 mg CAPSULAS, 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52190/52190_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52190/52190_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67965 | 13592 | 1974-03-01 | 1 | 1 | 1 | 1974-03-01 | 1997-11-01 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 664558 | 09596003 | LAMIVUDINA TEVA PHARMA B.V. 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LAMIVUDINA TEVA PHARMA B.V. 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 150 mg | 69 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09596003/09596003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09596003/09596003_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2011-02-25 | 1 | 1 | 1 | 2011-02-25 | 2011-02-25 | 1 | 2011-08-03 | View Edit Delete | ||||||||||||
| 664714 | 61835 | SALAGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SALAGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 84 comprimidos | 5 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61835/61835_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61835/61835_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41928 | 67164 | 2002-09-20 | 1 | 1 | 1 | 2002-09-20 | 2002-09-20 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 664763 | 61831 | GEMFIBROZILO STADA 900 mg COMPRIMIDOS EFG | GEMFIBROZILO STADA 900 mg COMPRIMIDOS EFG, 30 comprimidos | 900 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61831/61831_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61831/61831_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6220 | 6220 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 664771 | 61830 | GEMFIBROZILO STADA 600 mg COMPRIMIDOS EFG | GEMFIBROZILO STADA 600 mg COMPRIMIDOS EFG, 60 comprimidos | 600 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61830/61830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61830/61830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6220 | 6220 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 665072 | 72077 | DECAPEPTYL SEMESTRAL 22,5 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | DECAPEPTYL SEMESTRAL 22,5 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE, 1 vial + 1 ampolla de disolvente | 22,5 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72077/72077_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72077/72077_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68629 | 68629 | 2010-04-13 | 1 | 1 | 1 | 2010-04-13 | 2010-04-13 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 665314 | 72280 | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72280/72280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72280/72280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2010-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665534 | 72440 | ATORVASTATINA VIR PHARMA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72440/72440_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72440/72440_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665535 | 72441 | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72441/72441_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72441/72441_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665536 | 72442 | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72442/72442_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72442/72442_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665537 | 72443 | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72443/72443_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72443/72443_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665667 | 72516 | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS, 30 chicles | 2 mg | 5 | 30 | 9 | 30 chicles | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72516/72516_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72516/72516_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2010-07-13 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665668 | 72516 | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS, 105 chicles | 2 mg | 5 | 105 | 9 | 105 chicles | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72516/72516_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72516/72516_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2010-07-13 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665670 | 72517 | NICORETTE ICE MINT 4 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 4 mg CHICLES MEDICAMENTOSOS, 30 chicles | 4 mg | 5 | 30 | 9 | 30 chicles | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72517/72517_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72517/72517_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2010-07-13 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665671 | 72517 | NICORETTE ICE MINT 4 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 4 mg CHICLES MEDICAMENTOSOS, 105 chicles | 4 mg | 5 | 105 | 9 | 105 chicles | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72517/72517_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72517/72517_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2010-07-13 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665749 | 96016005 | NORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | NORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 100 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96016005/96016005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96016005/96016005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 665779 | 08494003 | STELARA 45 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | STELARA 45 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08494003/08494003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08494003/08494003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2010-03-23 | 1 | 1 | 1 | 2010-03-23 | 2010-03-23 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665782 | 10612002 | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612002/10612002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612002/10612002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665783 | 10612005 | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612005/10612005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612005/10612005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665787 | 08479001 | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 210 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479001/08479001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479001/08479001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | 2495 | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665788 | 08479002 | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 300 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479002/08479002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479002/08479002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | 2495 | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665789 | 08479003 | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 405 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479003/08479003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479003/08479003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | 2495 | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665806 | 10628001 | VOTRIENT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VOTRIENT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 200 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10628001/10628001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10628001/10628001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2010-07-14 | 1 | 1 | 1 | 2010-07-14 | 2010-07-14 | 1 | 2011-03-31 | View Edit Delete | ||||||||||||
| 665807 | 10628004 | VOTRIENT 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VOTRIENT 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 400 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10628004/10628004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10628004/10628004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2010-07-14 | 1 | 1 | 1 | 2010-07-14 | 2010-07-14 | 1 | 2011-03-31 | View Edit Delete | ||||||||||||
| 665856 | 110631002 | NIVESTIM 12 MU/0,2 ml SOLUCION INYECTABLE O PARA PERFUSION | NIVESTIM 12 MU/0,2 ml SOLUCION INYECTABLE O PARA PERFUSION, 5 jeringas precargadas de 0,2 ml | 12 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631002/110631002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631002/110631002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2010-10-19 | 1 | 2023-11-27 | View Edit Delete | ||||||||||||
| 665857 | 110631005 | NIVESTIM 30 MU/0,5 ml SOLUCION INYECTABLE Y PARA PERFUSION | NIVESTIM 30 MU/0,5 ml SOLUCION INYECTABLE Y PARA PERFUSION , 5 jeringas precargadas de 0,5 ml | 30 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631005/110631005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631005/110631005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2010-10-19 | 1 | 2023-11-27 | View Edit Delete | ||||||||||||
| 665858 | 110631008 | NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION | NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION, 5 jeringas precargadas de 0,5 ml | 48 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631008/110631008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631008/110631008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2010-10-19 | 1 | 2023-11-27 | View Edit Delete | ||||||||||||
| 665878 | 07437003 | IVEMEND 150 MG POLVO PARA SOLUCION PARA PERFUSION | IVEMEND 150 MG POLVO PARA SOLUCION PARA PERFUSION , 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07437003/07437003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07437003/07437003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 69623 | 2010-10-04 | 1 | 1 | 1 | 2010-10-04 | 2010-10-04 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 665955 | 07440005 | TYVERB 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TYVERB 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 140 comprimidos | 250 mg | 6 | 140 | 10 | 140 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07440005/07440005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07440005/07440005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2011-03-16 | 1 | 1 | 1 | 2011-03-16 | 2011-03-16 | 1 | 2012-01-23 | View Edit Delete | ||||||||||||
| 665971 | 07410047 | BINOCRIT 20.000 UI/0,5 ml SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT 20.000 UI/0,5 ml SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 20.000 UI inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410047/07410047_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410047/07410047_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 1092 | 2011-03-23 | 1 | 1 | 1 | 2011-03-23 | 2011-03-23 | 1 | 2012-03-22 | View Edit Delete | ||||||||||||
| 665973 | 07410051 | BINOCRIT 40.000 UI/1 ml SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT 40.000 UI/1 ml SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA , 1 jeringa precargada de 1 ml | 40.000 UI inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410051/07410051_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410051/07410051_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 1092 | 2011-03-23 | 1 | 1 | 1 | 2011-03-28 | 2011-03-28 | 1 | 2013-10-21 | View Edit Delete | ||||||||||||
| 666107 | 59166 | DALSY 20 mg/ml SUSPENSION ORAL | DALSY 20 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59166/59166_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59166/59166_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 1991-12-01 | 1 | 1 | 1 | 1991-12-01 | 1997-10-01 | 1 | 2012-01-09 | 880419, 684217 | View Edit Delete | |||||||||||
| 667213 | 71799 | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 10 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71799/71799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71799/71799_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | 11622 | 2010-04-13 | 1 | 1 | 1 | 2010-04-13 | 2010-04-13 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 667214 | 71799 | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 10 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71799/71799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71799/71799_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | 11622 | 2010-04-13 | 1 | 1 | 1 | 2010-04-13 | 2010-04-13 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 667451 | 61744 | PREVENCOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61744/61744_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61744/61744_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2001-02-27 | 1 | 1 | 1 | 2001-02-27 | 2001-02-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 667469 | 61743 | PREVENCOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61743/61743_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61743/61743_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2001-03-02 | 1 | 1 | 1 | 2001-03-02 | 2001-03-02 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 667585 | 71370 | TAMSULOSINA TECNIGEN 0,4 mg CAPSULAS DE LIBERACION PROLONGADA EFG | TAMSULOSINA TECNIGEN 0,4 mg CAPSULAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71370/71370_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71370/71370_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2010-12-15 | 1 | 1 | 1 | 2010-12-15 | 2010-12-15 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 667709 | 61728 | ENTOCORD 3 mg CAPSULAS DE LIBERACION MODIFICADA | ENTOCORD 3 mg CAPSULAS DE LIBERACION MODIFICADA, 50 cápsulas | 3 mg | 6 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61728/61728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61728/61728_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 20368 | 71054 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 667865 | 61718 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61718/61718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61718/61718_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2000-11-14 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 667873 | 61717 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61717/61717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61717/61717_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2000-11-14 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 668001 | 72022 | DROSIANELLE 3 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANELLE 3 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 63 (3 x 21) comprimidos | 3 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72022/72022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72022/72022_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-05-10 | 1 | 1 | 1 | 2011-05-10 | 2011-05-10 | 1 | 2012-03-06 | View Edit Delete | ||||||||||||
| 668005 | 71747 | DROSIANE 3 MG/0.03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANE 3 MG/0.03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71747/71747_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71747/71747_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-05-10 | 1 | 1 | 1 | 2011-05-10 | 2011-05-10 | 1 | 2012-01-24 | View Edit Delete | ||||||||||||
| 668006 | 71747 | DROSIANE 3 MG/0.03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANE 3 MG/0.03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 63 (3 x 21) comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71747/71747_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71747/71747_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-05-10 | 1 | 1 | 1 | 2011-05-10 | 2011-05-10 | 1 | 2012-01-24 | View Edit Delete | ||||||||||||
| 668019 | 72025 | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72025/72025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72025/72025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-07-07 | 1 | 2011-07-05 | View Edit Delete | ||||||||||||
| 668024 | 72027 | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72027/72027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72027/72027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-07-07 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 668027 | 72028 | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72028/72028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72028/72028_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668028 | 72028 | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72028/72028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72028/72028_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668031 | 72031 | DROSURE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72031/72031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72031/72031_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668032 | 72031 | DROSURE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72031/72031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72031/72031_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668035 | 72032 | DROSIANELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72032/72032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72032/72032_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2012-01-24 | View Edit Delete | ||||||||||||
| 668036 | 72032 | DROSIANELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72032/72032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72032/72032_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2012-03-06 | View Edit Delete | ||||||||||||
| 668040 | 72033 | DROSIANE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72033/72033_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72033/72033_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2012-01-24 | View Edit Delete | ||||||||||||
| 668041 | 72033 | DROSIANE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSIANE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72033/72033_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72033/72033_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2012-01-24 | View Edit Delete | ||||||||||||
| 668050 | 72035 | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72035/72035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72035/72035_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-07-05 | 1 | 2011-07-05 | View Edit Delete | ||||||||||||
| 668065 | 72037 | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72037/72037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72037/72037_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668066 | 72037 | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72037/72037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72037/72037_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668073 | 72039 | DROSURELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72039/72039_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72039/72039_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668074 | 72039 | DROSURELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72039/72039_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72039/72039_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 668327 | 61697 | TRINIPATCH 15 mg/ 24 HORAS PARCHES TRANSDÉRMICOS | TRINIPATCH 15 mg/ 24 HORAS PARCHES TRANSDÉRMICOS, 30 parches | 15 mg/24 h | 3 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61697/61697_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61697/61697_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4115 | 4115 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 668335 | 61696 | TRINIPATCH 10 mg/ 24 HORAS PARCHES TRANSDÉRMICOS | TRINIPATCH 10 mg/ 24 HORAS PARCHES TRANSDÉRMICOS, 30 parches | 10 mg/24 h | 3 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61696/61696_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61696/61696_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4115 | 4115 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 668343 | 61695 | TRINIPATCH 5 mg/24 HORAS PARCHES TRANSDÉRMICOS | TRINIPATCH 5 mg/24 HORAS PARCHES TRANSDÉRMICOS, 30 parches | 5 mg/24 h | 3 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61695/61695_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61695/61695_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4115 | 4115 | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 668830 | 61670 | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 45 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61670/61670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61670/61670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 668889 | 61665 | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE, 1 vial + 1 ampolla de disolvente | 11,25 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61665/61665_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61665/61665_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68629 | 68629 | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 669051 | 61656 | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61656/61656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61656/61656_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-08 | 1 | 1 | 1 | 2000-11-08 | 2000-11-08 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 669069 | 61655 | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61655/61655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61655/61655_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2000-11-08 | 1 | 1 | 1 | 2000-11-08 | 2000-11-08 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 669632 | 72192 | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72192/72192_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72192/72192_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-07-05 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672326 | 72599 | ZARATOR 10 mg COMPRIMIDOS MASTICABLES | ZARATOR 10 mg COMPRIMIDOS MASTICABLES , 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72599/72599_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72599/72599_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2010-07-30 | 1 | 1 | 1 | 2010-07-30 | 2010-07-30 | 1 | 2012-01-20 | View Edit Delete | ||||||||||||
| 672327 | 72601 | ZARATOR 20 mg COMPRIMIDOS MASTICABLES | ZARATOR 20 mg COMPRIMIDOS MASTICABLES , 30 comprimidos | 20 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72601/72601_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72601/72601_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2010-07-30 | 1 | 1 | 1 | 2010-07-30 | 2010-07-30 | 1 | 2012-01-20 | View Edit Delete | ||||||||||||
| 672370 | 72025 | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72025/72025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72025/72025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672371 | 72027 | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72027/72027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72027/72027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672372 | 72035 | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72035/72035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72035/72035_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672373 | 72192 | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72192/72192_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72192/72192_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-08-09 | 1 | 2011-07-05 | View Edit Delete | ||||||||||||
| 672736 | 72902 | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72902/72902_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72902/72902_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2010-10-21 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 672737 | 72902 | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72902/72902_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72902/72902_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2010-10-21 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 672738 | 72903 | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72903/72903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72903/72903_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2010-10-21 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 672739 | 72903 | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72903/72903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72903/72903_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2010-10-21 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 672988 | 71268 | LOBIVON PLUS 5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOBIVON PLUS 5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71268/71268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71268/71268_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1803 | 2009-07-24 | 1 | 1 | 1 | 2009-07-24 | 2011-07-14 | 1 | 2011-10-14 | 663681 | View Edit Delete | |||||||||||
| 672989 | 71267 | LOBIVON PLUS 5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOBIVON PLUS 5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71267/71267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71267/71267_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1803 | 2009-07-23 | 1 | 1 | 1 | 2009-07-23 | 2011-07-14 | 1 | 2011-10-14 | 663683 | View Edit Delete | |||||||||||
| 672990 | 71256 | SILOSTAR PLUS 5mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SILOSTAR PLUS 5mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71256/71256_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71256/71256_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1242 | 2009-07-21 | 1 | 1 | 1 | 2009-07-21 | 2011-09-01 | 1 | 2011-10-14 | 663692 | View Edit Delete | |||||||||||
| 672991 | 71255 | SILOSTAR PLUS 5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SILOSTAR PLUS 5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71255/71255_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71255/71255_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1242 | 2009-07-21 | 1 | 1 | 1 | 2009-07-21 | 2011-09-01 | 1 | 2011-10-14 | 663693 | View Edit Delete | |||||||||||
| 673034 | 72281 | ATORVASTATINA MABO 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72281/72281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72281/72281_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2011-06-13 | 1 | 2013-01-03 | 665313 | View Edit Delete | |||||||||||
| 673035 | 72282 | ATORVASTATINA MABO 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72282/72282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72282/72282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2011-06-13 | 1 | 2013-01-03 | 665312 | View Edit Delete | |||||||||||
| 673036 | 72283 | ATORVASTATINA MABO 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72283/72283_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72283/72283_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2011-06-13 | 1 | 2013-01-03 | 665311 | View Edit Delete | |||||||||||
| 673232 | 72145 | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72145/72145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72145/72145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2011-08-08 | 1 | 2011-09-27 | 673607 | View Edit Delete | |||||||||||
| 673244 | 61448 | OPIREN 15 mg CAPSULAS | OPIREN 15 mg CAPSULAS , 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61448/61448_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61448/61448_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 1997-04-01 | 1 | 1 | 1 | 1997-04-01 | 1997-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673261 | 64186 | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (blister) | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64186/64186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64186/64186_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-08-17 | 1 | 1 | 1 | 2001-08-17 | 2011-08-18 | 1 | 2012-10-16 | 926428 | View Edit Delete | |||||||||||
| 673413 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673414 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 7 ml | 20 mg/ml inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673467 | 61428 | LOBIVON 5 mg COMPRIMIDOS | LOBIVON 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61428/61428_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61428/61428_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1803 | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 673475 | 61427 | SILOSTAR 5 mg COMPRIMIDOS | SILOSTAR 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61427/61427_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61427/61427_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 1242 | 2000-02-09 | 1 | 1 | 1 | 2000-02-09 | 2000-02-09 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 673483 | 61426 | OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA | OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA , 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61426/61426_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61426/61426_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40569 | 40569 | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 1997-05-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 673606 | 72146 | OMEPRAZOL AUROVITAS SPAIN 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL AUROVITAS SPAIN 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72146/72146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72146/72146_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2011-03-15 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673622 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2011-03-16 | 1 | 2015-08-11 | View Edit Delete | ||||||||||||
| 673623 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2011-03-16 | 1 | 2016-04-07 | View Edit Delete | ||||||||||||
| 673988 | 61390 | TARMED 40 MG/G CHAMPÚ | TARMED 40 MG/G CHAMPÚ , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61390/61390_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61390/61390_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21062 | 70368 | 1997-02-01 | 1 | 1 | 1 | 1997-02-01 | 1997-02-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 674751 | 72679 | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72679/72679_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72679/72679_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2011-07-15 | 1 | 1 | 1 | 2011-07-15 | 2011-07-15 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 674753 | 72679 | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72679/72679_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72679/72679_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2011-07-15 | 1 | 1 | 1 | 2011-07-15 | 2011-07-15 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 676097 | 73748 | EXEMESTANO NORMON 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO NORMON 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73748/73748_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73748/73748_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2011-03-29 | 1 | 1 | 1 | 2011-03-29 | 2011-03-29 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 676229 | 73005 | SETOFILM 4 mg PELICULAS BUCODISPERSABLES EFG | SETOFILM 4 mg PELICULAS BUCODISPERSABLES EFG , 10 sobres | 4 mg | 35 | 10 | 10 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73005/73005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73005/73005_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 67164 | 67164 | 2012-05-10 | 1 | 1 | 1 | 2012-05-10 | 2012-05-10 | 1 | 2013-12-16 | View Edit Delete | ||||||||||||
| 676232 | 73006 | SETOFILM 8 mg PELICULAS BUCODISPERSABLES EFG | SETOFILM 8 mg PELICULAS BUCODISPERSABLES EFG , 10 sobres | 8 mg | 35 | 10 | 10 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73006/73006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73006/73006_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 67164 | 67164 | 2012-05-10 | 1 | 1 | 1 | 2012-05-10 | 2012-05-10 | 1 | 2013-12-16 | View Edit Delete | ||||||||||||
| 676735 | 73182 | VIMOVO 500 mg/20 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VIMOVO 500 mg/20 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 60 comprimidos | 500 mg/20 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73182/73182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73182/73182_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-07-15 | View Edit Delete | ||||||||||||
| 677306 | 73273 | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73273/73273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73273/73273_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-01-10 | 1 | 1 | 1 | 2025-04-14 | 2025-04-14 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 677337 | 73773 | ATORVASTATINA COMBIX 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73773/73773_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73773/73773_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2011-03-31 | 1 | 1 | 1 | 2011-03-31 | 2011-03-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677358 | 73776 | ATORVASTATINA COMBIX 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73776/73776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73776/73776_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2011-03-31 | 1 | 1 | 1 | 2011-03-31 | 2011-03-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677365 | 73778 | ATORVASTATINA COMBIX 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73778/73778_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73778/73778_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2011-03-31 | 1 | 1 | 1 | 2011-03-31 | 2011-03-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677384 | 73779 | ATORVASTATINA COMBIX 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73779/73779_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73779/73779_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2011-03-31 | 1 | 1 | 1 | 2011-03-31 | 2011-03-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677730 | 11687002 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 5 ml | 200 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687002/11687002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687002/11687002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2012-07-31 | View Edit Delete | ||||||||||||
| 677734 | 11687005 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 10 ml | 200 mg/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687005/11687005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687005/11687005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 677742 | 11687012 | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, 20 viales de 20 ml | 4 g inyectable 20 ml | 45 | 20 | 34 | 20 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687012/11687012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687012/11687012_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 677745 | 07434003IP | AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL | AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 34 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07434003IP/07434003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07434003IP/07434003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4679 | 18672 | 2011-09-13 | 1 | 1 | 1 | 2011-09-13 | 2011-09-13 | 1 | 2013-09-12 | View Edit Delete | ||||||||||||
| 678200 | 73001 | CICLOPIROX OLAMINA CAPITEC 15 mg/g CHAMPU | CICLOPIROX OLAMINA CAPITEC 15 mg/g CHAMPU, 1 frasco de 100 ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73001/73001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73001/73001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 2010-11-12 | 1 | 1 | 1 | 2010-11-12 | 2010-11-12 | 1 | 2012-09-13 | View Edit Delete | ||||||||||||
| 678607 | 63625 | ETOPÓSIDO SANDOZ 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG | ETOPÓSIDO SANDOZ 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG , 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63625/63625_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63625/63625_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2001-01-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 678883 | 73308 | MEDIKINET 5 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 5 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73308/73308_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73308/73308_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2011-06-07 | 1 | 1 | 1 | 2011-06-07 | 2011-06-07 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 678887 | 73312 | RABEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | RABEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73312/73312_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73312/73312_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-08-03 | 1 | 1 | 1 | 2012-10-02 | 2012-10-02 | 1 | 2012-11-14 | View Edit Delete | ||||||||||||
| 679300 | 73591 | LEVOFLOXACINO MABO-FARMA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOFLOXACINO MABO-FARMA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 7 comprimidos | 500 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73591/73591_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73591/73591_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2019-12-11 | 1 | 1 | 1 | 2019-12-11 | 2019-12-11 | 1 | 2020-10-06 | View Edit Delete | ||||||||||||
| 679403 | 73827 | ATORVASTATINA TARBIS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73827/73827_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73827/73827_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679404 | 73828 | ATORVASTATINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73828/73828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73828/73828_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679408 | 73830 | ATORVASTATINA TARBIS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73830/73830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73830/73830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679411 | 73832 | ATORVASTATINA TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73832/73832_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73832/73832_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679561 | 73872 | DEFLAZACORT CINFA 6 mg COMPRIMIDOS EFG | DEFLAZACORT CINFA 6 mg COMPRIMIDOS EFG, 20 comprimidos | 6 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73872/73872_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73872/73872_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | 684 | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679562 | 73873 | DEFLAZACORT CINFA 30 mg COMPRIMIDOS EFG | DEFLAZACORT CINFA 30 mg COMPRIMIDOS EFG, 10 comprimidos | 30 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73873/73873_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73873/73873_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | 684 | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679726 | 73919 | PLANTAGO OVATA LAINCO 3,5 g POLVO PARA SUSPENSION ORAL | PLANTAGO OVATA LAINCO 3,5 g POLVO PARA SUSPENSION ORAL, 30 sobres | 3.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73919/73919_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73919/73919_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | 1614 | 2011-04-19 | 1 | 1 | 1 | 2011-04-19 | 2011-04-19 | 1 | 2011-11-07 | View Edit Delete | ||||||||||||
| 679734 | 73926 | NEBIVOLOL CINFA 5 mg COMPRIMIDOS EFG | NEBIVOLOL CINFA 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73926/73926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73926/73926_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-04-19 | 1 | 1 | 1 | 2011-04-19 | 2011-04-19 | 1 | 2011-09-05 | View Edit Delete | ||||||||||||
| 679764 | 73938 | TRANALEX 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRANALEX 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73938/73938_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73938/73938_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2011-04-25 | 1 | 1 | 1 | 2011-04-25 | 2011-04-25 | 1 | 2011-11-02 | View Edit Delete | ||||||||||||
| 679951 | 61051 | TRIALMIN 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TRIALMIN 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 900 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61051/61051_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61051/61051_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1803 | 1803 | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 679969 | 61050 | ZAMENE 22,75 mg/ml GOTAS ORALES EN SUSPENSION | ZAMENE 22,75 mg/ml GOTAS ORALES EN SUSPENSION , 1 frasco de 13 ml | 22,75 mg/ml | 6 | 13 | 26 | 1 frasco de 13 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61050/61050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61050/61050_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1803 | 1803 | 1996-11-01 | 1 | 1 | 1 | 1996-11-01 | 1996-11-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 679977 | 61049 | DEZACOR 22,75 mg/ml GOTAS ORALES EN SUSPENSION | DEZACOR 22,75 mg/ml GOTAS ORALES EN SUSPENSION, 1 frasco de 13 ml | 22,75 mg/ml | 6 | 13 | 26 | 1 frasco de 13 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61049/61049_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61049/61049_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41329 | 5101 | 1996-11-01 | 1 | 1 | 1 | 1996-11-01 | 1996-11-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 680348 | 61026 | LOPID 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOPID 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 900 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61026/61026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61026/61026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11622 | 11622 | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 680422 | 74056 | CARBOCAL D 600 mg/400 UI COMPRIMIDOS MASTICABLES SABOR NARANJA | CARBOCAL D 600 mg/400 UI COMPRIMIDOS MASTICABLES SABOR NARANJA, 60 comprimidos | 1.500 mg (600 mg Ca)/400 UI | 71 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74056/74056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74056/74056_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | 5478 | 2011-05-17 | 1 | 1 | 1 | 2011-05-17 | 2011-05-17 | 1 | 2020-11-10 | View Edit Delete | ||||||||||||
| 680759 | 74095 | PROCRIN SEMESTRAL 30 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA | PROCRIN SEMESTRAL 30 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de doble cámara | 30 mg | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74095/74095_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74095/74095_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16052 | 16052 | 2011-05-20 | 1 | 1 | 1 | 2011-05-20 | 2011-05-20 | 1 | 2012-01-12 | View Edit Delete | ||||||||||||
| 681197 | 60976 | NERDIPINA RETARD 40 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | NERDIPINA RETARD 40 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 60 cápsulas | 40 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60976/60976_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60976/60976_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 1996-10-01 | 1 | 1 | 1 | 1996-10-01 | 1996-10-01 | 1 | 2011-03-18 | View Edit Delete | ||||||||||||
| 681372 | 74275 | ACIDO ACETILSALICILICO AUROVITAS SPAIN 100 mg COMPRIMIDOS GASTRORRESISTENTES | ACIDO ACETILSALICILICO AUROVITAS SPAIN 100 mg COMPRIMIDOS GASTRORRESISTENTES , 30 comprimidos | 100 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74275/74275_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74275/74275_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | 16109 | 2011-11-17 | 1 | 1 | 1 | 2011-11-17 | 2011-11-17 | 1 | 2012-10-22 | View Edit Delete | ||||||||||||
| 681990 | 74409 | TRAMADOL/ PARACETAMOL KERN PHARMA 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/ PARACETAMOL KERN PHARMA 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 37,5 mg/325 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74409/74409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74409/74409_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-07-14 | 1 | 1 | 1 | 2011-07-14 | 2011-07-14 | 1 | 2012-10-10 | View Edit Delete | ||||||||||||
| 681991 | 74409 | TRAMADOL/ PARACETAMOL KERN PHARMA 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/ PARACETAMOL KERN PHARMA 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74409/74409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74409/74409_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-07-14 | 1 | 1 | 1 | 2011-07-14 | 2011-07-14 | 1 | 2020-12-10 | View Edit Delete | ||||||||||||
| 682084 | 11698002 | YERVOY 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | YERVOY 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11698002/11698002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11698002/11698002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2011-07-19 | 1 | 1 | 1 | 2011-07-19 | 2011-07-19 | 1 | 2012-10-22 | View Edit Delete | ||||||||||||
| 682096 | 60920 | REACTINE LEVOCABASTINA 0,5mg/ml COLIRIO EN SUSPENSION | REACTINE LEVOCABASTINA 0,5mg/ml COLIRIO EN SUSPENSION , 1 frasco de 4 ml | 0,5 mg/ml | 6 | 4 | 26 | 1 frasco de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60920/60920_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60920/60920_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 682120 | 60917 | BILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓN | BILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓN, 1 frasco de 4 ml | 0,5 mg/ml | 6 | 4 | 26 | 1 frasco de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60917/60917_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60917/60917_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | 29206 | 1996-07-01 | 1 | 1 | 1 | 1996-07-01 | 1996-07-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 682152 | 11698001 | YERVOY 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | YERVOY 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11698001/11698001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11698001/11698001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2011-07-19 | 1 | 1 | 1 | 2011-07-19 | 2011-07-19 | 1 | 2012-10-22 | View Edit Delete | ||||||||||||
| 682490 | 74475 | LANSOPRAZOL VIATRIS 15 MG CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIATRIS 15 MG CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74475/74475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74475/74475_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2011-11-07 | 1 | 1 | 1 | 2015-02-23 | 2015-02-23 | 1 | 2015-07-30 | View Edit Delete | ||||||||||||
| 682512 | 74476 | LANSOPRAZOL VIATRIS 30 MG CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIATRIS 30 MG CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74476/74476_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74476/74476_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2011-11-07 | 1 | 1 | 1 | 2015-02-23 | 2015-02-23 | 1 | 2015-08-26 | View Edit Delete | ||||||||||||
| 682676 | 74511 | CLOPERASTINA KERN PHARMA 3,54 mg/ml JARABE | CLOPERASTINA KERN PHARMA 3,54 mg/ml JARABE, 1 frasco de 200 ml | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74511/74511_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74511/74511_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-08-01 | 1 | 1 | 1 | 2011-08-01 | 2011-08-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 682755 | 74522 | EXEMESTANO VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74522/74522_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74522/74522_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2011-10-05 | 1 | 1 | 1 | 2011-10-05 | 2011-10-05 | 1 | 2012-02-28 | View Edit Delete | ||||||||||||
| 683043 | 11700002 | BENLYSTA 400 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | BENLYSTA 400 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 400 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/11700002/11700002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11700002/11700002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30289 | 3732 | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2011-11-22 | View Edit Delete | ||||||||||||
| 683044 | 11700001 | BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 120 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/11700001/11700001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11700001/11700001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30289 | 3732 | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2011-11-22 | View Edit Delete | ||||||||||||
| 683680 | 54723 | TRANGOREX 150 mg / 3 ml SOLUCION INYECTABLE | TRANGOREX 150 mg / 3 ml SOLUCION INYECTABLE , 6 ampollas de 3 ml | 150 mg | 1 | 6 | 1 | 6 ampollas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54723/54723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54723/54723_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40842 | 40842 | 1980-04-01 | 1 | 1 | 1 | 1980-04-01 | 1995-06-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 683756 | 74670 | IBUPROFENO FARMALID 20 mg/ml SUSPENSION ORAL. EFG | IBUPROFENO FARMALID 20 mg/ml SUSPENSION ORAL. EFG, 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74670/74670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74670/74670_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | 8730 | 2011-09-08 | 1 | 1 | 1 | 2011-09-08 | 2011-09-08 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 683758 | 74672 | IBUPROFENO CODRAMOL 20 mg / ml SUSPENSION ORAL EFG | IBUPROFENO CODRAMOL 20 mg / ml SUSPENSION ORAL EFG , 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74672/74672_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74672/74672_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | 8730 | 2011-09-08 | 1 | 1 | 1 | 2011-09-08 | 2011-09-08 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 683809 | 74684 | ATORIS 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORIS 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74684/74684_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74684/74684_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2012-05-10 | 1 | 1 | 1 | 2012-05-10 | 2012-05-10 | 1 | 2016-02-15 | View Edit Delete | ||||||||||||
| 683825 | 74685 | ATORIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74685/74685_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74685/74685_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2012-05-10 | 1 | 1 | 1 | 2012-05-10 | 2012-05-10 | 1 | 2012-09-11 | View Edit Delete | ||||||||||||
| 684093 | 74711 | VALACICLOVIR ALMUS 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR ALMUS 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 1.000 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74711/74711_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74711/74711_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2011-09-14 | 1 | 1 | 1 | 2011-09-14 | 2011-09-14 | 1 | 2012-06-21 | View Edit Delete | ||||||||||||
| 684103 | 74717 | VALACICLOVIR TECNIGEN 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR TECNIGEN 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 1.000 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74717/74717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74717/74717_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2011-09-16 | 1 | 1 | 1 | 2011-09-16 | 2011-09-16 | 1 | 2012-03-27 | View Edit Delete | ||||||||||||
| 684155 | 99103006 | REFACTO AF 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | REFACTO AF 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de doble cámara | 500 UI | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99103006/99103006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99103006/99103006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2011-09-20 | 1 | 1 | 1 | 2011-09-20 | 2011-09-20 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 684156 | 99103007 | REFACTO AF 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | REFACTO AF 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de doble cámara | 1.000 UI | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99103007/99103007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99103007/99103007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2011-09-20 | 1 | 1 | 1 | 2011-09-20 | 2011-09-20 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 684157 | 99103008 | REFACTO AF 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | REFACTO AF 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de doble cámara | 2.000 UI | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99103008/99103008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99103008/99103008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2011-09-20 | 1 | 1 | 1 | 2011-09-20 | 2011-09-20 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 684158 | 99103005 | REFACTO AF 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | REFACTO AF 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de doble cámara | 3.000 UI | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99103005/99103005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99103005/99103005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2011-09-20 | 1 | 1 | 1 | 2011-09-20 | 2011-09-20 | 1 | 2012-06-08 | View Edit Delete | ||||||||||||
| 684399 | 60783 | MAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORAL | MAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORAL, 1 frasco de 240 ml | 40 mg/ml | 6 | 240 | 26 | 1 frasco de 240 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60783/60783_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60783/60783_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | 39759 | 1996-07-01 | 1 | 1 | 1 | 2016-10-10 | 2016-10-10 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 685298 | 74921 | EXEMESTANO DESGEN 25 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EXEMESTANO DESGEN 25 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74921/74921_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74921/74921_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7735 | 7735 | 2011-11-21 | 1 | 1 | 1 | 2015-01-15 | 2015-01-15 | 1 | 2017-05-22 | View Edit Delete | ||||||||||||
| 685461 | 58281 | TUBERCULINA PPD EVANS 2 UT/0,1 ml SOLUCION INYECTABLE. | TUBERCULINA PPD EVANS 2 UT/0,1 ml SOLUCION INYECTABLE., 1 vial de 1,5 ml | 2 UT/0,1 ml inyectable 1,5 ml | 45 | 15 | 45 | 1 vial de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58281/58281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58281/58281_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23742 | 15963 | 1990-06-01 | 1 | 1 | 1 | 1990-06-01 | 1995-03-01 | 1 | 2011-05-04 | View Edit Delete | ||||||||||||
| 686033 | 75057 | ESOMEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75057/75057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75057/75057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2024-02-22 | View Edit Delete | ||||||||||||
| 686037 | 75059 | ESOMEPRAZOL AUROVITAS SPAIN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL AUROVITAS SPAIN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 40 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75059/75059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75059/75059_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2024-02-22 | View Edit Delete | ||||||||||||
| 686041 | 75061 | ESOMEPRAZOL ALTER 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALTER 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75061/75061_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75061/75061_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 686069 | 75067 | ESOMEPRAZOL ALTER 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALTER 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 40 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75067/75067_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75067/75067_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 686072 | 75068 | ESOMEPRAZOL KERN PHARMA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL KERN PHARMA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75068/75068_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75068/75068_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2018-06-22 | View Edit Delete | ||||||||||||
| 686077 | 75071 | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos (BLISTER) | 20 mg | 5 | 14 | 10 | 14 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75071/75071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75071/75071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 686078 | 75071 | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75071/75071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75071/75071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 686082 | 75073 | ESOMEPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos (BLISTER) | 40 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75073/75073_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75073/75073_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2018-06-22 | View Edit Delete | ||||||||||||
| 686083 | 75074 | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos (BLISTER) | 40 mg | 5 | 14 | 10 | 14 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75074/75074_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75074/75074_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 686084 | 75074 | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 40 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75074/75074_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75074/75074_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-03-07 | View Edit Delete | ||||||||||||
| 686086 | 75075 | ESOMEPRAZOL PENSA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75075/75075_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75075/75075_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-01-31 | View Edit Delete | ||||||||||||
| 686088 | 75076 | ESOMEPRAZOL PENSA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 40 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75076/75076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75076/75076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-01-31 | View Edit Delete | ||||||||||||
| 686211 | 11717001 | VYNDAQEL 20 MG CAPSULAS BLANDAS | VYNDAQEL 20 MG CAPSULAS BLANDAS, 30 x 1 cápsulas (unidosis) | 20 mg | 5 | 30 | 43 | 30 x 1 cápsulas (unidosis) | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/11717001/11717001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11717001/11717001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29446 | 11622 | 2011-11-30 | 1 | 1 | 1 | 2011-11-30 | 2011-11-30 | 1 | 2013-11-29 | View Edit Delete | ||||||||||||
| 686296 | 75114 | CICLOPIROX OLAMINA ISDIN 15 MG/G CHAMPU | CICLOPIROX OLAMINA ISDIN 15 MG/G CHAMPU , 1 frasco de 100 ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75114/75114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75114/75114_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 2011-11-30 | 1 | 1 | 1 | 2011-11-30 | 2011-11-30 | 1 | 2012-05-21 | View Edit Delete | ||||||||||||
| 687025 | 75279 | QUETIAPINA TEVA-RATIO 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TEVA-RATIO 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75279/75279_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75279/75279_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2012-03-07 | 1 | 1 | 1 | 2012-03-07 | 2012-03-07 | 1 | 2013-12-20 | View Edit Delete | ||||||||||||
| 687034 | 75280 | QUETIAPINA TEVA-RATIO 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TEVA-RATIO 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75280/75280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75280/75280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2012-03-07 | 1 | 1 | 1 | 2012-03-07 | 2012-03-07 | 1 | 2013-12-20 | View Edit Delete | ||||||||||||
| 687044 | 75281 | QUETIAPINA TEVA-RATIO 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TEVA-RATIO 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75281/75281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75281/75281_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2012-03-07 | 1 | 1 | 1 | 2012-03-07 | 2012-03-07 | 1 | 2013-12-20 | View Edit Delete | ||||||||||||
| 687055 | 75282 | QUETIAPINA TEVA-RATIO 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TEVA-RATIO 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75282/75282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75282/75282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2012-03-07 | 1 | 1 | 1 | 2012-03-07 | 2012-03-07 | 1 | 2013-12-20 | View Edit Delete | ||||||||||||
| 687405 | 75369 | VALACICLOVIR AUROVITAS 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR AUROVITAS 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 10 comprimidos | 500 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75369/75369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75369/75369_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2012-08-02 | 1 | 1 | 1 | 2012-08-02 | 2012-08-02 | 1 | 2018-04-09 | View Edit Delete | ||||||||||||
| 687408 | 75369 | VALACICLOVIR AUROVITAS 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR AUROVITAS 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 42 comprimidos | 500 mg | 5 | 42 | 10 | 42 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75369/75369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75369/75369_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2012-08-02 | 1 | 1 | 1 | 2012-08-02 | 2012-08-02 | 1 | 2018-04-09 | View Edit Delete | ||||||||||||
| 687416 | 75370 | VALACICLOVIR AUROVITAS 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALACICLOVIR AUROVITAS 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 21 comprimidos | 1.000 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75370/75370_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75370/75370_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2012-08-02 | 1 | 1 | 1 | 2012-08-02 | 2012-08-02 | 1 | 2020-10-29 | View Edit Delete | ||||||||||||
| 687438 | 75380 | CICLOPIROX OLAMINA SERRA 15 mg/g CHAMPU | CICLOPIROX OLAMINA SERRA 15 mg/g CHAMPU, 1 frasco de 100 ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75380/75380_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75380/75380_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | 2616 | 2012-02-03 | 1 | 1 | 1 | 2012-02-03 | 2012-02-03 | 1 | 2012-10-30 | View Edit Delete | ||||||||||||
| 687660 | 75423 | GASTROLUX 370 mg/ml SOLUCION ORAL Y RECTAL EFG | GASTROLUX 370 mg/ml SOLUCION ORAL Y RECTAL EFG, 10 frascos de 100 ml | 100 mg/ml + 660 mg/ml | 71 | 1000 | 26 | 10 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75423/75423_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75423/75423_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20219 | 20219 | 2012-02-08 | 1 | 1 | 1 | 2012-02-08 | 2012-02-08 | 1 | 2012-06-04 | View Edit Delete | ||||||||||||
| 687892 | 75474 | RABEPRAZOL COMBIX 10 mg COMPRIMIDOS GASTRORRESISTENTES EFG | RABEPRAZOL COMBIX 10 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75474/75474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75474/75474_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2012-02-16 | 1 | 1 | 1 | 2012-02-16 | 2012-02-16 | 1 | 2013-01-31 | View Edit Delete | ||||||||||||
| 687895 | 75476 | RABEPRAZOL COMBIX 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | RABEPRAZOL COMBIX 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75476/75476_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75476/75476_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2012-02-16 | 1 | 1 | 1 | 2012-02-16 | 2012-02-16 | 1 | 2013-01-31 | View Edit Delete | ||||||||||||
| 687903 | 75481 | RABEPRAZOL QUALIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | RABEPRAZOL QUALIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75481/75481_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75481/75481_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2012-02-16 | 1 | 1 | 1 | 2012-02-16 | 2012-02-16 | 1 | 2012-11-26 | View Edit Delete | ||||||||||||
| 687957 | 75500 | QUETIAPINA CINFA 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA CINFA 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75500/75500_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75500/75500_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-03-27 | 1 | 1 | 1 | 2012-03-27 | 2012-03-27 | 1 | 2014-03-20 | View Edit Delete | ||||||||||||
| 687967 | 75501 | QUETIAPINA CINFA 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA CINFA 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75501/75501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75501/75501_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-03-27 | 1 | 1 | 1 | 2012-03-27 | 2012-03-27 | 1 | 2014-03-20 | View Edit Delete | ||||||||||||
| 687977 | 75502 | QUETIAPINA CINFA 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA CINFA 300 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75502/75502_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75502/75502_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-03-27 | 1 | 1 | 1 | 2012-03-27 | 2012-03-27 | 1 | 2014-03-20 | View Edit Delete | ||||||||||||
| 687986 | 75503 | QUETIAPINA CINFA 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA CINFA 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75503/75503_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75503/75503_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-03-27 | 1 | 1 | 1 | 2012-03-27 | 2012-03-27 | 1 | 2014-03-20 | View Edit Delete | ||||||||||||
| 688267 | 60583 | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 10000 UI/1 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 1 ml | 10.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60583/60583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60583/60583_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1995-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 688275 | 60582 | EPREX 4000 UI/0,4 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 4000 UI/0,4 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,4 ml | 4.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60582/60582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60582/60582_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1995-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 688283 | 60581 | EPREX 3000 UI/0,3 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 3000 UI/0,3 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,3 ml | 3.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60581/60581_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60581/60581_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1995-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 688291 | 60580 | EPREX 2000 UI/0,5 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 2000 UI/0,5 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,5 ml | 2.00 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60580/60580_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60580/60580_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1995-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 688309 | 60579 | EPREX 1000 UI/0,5 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | EPREX 1000 UI/0,5 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADAS , 6 jeringas precargadas de 0,5 ml | 1.000 UI | 33 | 6 | 61 | 6 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60579/60579_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60579/60579_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71027 | 71027 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1995-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 688585 | 75625 | WILATE 500 UI FvW/500 UI FVIII, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WILATE 500 UI FvW/500 UI FVIII, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 vial de disolvente | 500 UI/500 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75625/75625_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75625/75625_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30564 | 30564 | 2012-04-24 | 1 | 1 | 1 | 2012-04-24 | 2012-04-24 | 1 | 2015-03-13 | View Edit Delete | ||||||||||||
| 688714 | 75648 | WILATE 1000 UI FvW/1000 UI FVIII, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WILATE 1000 UI FvW/1000 UI FVIII, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 vial de disolvente | 1.000 UI/1.000 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75648/75648_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75648/75648_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30564 | 30564 | 2012-04-24 | 1 | 1 | 1 | 2012-04-24 | 2012-04-24 | 1 | 2013-03-27 | View Edit Delete | ||||||||||||
| 688913 | 75724 | EPLERENONA VIR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA VIR 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75724/75724_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75724/75724_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2012-05-08 | 1 | 1 | 1 | 2012-05-08 | 2012-05-08 | 1 | 2013-11-06 | View Edit Delete | ||||||||||||
| 688939 | 75725 | EPLERENONA VIR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA VIR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75725/75725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75725/75725_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2012-05-08 | 1 | 1 | 1 | 2012-05-08 | 2012-05-08 | 1 | 2013-11-06 | View Edit Delete | ||||||||||||
| 689115 | 75754 | EPLERENONA AUROVITAS SPAIN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA AUROVITAS SPAIN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75754/75754_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75754/75754_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2012-05-31 | 1 | 1 | 1 | 2012-05-31 | 2012-05-31 | 1 | 2012-10-19 | View Edit Delete | ||||||||||||
| 689128 | 75755 | EPLERENONA AUROVITAS SPAIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA AUROVITAS SPAIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75755/75755_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75755/75755_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2012-06-01 | 1 | 1 | 1 | 2012-06-01 | 2012-06-01 | 1 | 2012-10-19 | View Edit Delete | ||||||||||||
| 689679 | 60483 | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL , 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60483/60483_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60483/60483_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1997-11-01 | 1 | 1 | 1 | 1997-11-01 | 1997-11-03 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 690563 | 61464 | REQUIP 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | REQUIP 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 84 comprimidos | 0,25 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61464/61464_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61464/61464_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2012-05-28 | 1 | 2013-04-12 | View Edit Delete | ||||||||||||
| 691349 | 76056 | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76056/76056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76056/76056_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691350 | 76056 | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76056/76056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76056/76056_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691351 | 76057 | ETINILESTRADIOL/DROSPIRENONA STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76057/76057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76057/76057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691353 | 76057 | ETINILESTRADIOL/DROSPIRENONA STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76057/76057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76057/76057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691354 | 76058 | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76058/76058_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76058/76058_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691355 | 76058 | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 63 (3 x 21) comprimidos | 3 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76058/76058_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76058/76058_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691356 | 76059 | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76059/76059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76059/76059_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691357 | 76059 | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ETINILESTRADIOL/DROSPIRENONA DIARIO STADA 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76059/76059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76059/76059_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-06-03 | View Edit Delete | ||||||||||||
| 691454 | 76080 | ANTINELLE DIARIO 0,02 mg/3 mg COMPRIMIDOS CON PELICULA EFG | ANTINELLE DIARIO 0,02 mg/3 mg COMPRIMIDOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76080/76080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76080/76080_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2013-03-12 | View Edit Delete | ||||||||||||
| 691475 | 76087 | ANTIN 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANTIN 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76087/76087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76087/76087_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2013-03-12 | View Edit Delete | ||||||||||||
| 691476 | 76087 | ANTIN 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANTIN 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 63 (3 x 21) comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76087/76087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76087/76087_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2014-04-12 | View Edit Delete | ||||||||||||
| 691478 | 76088 | ANTIN DIARIO 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANTIN DIARIO 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76088/76088_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76088/76088_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2013-03-12 | View Edit Delete | ||||||||||||
| 691479 | 76088 | ANTIN DIARIO 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANTIN DIARIO 0,03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76088/76088_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76088/76088_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2014-04-08 | View Edit Delete | ||||||||||||
| 691480 | 76089 | ANTINELLE 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANTINELLE 0,02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76089/76089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76089/76089_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2013-03-12 | View Edit Delete | ||||||||||||
| 691713 | 12769001 | DOCETAXEL ACCORD 20 mg/1 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL ACCORD 20 mg/1 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/12769001/12769001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/12769001/12769001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2012-06-26 | 1 | 1 | 1 | 2012-06-26 | 2012-06-26 | 1 | 2012-11-29 | View Edit Delete | ||||||||||||
| 691718 | 12769002 | DOCETAXEL ACCORD 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL ACCORD 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/12769002/12769002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/12769002/12769002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2012-06-26 | 1 | 1 | 1 | 2012-06-26 | 2012-06-26 | 1 | 2012-11-29 | View Edit Delete | ||||||||||||
| 691719 | 12769003 | DOCETAXEL ACCORD 160 mg/8 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL ACCORD 160 mg/8 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/12769003/12769003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/12769003/12769003_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2012-06-26 | 1 | 1 | 1 | 2012-06-26 | 2012-06-26 | 1 | 2012-12-07 | View Edit Delete | ||||||||||||
| 692442 | 63908 | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 20 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63908/63908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63908/63908_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2012-07-30 | 1 | 2012-10-25 | View Edit Delete | ||||||||||||
| 693703 | 76618 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL , frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76618/76618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76618/76618_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2013-04-24 | 1 | 1 | 1 | 2013-04-24 | 2013-04-24 | 1 | 2014-11-11 | View Edit Delete | ||||||||||||
| 694279 | 76699 | EXEMESTANO CINFA 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO CINFA 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76699/76699_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76699/76699_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-10-29 | 1 | 1 | 1 | 2012-10-29 | 2012-10-29 | 1 | 2013-03-13 | View Edit Delete | ||||||||||||
| 694338 | 76719 | TRAMADOL/PARACETAMOL ALMUS 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL ALMUS 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76719/76719_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76719/76719_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2012-11-02 | 1 | 1 | 1 | 2020-01-20 | 2020-01-20 | 1 | 2020-04-06 | View Edit Delete | ||||||||||||
| 694341 | 76720 | TRAMADOL/PARACETAMOL VIR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL VIR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76720/76720_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76720/76720_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2012-11-02 | 1 | 1 | 1 | 2019-12-18 | 2019-12-18 | 1 | 2021-09-22 | View Edit Delete | ||||||||||||
| 694342 | 76720 | TRAMADOL/PARACETAMOL VIR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL VIR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 37,5 mg/325 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76720/76720_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76720/76720_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2012-11-02 | 1 | 1 | 1 | 2019-12-18 | 2019-12-18 | 1 | 2021-09-22 | View Edit Delete | ||||||||||||
| 694382 | 76726 | DRELLE 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRELLE 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/ 0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76726/76726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76726/76726_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2012-11-06 | 1 | 1 | 1 | 2012-11-06 | 2012-11-06 | 1 | 2013-02-14 | View Edit Delete | ||||||||||||
| 694383 | 76726 | DRELLE 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRELLE 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76726/76726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76726/76726_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2012-11-06 | 1 | 1 | 1 | 2012-11-06 | 2012-11-06 | 1 | 2013-02-14 | View Edit Delete | ||||||||||||
| 694404 | 197047008 | BENEFIX 3000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | BENEFIX 3000 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 jeringa precargada de disolvente | 3.000 UI | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/197047008/197047008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/197047008/197047008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2012-11-12 | 1 | 1 | 1 | 2012-11-12 | 2012-11-12 | 1 | 2013-09-09 | View Edit Delete | ||||||||||||
| 694416 | 76742 | TRAMADOL/PARACETAMOL KRKA 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL KRKA 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 37,5 mg/325 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76742/76742_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76742/76742_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-03-07 | 1 | 1 | 1 | 2013-03-07 | 2013-03-07 | 1 | 2013-10-03 | View Edit Delete | ||||||||||||
| 694420 | 76742 | TRAMADOL/PARACETAMOL KRKA 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL KRKA 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76742/76742_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76742/76742_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-03-07 | 1 | 1 | 1 | 2013-03-07 | 2013-03-07 | 1 | 2015-08-21 | View Edit Delete | ||||||||||||
| 694554 | 60204 | KYTRIL 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | KYTRIL 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 10 comprimidos | 1 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60204/60204_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60204/60204_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35106 | 35106 | 1994-03-01 | 1 | 1 | 1 | 1994-03-01 | 1994-03-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 694656 | 76781 | TRAMADOL/PARACETAMOL KRKA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL KRKA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 20 comprimidos | 75 mg/650 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76781/76781_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76781/76781_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-03-07 | 1 | 1 | 1 | 2013-03-07 | 2013-03-07 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 694660 | 76781 | TRAMADOL/PARACETAMOL KRKA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL KRKA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 75 mg/650 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76781/76781_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76781/76781_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-03-07 | 1 | 1 | 1 | 2013-03-07 | 2013-03-07 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 694673 | R-6898 | ANAGASTRA 40mg comprimidos gastrorresistentes | ANAGASTRA 40mg comprimidos gastrorresistentes , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R-6898/R-6898_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14994 | 17193 | 2012-11-21 | 1 | 1 | 1 | 2012-11-21 | 2012-11-21 | 1 | 2023-10-26 | View Edit Delete | ||||||||||||
| 694773 | 76790 | DROSPIL 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIL 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76790/76790_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76790/76790_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-11-21 | 1 | 1 | 1 | 2012-11-21 | 2012-11-21 | 1 | 2013-02-15 | View Edit Delete | ||||||||||||
| 694774 | 76790 | DROSPIL 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIL 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76790/76790_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76790/76790_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-11-21 | 1 | 1 | 1 | 2012-11-21 | 2012-11-21 | 1 | 2013-02-15 | View Edit Delete | ||||||||||||
| 695032 | 112794001 | ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112794001/112794001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112794001/112794001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35004 | 70973 | 2012-11-29 | 1 | 1 | 1 | 2012-11-29 | 2012-11-29 | 1 | 2014-07-10 | View Edit Delete | ||||||||||||
| 695147 | 76843 | LANSOPRAZOL FLAS VIATRIS 30 MG COMPRIMIDOS BUCODISPERSABLES EFG | LANSOPRAZOL FLAS VIATRIS 30 MG COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76843/76843_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76843/76843_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2012-11-30 | 1 | 1 | 1 | 2012-11-30 | 2012-11-30 | 1 | 2013-06-19 | View Edit Delete | ||||||||||||
| 695153 | 76847 | LANSOPRAZOL FLAS VIATRIS 15 MG COMPRIMIDOS BUCODISPERSABLES EFG | LANSOPRAZOL FLAS VIATRIS 15 MG COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76847/76847_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76847/76847_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2012-11-30 | 1 | 1 | 1 | 2012-11-30 | 2012-11-30 | 1 | 2013-06-19 | View Edit Delete | ||||||||||||
| 695268 | 76859 | MOMETASONA SANDOZ 50 MICROGRAMOS/DOSIS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA SANDOZ 50 MICROGRAMOS/DOSIS SUSPENSION PARA PULVERIZACION NASAL , 1 envase de 18 g (140 nebulizaciones) | 50 microgramos/dosis | 65 | 140 | 31 | 1 envase de 18 g (140 nebulizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76859/76859_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76859/76859_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2013-05-06 | 1 | 1 | 1 | 2013-08-27 | 2013-08-27 | 1 | 2014-03-05 | View Edit Delete | ||||||||||||
| 695270 | 99103009 | REFACTO AF 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | REFACTO AF 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de doble cámara | 250 UI | 33 | 1 | 61 | 1 jeringa precargada de doble cámara | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99103009/99103009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99103009/99103009_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2012-12-03 | 1 | 1 | 1 | 2012-12-03 | 2012-12-03 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 695757 | 196006008 | NOVOSEVEN 1 mg (50 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOSEVEN 1 mg (50 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 1 mg (50.000 UI) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/196006008/196006008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/196006008/196006008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2013-01-04 | 1 | 1 | 1 | 2013-01-04 | 2013-01-04 | 1 | 2017-11-08 | View Edit Delete | ||||||||||||
| 695758 | 196006009 | NOVOSEVEN 2 mg (100 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOSEVEN 2 mg (100 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 2 mg (100.000 UI) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/196006009/196006009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/196006009/196006009_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2013-01-04 | 1 | 1 | 1 | 2013-01-04 | 2013-01-04 | 1 | 2017-10-30 | View Edit Delete | ||||||||||||
| 695760 | 196006010 | NOVOSEVEN 5 mg (250 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOSEVEN 5 mg (250 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 5 mg (250.000 UI) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/196006010/196006010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/196006010/196006010_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2013-01-04 | 1 | 1 | 1 | 2013-01-04 | 2013-01-04 | 1 | 2017-10-30 | View Edit Delete | ||||||||||||
| 695787 | 76951 | OMEPRAZOL SANDOZ CARE 20 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL SANDOZ CARE 20 MG CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 20 mg | 72 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76951/76951_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76951/76951_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2013-01-04 | 1 | 1 | 1 | 2013-01-04 | 2013-01-04 | 1 | 2016-06-14 | View Edit Delete | ||||||||||||
| 696053 | 77006 | EXEMESTANO WINADOL 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO WINADOL 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77006/77006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77006/77006_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20366 | 20366 | 2013-01-18 | 1 | 1 | 1 | 2013-01-18 | 2013-01-18 | 1 | 2015-12-14 | View Edit Delete | ||||||||||||
| 696063 | 77013 | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 15 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77013/77013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77013/77013_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2013-01-22 | 1 | 2013-10-17 | View Edit Delete | ||||||||||||
| 696064 | 77013 | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 15 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77013/77013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77013/77013_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2013-01-22 | 1 | 2013-07-04 | View Edit Delete | ||||||||||||
| 696065 | 77014 | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 30 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77014/77014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77014/77014_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2013-01-22 | 1 | 2013-10-17 | View Edit Delete | ||||||||||||
| 696068 | 77014 | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 30 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77014/77014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77014/77014_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2013-01-22 | 1 | 2013-07-04 | View Edit Delete | ||||||||||||
| 696108 | 71603 | LEVOFLOXACINO TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOFLOXACINO TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 7 comprimidos | 500 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71603/71603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71603/71603_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2013-01-22 | 1 | 2013-10-07 | View Edit Delete | ||||||||||||
| 696119 | 62316 | ESTOMIL 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESTOMIL 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62316/62316_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62316/62316_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88146 | 88146 | 1998-11-01 | 1 | 1 | 1 | 1998-11-01 | 2013-01-22 | 1 | 2013-07-04 | 708685 | View Edit Delete | |||||||||||
| 696126 | 62317 | ESTOMIL 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESTOMIL 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62317/62317_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62317/62317_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88146 | 88146 | 1998-11-01 | 1 | 1 | 1 | 1998-11-01 | 2013-01-22 | 1 | 2013-07-04 | 708826 | View Edit Delete | |||||||||||
| 696144 | 77034 | ESOMEPRAZOL KRKA 20 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL KRKA 20 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 MG | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77034/77034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77034/77034_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-01-24 | 1 | 1 | 1 | 2013-01-24 | 2013-01-24 | 1 | 2015-04-15 | View Edit Delete | ||||||||||||
| 696147 | 77035 | ESOMEPRAZOL KRKA 40 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL KRKA 40 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77035/77035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77035/77035_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-01-24 | 1 | 1 | 1 | 2013-01-24 | 2013-01-24 | 1 | 2015-04-15 | View Edit Delete | ||||||||||||
| 696429 | 77051 | LANSOPRAZOL TECNIGEN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TECNIGEN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 15 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77051/77051_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77051/77051_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2014-03-11 | View Edit Delete | ||||||||||||
| 696431 | 77052 | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 30 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77052/77052_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77052/77052_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2014-03-11 | View Edit Delete | ||||||||||||
| 696433 | 77052 | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 30 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77052/77052_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77052/77052_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2015-09-29 | View Edit Delete | ||||||||||||
| 696436 | 77053 | LANSOPRAZOL AUROVITAS SPAIN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL AUROVITAS SPAIN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 30 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77053/77053_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77053/77053_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2013-06-10 | View Edit Delete | ||||||||||||
| 696438 | 77053 | LANSOPRAZOL AUROVITAS SPAIN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL AUROVITAS SPAIN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 30 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77053/77053_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77053/77053_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2013-06-10 | View Edit Delete | ||||||||||||
| 696440 | 77054 | LANSOPRAZOL AUROVITAS SPAIN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL AUROVITAS SPAIN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (BLISTER) | 15 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77054/77054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77054/77054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2013-06-10 | View Edit Delete | ||||||||||||
| 696441 | 77054 | LANSOPRAZOL AUROVITAS SPAIN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL AUROVITAS SPAIN 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (FRASCO) | 15 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77054/77054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77054/77054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2013-01-28 | 1 | 2013-06-10 | View Edit Delete | ||||||||||||
| 696954 | 61221 | MONOLITUM 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | MONOLITUM 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61221/61221_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61221/61221_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 1997-04-01 | 1 | 1 | 1 | 1997-04-01 | 2013-02-20 | 1 | 2013-02-22 | 654459 | View Edit Delete | |||||||||||
| 696956 | 62325 | MONOLITUM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | MONOLITUM 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62325/62325_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62325/62325_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 1998-11-01 | 1 | 1 | 1 | 1998-11-01 | 2013-02-20 | 1 | 2013-02-22 | 712000 | View Edit Delete | |||||||||||
| 697084 | 77268 | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77268/77268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77268/77268_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697085 | 77268 | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 3 x 28 comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 3 x 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77268/77268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77268/77268_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697130 | 110631001 | NIVESTIM 12 MU/0,2 ml SOLUCION INYECTABLE O PARA PERFUSION | NIVESTIM 12 MU/0,2 ml SOLUCION INYECTABLE O PARA PERFUSION, 1 jeringa precargada de 0,2 ml | 12 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631001/110631001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631001/110631001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2013-03-03 | 1 | 1 | 1 | 2013-03-03 | 2013-03-03 | 1 | 2015-07-20 | View Edit Delete | ||||||||||||
| 697131 | 110631004 | NIVESTIM 30 MU/0,5 ml SOLUCION INYECTABLE Y PARA PERFUSION | NIVESTIM 30 MU/0,5 ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 jeringa precargada de 0,5 ml | 30 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631004/110631004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631004/110631004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2013-03-03 | 1 | 1 | 1 | 2013-03-03 | 2013-03-03 | 1 | 2015-07-20 | View Edit Delete | ||||||||||||
| 697132 | 110631007 | NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION | NIVESTIM 48 MU/0,5 ml SOLUCION INYECTABLE O PARA PERFUSION, 1 jeringa precargada de 0,5 ml | 48 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110631007/110631007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110631007/110631007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2013-03-03 | 1 | 1 | 1 | 2013-03-03 | 2013-03-03 | 1 | 2015-07-20 | View Edit Delete | ||||||||||||
| 697138 | 77272 | DROSBELALLE DIARIO 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSBELALLE DIARIO 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77272/77272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77272/77272_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2016-10-24 | View Edit Delete | ||||||||||||
| 697139 | 77272 | DROSBELALLE DIARIO 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSBELALLE DIARIO 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 x 28 comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 3 x 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77272/77272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77272/77272_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2016-10-24 | View Edit Delete | ||||||||||||
| 697140 | 77273 | DROSBELA DIARIO 3 mg /0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSBELA DIARIO 3 mg /0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77273/77273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77273/77273_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2016-10-24 | View Edit Delete | ||||||||||||
| 697141 | 77273 | DROSBELA DIARIO 3 mg /0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSBELA DIARIO 3 mg /0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 x 28 comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 3 x 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77273/77273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77273/77273_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2016-10-24 | View Edit Delete | ||||||||||||
| 697179 | 77269 | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77269/77269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77269/77269_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697180 | 77269 | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL DIARIO EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 3 x 28 comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 3 x 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77269/77269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77269/77269_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697181 | 77299 | DROSPIRENONA/ETINILESTRADIOL EXELTIS HEALTHCARE 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL EXELTIS HEALTHCARE 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77299/77299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77299/77299_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-18 | 1 | 1 | 1 | 2013-03-18 | 2013-03-18 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697182 | 77299 | DROSPIRENONA/ETINILESTRADIOL EXELTIS HEALTHCARE 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSPIRENONA/ETINILESTRADIOL EXELTIS HEALTHCARE 3MG/0,02MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 3 x 21 comprimidos | 3 mg/0,02 mg | 5 | 63 | 10 | 3 x 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77299/77299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77299/77299_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-18 | 1 | 1 | 1 | 2013-03-18 | 2013-03-18 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697183 | 77300 | DROSPIRENONA/ETINILESTRADIOL EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DROSPIRENONA/ETINILESTRADIOL EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77300/77300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77300/77300_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-18 | 1 | 1 | 1 | 2013-03-18 | 2013-03-18 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697184 | 77300 | DROSPIRENONA/ETINILESTRADIOL EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DROSPIRENONA/ETINILESTRADIOL EXELTIS 3MG/0,03MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 3 x 21 comprimidos | 3 mg/0,03 mg | 5 | 63 | 10 | 3 x 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77300/77300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77300/77300_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2013-03-18 | 1 | 1 | 1 | 2013-03-18 | 2013-03-18 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 697198 | 77248 | EXEMESTANO SANDOZ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO SANDOZ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77248/77248_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77248/77248_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2013-05-30 | 1 | 1 | 1 | 2013-05-30 | 2013-06-04 | 1 | 2014-02-25 | View Edit Delete | ||||||||||||
| 697226 | 74795 | OMEPRAZOL AUROVITAS PHARMA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS PHARMA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas (blister Al/Al) | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74795/74795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74795/74795_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-10-04 | 1 | 1 | 1 | 2011-10-04 | 2013-03-05 | 1 | 2024-09-19 | View Edit Delete | ||||||||||||
| 697228 | 74795 | OMEPRAZOL AUROVITAS PHARMA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS PHARMA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas (frasco HDPE) | 20 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74795/74795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74795/74795_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-10-04 | 1 | 1 | 1 | 2011-10-04 | 2013-03-05 | 1 | 2025-09-30 | View Edit Delete | ||||||||||||
| 697508 | 102221017 | Pegasys 90mcg solucion inyectable en jeringa precargada | Pegasys 90mcg solucion inyectable en jeringa precargada 1 jeringa precargada y 1 aguja | 90 microgramos | 33 | 1 | 61 | 1 jeringa precargada y 1 aguja | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/102221017/102221017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/102221017/102221017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44015 | 2488 | 2013-04-07 | 1 | 1 | 1 | 2013-04-07 | 2013-04-07 | 1 | 2014-01-21 | View Edit Delete | ||||||||||||
| 697512 | 77376 | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA (24+4) EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA (24+4) EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77376/77376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77376/77376_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-04-07 | 1 | 1 | 1 | 2013-04-07 | 2013-04-07 | 1 | 2013-10-29 | View Edit Delete | ||||||||||||
| 697513 | 77376 | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA (24+4) EFG | ETINILESTRADIOL/DROSPIRENONA STADA 0,02 MG/3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA (24+4) EFG , 84 (3 x 28) comprimidos | 3 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77376/77376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77376/77376_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-04-07 | 1 | 1 | 1 | 2013-04-07 | 2013-04-07 | 1 | 2013-10-29 | View Edit Delete | ||||||||||||
| 697643 | 72699 | EMANERA 20 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | EMANERA 20 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG , 14 capsulas (OPA/AL/PVC/AL) | 20 mg | 5 | 14 | 43 | 14 capsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72699/72699_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72699/72699_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-04-11 | 1 | 2022-06-17 | View Edit Delete | ||||||||||||
| 697644 | 72700 | EMANERA 40 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | EMANERA 40 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG , 28 capsulas (OPA/AL/PVC/AL) | 40 mg | 5 | 28 | 43 | 28 capsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72700/72700_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72700/72700_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-04-11 | 1 | 2019-06-26 | View Edit Delete | ||||||||||||
| 697787 | 71289 | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos (frasco) | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71289/71289_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71289/71289_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2013-04-22 | 1 | 2013-09-09 | View Edit Delete | ||||||||||||
| 697788 | 71288 | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos (frasco) | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71288/71288_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71288/71288_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2013-04-22 | 1 | 2013-11-08 | View Edit Delete | ||||||||||||
| 697868 | 70026 | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (frasco) | 40 mg | 6 | 28 | 10 | 28 comprimidos (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70026/70026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70026/70026_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2013-04-25 | 1 | 2013-07-26 | View Edit Delete | ||||||||||||
| 697869 | 70025 | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (frasco) | 20 mg | 6 | 28 | 10 | 28 comprimidos (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70025/70025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70025/70025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2013-04-25 | 1 | 2013-07-30 | View Edit Delete | ||||||||||||
| 697894 | 77481 | TRECLINAC 10 MG/G + 0,25 MG/G GEL | TRECLINAC 10 MG/G + 0,25 MG/G GEL , tubo de 30 g | 10 mg/g + 0,25 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77481/77481_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77481/77481_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2013-04-30 | 1 | 1 | 1 | 2013-04-30 | 2013-04-30 | 1 | 2014-03-10 | View Edit Delete | ||||||||||||
| 698019 | 72680 | ESOMEPRAZOL DAVUR 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL DAVUR 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (OPA/AL/PVC/AL) | 20 mg | 5 | 28 | 43 | 28 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72680/72680_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72680/72680_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2013-05-09 | 1 | 2014-03-04 | View Edit Delete | ||||||||||||
| 698021 | 72681 | ESOMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (OPA/AL/PVC/AL) | 40 mg | 5 | 28 | 43 | 28 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72681/72681_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72681/72681_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2013-05-09 | 1 | 2014-03-04 | View Edit Delete | ||||||||||||
| 698023 | 72703 | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas (OPA/AL/PVC/AL) | 20 mg | 5 | 14 | 43 | 14 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72703/72703_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72703/72703_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-05-09 | 1 | 2014-10-11 | View Edit Delete | ||||||||||||
| 698024 | 72703 | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (OPA/AL/PVC/AL) | 20 mg | 5 | 28 | 43 | 28 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72703/72703_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72703/72703_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-05-09 | 1 | 2014-03-04 | View Edit Delete | ||||||||||||
| 698025 | 72702 | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas (OPA/AL/PVC/AL) | 40 mg | 5 | 14 | 43 | 14 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72702/72702_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72702/72702_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-05-09 | 1 | 2014-10-11 | View Edit Delete | ||||||||||||
| 698026 | 72702 | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (OPA/AL/PVC/AL) | 40 mg | 5 | 28 | 43 | 28 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72702/72702_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72702/72702_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2013-05-09 | 1 | 2014-02-18 | View Edit Delete | ||||||||||||
| 698033 | 77507 | AZITROMICINA RATIO 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AZITROMICINA RATIO 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 comprimidos | 500 mg | 5 | 3 | 10 | 3 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77507/77507_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77507/77507_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2013-06-10 | 1 | 1 | 1 | 2013-06-10 | 2013-06-11 | 1 | 2014-01-29 | View Edit Delete | ||||||||||||
| 698143 | 71603 | LEVOFLOXACINO TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOFLOXACINO TEVA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 14 comprimidos | 500 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71603/71603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71603/71603_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2013-05-23 | 1 | 2013-10-10 | View Edit Delete | ||||||||||||
| 698336 | 77628 | LAMIVUDINA AUROVITAS 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LAMIVUDINA AUROVITAS 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 300 mg | 5 | 30 | 10 | 30, comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77628/77628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77628/77628_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-06-13 | 1 | 1 | 1 | 2013-06-13 | 2013-06-13 | 1 | 2015-10-15 | View Edit Delete | ||||||||||||
| 698630 | 77738 | LANSOPRAZOL FLAS SALVAT 15 MG COMPRIMIDO BUCODISPERSABLE | LANSOPRAZOL FLAS SALVAT 15 MG COMPRIMIDO BUCODISPERSABLE , 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77738/77738_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77738/77738_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2013-09-10 | 1 | 1 | 1 | 2013-09-10 | 2013-09-24 | 1 | 2023-05-29 | View Edit Delete | ||||||||||||
| 698646 | 77740 | DUOMATE FLAS 15 MG COMPRIMIDOS BUCODISPERSABLES | DUOMATE FLAS 15 MG COMPRIMIDOS BUCODISPERSABLES , 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77740/77740_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77740/77740_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2013-09-10 | 1 | 1 | 1 | 2013-09-10 | 2013-09-24 | 1 | 2023-05-29 | View Edit Delete | ||||||||||||
| 698702 | 77767 | TRAMADOL/PARACETAMOL AUROVITAS 37,5 MG / 325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL AUROVITAS 37,5 MG / 325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos (PVC/PVDC-ALUMINIO) | 37,5 mg/325 mg | 5 | 20 | 10 | 20 comprimidos (PVC/PVDC-ALUMINIO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77767/77767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77767/77767_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-07-17 | 1 | 1 | 1 | 2013-07-17 | 2013-07-17 | 1 | 2015-06-29 | View Edit Delete | ||||||||||||
| 698720 | 77774 | EPLERENONA MABO 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA MABO 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77774/77774_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77774/77774_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2013-07-22 | 1 | 1 | 1 | 2017-02-14 | 2017-02-14 | 1 | 2017-02-08 | View Edit Delete | ||||||||||||
| 698721 | 77775 | EPLERENONA MABO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA MABO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77775/77775_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77775/77775_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2013-07-22 | 1 | 1 | 1 | 2017-02-14 | 2017-02-14 | 1 | 2017-02-08 | View Edit Delete | ||||||||||||
| 699282 | 111687014 | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTÁNEA, 10 vials pack (filling size: 50 ml) | 200 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 vials pack (filling size: 50 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/111687014/111687014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/111687014/111687014_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2013-09-03 | 1 | 1 | 1 | 2013-09-03 | 2013-09-03 | 1 | 2014-04-26 | View Edit Delete | ||||||||||||
| 699533 | 109546005 | SIMPONI 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | SIMPONI 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 100 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/109546005/109546005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/109546005/109546005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2013-09-20 | 1 | 1 | 1 | 2013-09-20 | 2013-09-20 | 1 | 2014-05-01 | View Edit Delete | ||||||||||||
| 699638 | 77974 | MOMETASONA FUROATO TEVA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO TEVA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL , 1x140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 1x140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77974/77974_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77974/77974_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2013-11-18 | 1 | 1 | 1 | 2013-11-18 | 2013-12-03 | 1 | 2014-05-27 | View Edit Delete | ||||||||||||
| 699836 | 113879006 | GIOTRIF 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | GIOTRIF 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113879006/113879006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113879006/113879006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5126 | 470 | 2013-10-04 | 1 | 1 | 1 | 2013-10-04 | 2013-10-04 | 1 | 2014-06-03 | View Edit Delete | ||||||||||||
| 699837 | 113879009 | GIOTRIF 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | GIOTRIF 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113879009/113879009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113879009/113879009_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5126 | 470 | 2013-10-04 | 1 | 1 | 1 | 2013-10-04 | 2013-10-04 | 1 | 2014-06-03 | View Edit Delete | ||||||||||||
| 699839 | 113879003 | GIOTRIF 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | GIOTRIF 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113879003/113879003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113879003/113879003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5126 | 470 | 2013-10-04 | 1 | 1 | 1 | 2013-10-04 | 2013-10-04 | 1 | 2014-06-03 | View Edit Delete | ||||||||||||
| 699840 | 78033 | AMLODIPINO/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78033/78033_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78033/78033_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2013-10-04 | 1 | 1 | 1 | 2013-10-04 | 2013-10-04 | 1 | 2014-01-13 | View Edit Delete | ||||||||||||
| 699900 | 56926 | COPINAL 300 mg CAPSULAS | COPINAL 300 mg CAPSULAS, 60 cápsulas | 300 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56926/56926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56926/56926_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3047 | 3047 | 1987-01-01 | 1 | 1 | 1 | 1987-01-01 | 1993-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 699918 | 56926 | COPINAL 300 mg CAPSULAS | COPINAL 300 mg CAPSULAS, 30 cápsulas | 300 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56926/56926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56926/56926_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3047 | 3047 | 1987-01-01 | 1 | 1 | 1 | 1987-01-01 | 1993-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 700313 | 78174 | TRAMADOL/PARACETAMOL CINFA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL CINFA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 20 comprimidos (Blister PVC/PVDC/AL opaco) | 75 mg/650 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78174/78174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78174/78174_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2013-11-12 | 1 | 1 | 1 | 2016-11-14 | 2016-11-14 | 1 | 2020-01-03 | View Edit Delete | ||||||||||||
| 700314 | 78174 | TRAMADOL/PARACETAMOL CINFA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL CINFA 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos (Blister PVC/PVDC/AL opaco) | 75 mg/650 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78174/78174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78174/78174_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2013-11-12 | 1 | 1 | 1 | 2016-11-14 | 2016-11-14 | 1 | 2020-01-03 | View Edit Delete | ||||||||||||
| 700675 | 59381 | OTIX GOTAS OTICAS EN SOLUCIÓN | OTIX GOTAS OTICAS EN SOLUCIÓN , 1 frasco de 5 ml | 1 mg/ml + 10.000 UI/ml + 1 mg/ml | 56 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59381/59381_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59381/59381_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29808 | 945 | 1992-10-01 | 1 | 1 | 1 | 1992-10-01 | 2017-03-31 | 1 | 2014-01-02 | 903831, 654771 | View Edit Delete | |||||||||||
| 700696 | 11740001 | AMELUZ 78 MG/G GEL | AMELUZ 78 MG/G GEL , 1 tubo de 2 g | 78 mg/g | 44 | 2 | 21 | 1 tubo de 2 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11740001/11740001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11740001/11740001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13227 | 16645 | 2012-10-08 | 1 | 1 | 1 | 2012-10-08 | 2018-07-02 | 1 | 2013-08-08 | 693633 | View Edit Delete | |||||||||||
| 700710 | 52008 | BENORAL SUSPENSION | BENORAL SUSPENSION, 1 frasco de 100 ml | 250.000 UI/5 ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 1974-01-01 | 1 | 1 | 1 | 1974-01-01 | 2018-07-09 | 1 | 2013-06-07 | 694054 | View Edit Delete | |||||||||||
| 701018 | 112869001 | LEMTRADA 12 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | LEMTRADA 12 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 1,2 ml | 12 mg | 45 | 1 | 34 | 1 vial de 1,2 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/112869001/112869001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112869001/112869001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27935 | 40842 | 2013-12-20 | 1 | 1 | 1 | 2013-12-20 | 2013-12-20 | 1 | 2015-02-12 | View Edit Delete | ||||||||||||
| 701408 | 78453 | MEDIKINET 50 MG CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 50 MG CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78453/78453_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78453/78453_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2014-11-19 | 1 | 1 | 1 | 2014-11-19 | 2014-11-19 | 1 | 2017-11-24 | Lista II | View Edit Delete | |||||||||||
| 701410 | 78454 | MEDIKINET 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 60 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78454/78454_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78454/78454_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | 71077 | 2014-11-19 | 1 | 1 | 1 | 2014-11-19 | 2014-11-26 | 1 | 2017-11-24 | Lista II | View Edit Delete | |||||||||||
| 701428 | 78466 | NUROFEN PEDIATRICO 40 MG/ML SUSPENSION ORAL SABOR FRESA | NUROFEN PEDIATRICO 40 MG/ML SUSPENSION ORAL SABOR FRESA, 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78466/78466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78466/78466_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71183 | 71183 | 2014-02-18 | 1 | 1 | 1 | 2014-02-18 | 2014-02-18 | 1 | 2015-01-29 | View Edit Delete | ||||||||||||
| 701516 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2001-11-16 | 1 | 2014-12-15 | View Edit Delete | ||||||||||||
| 701633 | 113837001 | TECFIDERA 120 MG CAPSULAS DURAS GASTRORRESISTENTES | TECFIDERA 120 MG CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 120 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113837001/113837001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113837001/113837001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | 19066 | 2014-02-28 | 1 | 1 | 1 | 2014-02-28 | 2014-02-28 | 1 | 2015-01-08 | View Edit Delete | ||||||||||||
| 701634 | 113837002 | TECFIDERA 240 MG CAPSULAS DURAS GASTRORRESISTENTES | TECFIDERA 240 MG CAPSULAS DURAS GASTRORRESISTENTES, 56 cápsulas | 240 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113837002/113837002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113837002/113837002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | 19066 | 2014-02-28 | 1 | 1 | 1 | 2014-02-28 | 2014-02-28 | 1 | 2015-01-08 | View Edit Delete | ||||||||||||
| 701705 | 78530 | NUROFEN PEDIATRICO 20 MG/ML SUSPENSION ORAL SABOR NARANJA | NUROFEN PEDIATRICO 20 MG/ML SUSPENSION ORAL SABOR NARANJA 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78530/78530_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78530/78530_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71183 | 71183 | 2014-03-05 | 1 | 1 | 1 | 2014-03-05 | 2014-03-05 | 1 | 2014-12-15 | View Edit Delete | ||||||||||||
| 701814 | 78574 | TRINOMIA 100MG/20MG/2,5MG CAPSULAS DURAS | TRINOMIA 100MG/20MG/2,5MG CAPSULAS DURAS , 28 cápsulas | 20 mg/100 mg/2,5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78574/78574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78574/78574_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2014-03-21 | 1 | 1 | 1 | 2014-03-21 | 2014-03-21 | 1 | 2014-10-15 | View Edit Delete | ||||||||||||
| 701817 | 78575 | TRINOMIA 100MG/20MG/5MG CAPSULAS DURAS | TRINOMIA 100MG/20MG/5MG CAPSULAS DURAS , 28 cápsulas | 20 mg/100 mg/5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78575/78575_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78575/78575_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2014-03-21 | 1 | 1 | 1 | 2014-03-21 | 2014-03-21 | 1 | 2014-10-15 | View Edit Delete | ||||||||||||
| 701820 | 78576 | TRINOMIA 100MG/20MG/10MG CAPSULAS DURAS | TRINOMIA 100MG/20MG/10MG CAPSULAS DURAS , 28 cápsulas | 20 mg/100 mg/10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78576/78576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78576/78576_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2014-03-21 | 1 | 1 | 1 | 2014-03-21 | 2014-03-21 | 1 | 2014-10-15 | View Edit Delete | ||||||||||||
| 702043 | 78657 | EPLERENONA VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78657/78657_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78657/78657_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 44524 | 2014-11-20 | 1 | 1 | 1 | 2015-07-31 | 2015-07-31 | 1 | 2015-09-10 | View Edit Delete | ||||||||||||
| 702045 | 78658 | EPLERENONA VIATRIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA VIATRIS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78658/78658_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78658/78658_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 44524 | 2014-11-20 | 1 | 1 | 1 | 2015-07-31 | 2015-07-31 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 702077 | 198067003 | MABTHERA 1400 MG SOLUCION PARA INYECCION SUBCUTANEA | MABTHERA 1400 MG SOLUCION PARA INYECCION SUBCUTANEA, 1 vial de 11,7 ml (120 mg/ml) | 1.400 mg inyectable 11,7 ml | 45 | 1 | 34 | 1 vial de 11,7 ml (120 mg/ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/198067003/198067003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/198067003/198067003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 2014-04-11 | 1 | 1 | 1 | 2014-04-11 | 2014-04-11 | 1 | 2015-11-02 | View Edit Delete | ||||||||||||
| 702204 | 78710 | PSICOTRIC PROLONG 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PSICOTRIC PROLONG 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78710/78710_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78710/78710_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-29 | View Edit Delete | ||||||||||||
| 702205 | 78711 | PSICOTRIC PROLONG 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PSICOTRIC PROLONG 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78711/78711_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78711/78711_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-29 | View Edit Delete | ||||||||||||
| 702206 | 78712 | PSICOTRIC PROLONG 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PSICOTRIC PROLONG 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78712/78712_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78712/78712_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-29 | View Edit Delete | ||||||||||||
| 702207 | 78713 | PSICOTRIC PROLONG 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PSICOTRIC PROLONG 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78713/78713_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78713/78713_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-29 | View Edit Delete | ||||||||||||
| 702208 | 78714 | PSICOTRIC PROLONG 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PSICOTRIC PROLONG 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78714/78714_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78714/78714_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-29 | View Edit Delete | ||||||||||||
| 702211 | 78716 | QUETIAPINA SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78716/78716_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78716/78716_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-16 | View Edit Delete | ||||||||||||
| 702212 | 78717 | QUETIAPINA MABO 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA MABO 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78717/78717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78717/78717_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-10-10 | View Edit Delete | ||||||||||||
| 702216 | 78721 | QUETIAPINA SANDOZ FARMACEUTICA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA SANDOZ FARMACEUTICA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78721/78721_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78721/78721_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-16 | View Edit Delete | ||||||||||||
| 702218 | 78722 | QUETIAPINA SANDOZ FARMACEUTICA 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA SANDOZ FARMACEUTICA 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78722/78722_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78722/78722_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-16 | View Edit Delete | ||||||||||||
| 702219 | 78723 | QUETIAPINA SANDOZ FARMACEUTICA 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA SANDOZ FARMACEUTICA 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78723/78723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78723/78723_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-16 | View Edit Delete | ||||||||||||
| 702220 | 78724 | QUETIAPINA SANDOZ FARMACEUTICA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA SANDOZ FARMACEUTICA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78724/78724_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78724/78724_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-07-16 | View Edit Delete | ||||||||||||
| 702221 | 78725 | QUETIAPINA MABO 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA MABO 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78725/78725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78725/78725_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-10-10 | View Edit Delete | ||||||||||||
| 702222 | 78726 | QUETIAPINA MABO 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA MABO 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78726/78726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78726/78726_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-10-10 | View Edit Delete | ||||||||||||
| 702223 | 78727 | QUETIAPINA MABO 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA MABO 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78727/78727_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78727/78727_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-10-10 | View Edit Delete | ||||||||||||
| 702224 | 78728 | QUETIAPINA MABO 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA MABO 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78728/78728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78728/78728_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2014-10-10 | View Edit Delete | ||||||||||||
| 702255 | 113893002 | OPSUMIT 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPSUMIT 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos recubiertos con película | 10 mg | 5 | 30 | 10 | 30 comprimidos recubiertos con película | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113893002/113893002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113893002/113893002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2014-05-07 | 1 | 1 | 1 | 2014-05-07 | 2014-05-07 | 1 | 2015-05-14 | View Edit Delete | ||||||||||||
| 702285 | 108492007 | ROACTEMRA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | ROACTEMRA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA , 4 jeringas precargadas de 0,9 ml | 162 mg | 33 | 4 | 61 | 4 Jeringas precargadas de 0,9 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108492007/108492007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108492007/108492007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | 5458 | 2014-05-09 | 1 | 1 | 1 | 2014-05-09 | 2014-05-09 | 1 | 2014-12-30 | View Edit Delete | ||||||||||||
| 702387 | 78774 | LAMIVUDINA ACCORD 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LAMIVUDINA ACCORD 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78774/78774_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78774/78774_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2014-05-21 | 1 | 1 | 1 | 2014-05-21 | 2014-05-21 | 1 | 2018-01-04 | View Edit Delete | ||||||||||||
| 702393 | 78776 | LAMIVUDINA ACCORD 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LAMIVUDINA ACCORD 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (Blister) | 300 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78776/78776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78776/78776_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2014-05-21 | 1 | 1 | 1 | 2014-05-21 | 2014-05-21 | 1 | 2018-01-04 | View Edit Delete | ||||||||||||
| 702674 | 78831 | SINUSVICKS 200MG/30MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SINUSVICKS 200MG/30MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 12 comprimidos (Blister PVC/PCTFE/AL) | 200 mg/ 30 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78831/78831_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78831/78831_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | 9180 | 2014-06-13 | 1 | 1 | 1 | 2025-05-13 | 2025-05-13 | 1 | 2025-07-08 | View Edit Delete | ||||||||||||
| 702694 | 13853001 | REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/13853001/13853001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/13853001/13853001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2014-06-23 | 1 | 1 | 1 | 2014-06-23 | 2014-06-23 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 702754 | 78853 | AMLODIPINO/ATORVASTATINA KRKA 5 MG/10MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/ATORVASTATINA KRKA 5 MG/10MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 5 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78853/78853_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78853/78853_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2014-10-16 | 1 | 1 | 1 | 2014-10-16 | 2014-10-28 | 1 | 2015-01-14 | View Edit Delete | ||||||||||||
| 702821 | 114923001 | ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 300 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114923001/114923001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114923001/114923001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35004 | 70973 | 2014-06-30 | 1 | 1 | 1 | 2014-06-30 | 2014-06-30 | 1 | 2015-09-04 | View Edit Delete | ||||||||||||
| 703001 | 78899 | MOMETASONA FUROATO CIPLA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO CIPLA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL , 140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78899/78899_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78899/78899_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2014-07-14 | 1 | 1 | 1 | 2014-07-14 | 2014-07-14 | 1 | 2015-01-27 | View Edit Delete | ||||||||||||
| 703203 | 78955 | MOMETASONA FUROATO KERN PHARMA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO KERN PHARMA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL , 18 g (140 pulverizaciones) | 50 microgramos/dosis | 6 | 140 | 31 | 18 g (140 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78955/78955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78955/78955_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2014-07-29 | 1 | 1 | 1 | 2014-07-29 | 2014-07-29 | 1 | 2015-08-04 | View Edit Delete | ||||||||||||
| 703500 | 79022 | LEVODOPA/CARBIDOPA/ENTACAPONA TEVA-RATIOPHARM 100/25/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA TEVA-RATIOPHARM 100/25/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 100 comprimidos | 50 mg/12,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79022/79022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79022/79022_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2014-09-08 | 1 | 1 | 1 | 2014-09-08 | 2014-09-08 | 1 | 2014-12-12 | View Edit Delete | ||||||||||||
| 703962 | 114928001 | SYLVANT 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | SYLVANT 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/114928001/114928001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114928001/114928001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44105 | 44764 | 2014-10-24 | 1 | 1 | 1 | 2014-10-24 | 2014-10-24 | 1 | 2016-02-04 | View Edit Delete | ||||||||||||
| 704025 | 79157 | QUETIAPINA VIATRIS 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA VIATRIS 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79157/79157_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79157/79157_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-07-21 | 1 | 1 | 1 | 2015-07-21 | 2015-07-23 | 1 | 2015-11-13 | View Edit Delete | ||||||||||||
| 704036 | 79158 | QUETIAPINA VIATRIS 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA VIATRIS 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79158/79158_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79158/79158_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-07-21 | 1 | 1 | 1 | 2015-07-21 | 2015-07-24 | 1 | 2015-11-13 | View Edit Delete | ||||||||||||
| 704046 | 79159 | QUETIAPINA VIATRIS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA VIATRIS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79159/79159_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79159/79159_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-07-21 | 1 | 1 | 1 | 2015-07-21 | 2015-07-24 | 1 | 2015-11-13 | View Edit Delete | ||||||||||||
| 704058 | 79160 | QUETIAPINA VIATRIS 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA VIATRIS 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79160/79160_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79160/79160_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-07-21 | 1 | 1 | 1 | 2015-07-21 | 2015-07-23 | 1 | 2015-11-13 | View Edit Delete | ||||||||||||
| 704107 | 79167 | ORVATEZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORVATEZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79167/79167_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79167/79167_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 2488 | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-23 | 1 | 2015-05-12 | View Edit Delete | ||||||||||||
| 704113 | 79168 | ORVATEZ 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORVATEZ 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79168/79168_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79168/79168_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 2488 | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-23 | 1 | 2015-05-12 | View Edit Delete | ||||||||||||
| 704120 | 79169 | ORVATEZ 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORVATEZ 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79169/79169_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79169/79169_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 2488 | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-23 | 1 | 2015-07-10 | View Edit Delete | ||||||||||||
| 704293 | 79224 | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79224/79224_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79224/79224_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 35083 | 2015-02-13 | 1 | 1 | 1 | 2015-02-13 | 2015-02-18 | 1 | 2015-05-12 | View Edit Delete | ||||||||||||
| 704308 | 79226 | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79226/79226_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79226/79226_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 35083 | 2015-02-13 | 1 | 1 | 1 | 2015-02-13 | 2015-02-18 | 1 | 2015-05-12 | View Edit Delete | ||||||||||||
| 704315 | 79227 | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79227/79227_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79227/79227_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | 35083 | 2015-02-13 | 1 | 1 | 1 | 2015-02-13 | 2015-02-18 | 1 | 2015-07-10 | View Edit Delete | ||||||||||||
| 704482 | 79267 | MOMETASONA FUROATO STADA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO STADA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL , 18 g (140 pulverizaciones) | 50 microgramos/dosis | 6 | 140 | 31 | 18 g (140 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79267/79267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79267/79267_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2014-12-02 | 1 | 1 | 1 | 2014-12-02 | 2014-12-05 | 1 | 2015-06-04 | View Edit Delete | ||||||||||||
| 704587 | 79312 | VALGANCICLOVIR AUROVITAS 450 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALGANCICLOVIR AUROVITAS 450 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 450 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79312/79312_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79312/79312_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2015-03-06 | 1 | 1 | 1 | 2016-08-16 | 2016-08-16 | 1 | 2016-09-21 | View Edit Delete | ||||||||||||
| 704613 | 69139 | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69139/69139_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69139/69139_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2014-12-09 | 1 | 2015-03-03 | View Edit Delete | ||||||||||||
| 704626 | 79326 | ETOPOSIDO ACCORD 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ETOPOSIDO ACCORD 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79326/79326_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79326/79326_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2014-12-19 | 1 | 1 | 1 | 2014-12-19 | 2015-01-16 | 1 | 2015-08-26 | View Edit Delete | ||||||||||||
| 704632 | 114956007 | TRULICITY 1,5 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | TRULICITY 1,5 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA, 4 plumas precargadas | 1,5 mg inyectable 0,5 ml | 66 | 4 | 49 | 4 plumas precargadas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114956007/114956007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114956007/114956007_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20183 | 1673 | 2014-12-15 | 1 | 1 | 1 | 2014-12-15 | 2014-12-15 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 704633 | 114956002 | TRULICITY 0,75 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | TRULICITY 0,75 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA, 4 plumas precargadas | 0,75 mg inyectable 0,5 ml | 66 | 4 | 49 | 4 plumas precargadas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114956002/114956002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114956002/114956002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20183 | 1673 | 2014-12-15 | 1 | 1 | 1 | 2014-12-15 | 2014-12-15 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 704749 | 79370 | DULOXETINA PENSA PHARMA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA PENSA PHARMA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (Blister PVC/PVDC-ALUMINIO) | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79370/79370_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79370/79370_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2014-12-26 | 1 | 1 | 1 | 2014-12-26 | 2014-12-26 | 1 | 2015-03-06 | View Edit Delete | ||||||||||||
| 704751 | 79371 | DULOXETINA PENSA PHARMA 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA PENSA PHARMA 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (Blister PVC/PVDC-ALUMINIO) | 60 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79371/79371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79371/79371_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2014-12-26 | 1 | 1 | 1 | 2014-12-26 | 2014-12-26 | 1 | 2015-03-06 | View Edit Delete | ||||||||||||
| 704847 | 102203006 | KINERET 100 mg/0,67 ml solucion inyectable en jeringa precargada | KINERET 100 mg/0,67 ml solucion inyectable en jeringa precargada 7 jeringas graduadas precargadas de 0,67 ml | 100 mg inyectable 0,67 ml | 33 | 7 | 61 | 7 jeringas graduadas precargadas de 0,67 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/102203006/102203006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/102203006/102203006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 15522 | 30717 | 2015-01-15 | 1 | 1 | 1 | 2015-01-15 | 2015-01-15 | 1 | 2016-03-07 | View Edit Delete | ||||||||||||
| 705110 | 114957001 | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957001/114957001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957001/114957001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71735 | 1673 | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-16 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 705113 | 114957003 | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957003/114957003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957003/114957003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71735 | 1673 | 2015-02-16 | 1 | 1 | 1 | 2015-02-16 | 2015-02-16 | 1 | 2015-10-09 | View Edit Delete | ||||||||||||
| 705432 | 114980003 | COSENTYX 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | COSENTYX 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas 1 ml | 150 mg inyectable 1 ml | 33 | 2 | 61 | 2 jeringas precargadas 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114980003/114980003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114980003/114980003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2015-02-23 | 1 | 1 | 1 | 2015-02-23 | 2015-02-23 | 1 | 2015-10-14 | View Edit Delete | ||||||||||||
| 705433 | 114980005 | COSENTYX 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | COSENTYX 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas 1 ml | 150 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114980005/114980005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114980005/114980005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2015-02-23 | 1 | 1 | 1 | 2015-02-23 | 2015-02-23 | 1 | 2015-10-14 | View Edit Delete | ||||||||||||
| 705604 | 114946005 | Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada | Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada 1 jeringa precargada- | 30 millones U | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946005/114946005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946005/114946005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2015-03-03 | 1 | 1 | 1 | 2015-03-03 | 2015-03-03 | 1 | 2015-06-02 | View Edit Delete | ||||||||||||
| 705605 | 114946008 | Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada | Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada 5 jeringas precargadas | 30 millones U | 33 | 5 | 61 | 5 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946008/114946008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946008/114946008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2015-03-03 | 1 | 1 | 1 | 2015-03-03 | 2015-03-03 | 1 | 2015-06-02 | View Edit Delete | ||||||||||||
| 705606 | 114946014 | Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada | Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada 5 jeringas precargadas | 48 millones U | 33 | 5 | 61 | 5 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946014/114946014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946014/114946014_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2015-03-03 | 1 | 1 | 1 | 2015-03-03 | 2015-03-03 | 1 | 2015-06-02 | View Edit Delete | ||||||||||||
| 705607 | 114946011 | Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada | Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada 1 jeringa precargada | 48 millones U | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946011/114946011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946011/114946011_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2015-03-03 | 1 | 1 | 1 | 2015-03-03 | 2015-03-03 | 1 | 2015-06-02 | View Edit Delete | ||||||||||||
| 705714 | 113888002 | NOVOEIGHT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOEIGHT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 500 UI | 80 | 1 | 34 | 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113888002/113888002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113888002/113888002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2015-03-17 | 1 | 1 | 1 | 2015-03-17 | 2015-03-17 | 1 | 2015-10-02 | View Edit Delete | ||||||||||||
| 705717 | 113888003 | NOVOEIGHT 1000 UI UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOEIGHT 1000 UI UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 1.000 UI | 80 | 1 | 34 | 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113888003/113888003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113888003/113888003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2015-03-17 | 1 | 1 | 1 | 2015-03-17 | 2015-03-17 | 1 | 2015-10-02 | View Edit Delete | ||||||||||||
| 705722 | 113888005 | NOVOEIGHT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOEIGHT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 2.000 UI | 80 | 1 | 34 | 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113888005/113888005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113888005/113888005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2015-03-17 | 1 | 1 | 1 | 2015-03-17 | 2015-03-17 | 1 | 2015-10-02 | View Edit Delete | ||||||||||||
| 705724 | 113888006 | NOVOEIGHT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | NOVOEIGHT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 3.000 UI | 80 | 1 | 34 | 1 vial de polvo (turoctocog alfa) + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113888006/113888006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113888006/113888006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2015-03-17 | 1 | 1 | 1 | 2015-03-17 | 2015-03-17 | 1 | 2015-10-02 | View Edit Delete | ||||||||||||
| 705764 | 98073002 | EVISTA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EVISTA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98073002/98073002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98073002/98073002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29938 | 29938 | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 705800 | 79646 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 125 MG/31,25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 125 MG/31,25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 125 mg/31,25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79646/79646_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79646/79646_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705801 | 79647 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 100 mg/25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79647/79647_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79647/79647_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705802 | 79648 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 150 MG/37,5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 150 MG/37,5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 150 mg/37,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79648/79648_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79648/79648_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705803 | 79649 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 200 MG/50 MG /200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 200 MG/50 MG /200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 200 mg/50 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79649/79649_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79649/79649_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705804 | 79650 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 100 mg/25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79650/79650_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79650/79650_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2017-06-15 | View Edit Delete | ||||||||||||
| 705805 | 79651 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 125 mg /31,25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 125 mg /31,25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 125 mg/31,25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79651/79651_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79651/79651_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 705807 | 79652 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 150 mg /37,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 150 mg /37,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 150 mg/37,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79652/79652_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79652/79652_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2017-12-14 | View Edit Delete | ||||||||||||
| 705810 | 79655 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 50 mg /12,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 50 mg /12,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 50 mg/12,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79655/79655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79655/79655_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 705811 | 79656 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 75 mg /18,75 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 75 mg /18,75 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 75 mg/18,75 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79656/79656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79656/79656_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 705812 | 79657 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 75 MG/18,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 75 MG/18,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 75 mg/18,75 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79657/79657_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79657/79657_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705813 | 79658 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 50 MG/12,5 MG/200MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 50 MG/12,5 MG/200MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 50 mg/12,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79658/79658_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79658/79658_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705832 | 64186 | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64186/64186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64186/64186_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-08-17 | 1 | 1 | 1 | 2001-08-17 | 2015-03-17 | 1 | 2015-07-13 | View Edit Delete | ||||||||||||
| 705833 | 65569 | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 40 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65569/65569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65569/65569_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2003-09-05 | 1 | 1 | 1 | 2003-09-05 | 2015-03-17 | 1 | 2015-06-15 | View Edit Delete | ||||||||||||
| 705902 | 114941002 | VIZAMYL 400 MBq/ml solucion inyectable Flutemetamol (18F) | VIZAMYL 400 MBq/ml solucion inyectable Flutemetamol (18F), 1 vial de 1-15 ml | 400 MBq/ml | 45 | 1 | 34 | 1 vial de 1-15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114941002/114941002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114941002/114941002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7727 | 10603 | 2015-03-24 | 1 | 1 | 1 | 2015-03-24 | 2015-03-24 | 1 | 2016-03-14 | View Edit Delete | ||||||||||||
| 706086 | 64186 | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL SANDOZ FARMACEUTICA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64186/64186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64186/64186_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2001-08-17 | 1 | 1 | 1 | 2001-08-17 | 2015-04-08 | 1 | 2015-07-13 | View Edit Delete | ||||||||||||
| 706087 | 65569 | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL SANDOZ FARMACEUTICA 40 MG CAPSULAS DURAS GASTRORRESISTENTES, 56 cápsulas | 40 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65569/65569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65569/65569_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2003-09-05 | 1 | 1 | 1 | 2003-09-05 | 2015-04-08 | 1 | 2015-06-15 | View Edit Delete | ||||||||||||
| 706553 | 79371 | DULOXETINA PENSA PHARMA 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA PENSA PHARMA 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas (PVC/PVDC-Aluminio) | 60 mg | 5 | 56 | 43 | 56 cápsulas (PVC/PVDC-Aluminio) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79371/79371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79371/79371_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2014-12-26 | 1 | 1 | 1 | 2014-12-26 | 2015-05-25 | 1 | 2018-07-02 | View Edit Delete | ||||||||||||
| 706632 | 63983 | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas | 20 mg | 6 | 14 | 43 | 14 cápsulas (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63983/63983_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63983/63983_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2001-06-11 | 1 | 1 | 1 | 2001-06-11 | 2015-05-26 | 1 | 2016-01-18 | View Edit Delete | ||||||||||||
| 706633 | 63983 | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63983/63983_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63983/63983_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2001-06-11 | 1 | 1 | 1 | 2001-06-11 | 2015-05-26 | 1 | 2016-01-18 | View Edit Delete | ||||||||||||
| 706809 | 79947 | RHINOVIN ALERGIA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | RHINOVIN ALERGIA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 60 pulverizaciones | 50 microgramos/dosis | 6 | 60 | 31 | 60 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79947/79947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79947/79947_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71217 | 71217 | 2016-05-27 | 1 | 1 | 1 | 2016-05-27 | 2016-05-27 | 1 | 2016-12-21 | View Edit Delete | ||||||||||||
| 706934 | 1151014002 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002/1151014002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002/1151014002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2015-07-06 | 1 | 1 | 1 | 2015-07-06 | 2015-07-06 | 1 | 2015-12-17 | View Edit Delete | ||||||||||||
| 706935 | 1151014001 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001/1151014001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001/1151014001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2015-07-06 | 1 | 1 | 1 | 2015-07-06 | 2015-07-06 | 1 | 2015-12-17 | View Edit Delete | ||||||||||||
| 707062 | 80037 | TAPTIQOM 15 MICROGRAMOS/ML+ 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | TAPTIQOM 15 MICROGRAMOS/ML+ 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS , 30 envases de 0,3 ml | 15 microgramos/ml + 5 mg/ml | 37 | 30 | 16 | 30 envases de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80037/80037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80037/80037_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2015-07-22 | 1 | 1 | 1 | 2015-07-22 | 2015-07-22 | 1 | 2016-04-06 | View Edit Delete | ||||||||||||
| 707148 | 1-24293IP | SEBIPROX 15 MG/G CHAMPU | SEBIPROX 15 MG/G CHAMPU 1 frasco de 100ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/1-24293IP/1-24293IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5150 | 43579 | 2015-07-24 | 1 | 1 | 1 | 2015-07-24 | 2015-07-24 | 1 | 2015-11-12 | View Edit Delete | ||||||||||||
| 707150 | 104303005 | ORFADIN 4 mg/ml SUSPENSION ORAL | ORFADIN 4 mg/ml SUSPENSION ORAL , 1 frasco de 90 ml | 4 mg/ml | 6 | 90 | 26 | 1 frasco de 90 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/104303005/104303005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/104303005/104303005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30275 | 30717 | 2015-07-27 | 1 | 1 | 1 | 2015-07-27 | 2015-07-27 | 1 | 2016-07-28 | View Edit Delete | ||||||||||||
| 707342 | 1151007002 | GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA | GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml | N/A (Vacuna) | 33 | 1 | 61 | 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151007002/1151007002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151007002/1151007002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | 69623 | 2015-08-03 | 1 | 1 | 1 | 2015-08-03 | 2015-08-03 | 1 | 2017-04-11 | View Edit Delete | ||||||||||||
| 707491 | 1151016002 | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 140 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016002/1151016002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016002/1151016002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2015-08-19 | 1 | 1 | 1 | 2015-08-19 | 2015-08-19 | 1 | 2016-01-27 | View Edit Delete | ||||||||||||
| 707562 | 96015003 | EPIVIR 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EPIVIR 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 300 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96015003/96015003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96015003/96015003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | 3776 | 2002-05-14 | 1 | 1 | 1 | 2008-03-28 | 2008-03-28 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 707730 | 114931006 | MEKINIST 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | MEKINIST 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 COMPRIMIDOS | 2 mg | 6 | 30 | 10 | 30 COMPRIMIDOS | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114931006/114931006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114931006/114931006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2015-09-24 | 1 | 1 | 1 | 2015-09-24 | 2015-09-24 | 1 | 2016-03-09 | View Edit Delete | ||||||||||||
| 707852 | 80236 | QUETIAPINA PHARMA COMBIX 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA PHARMA COMBIX 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80236/80236_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80236/80236_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2016-06-06 | View Edit Delete | ||||||||||||
| 707855 | 80237 | QUETIAPINA PHARMA COMBIX 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA PHARMA COMBIX 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80237/80237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80237/80237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2016-06-06 | View Edit Delete | ||||||||||||
| 707857 | 80238 | QUETIAPINA PHARMA COMBIX 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA PHARMA COMBIX 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80238/80238_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80238/80238_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2016-06-06 | View Edit Delete | ||||||||||||
| 707859 | 80239 | QUETIAPINA PHARMA COMBIX 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA PHARMA COMBIX 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80239/80239_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80239/80239_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2016-06-06 | View Edit Delete | ||||||||||||
| 707861 | 80240 | QUETIAPINA PHARMA COMBIX 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA PHARMA COMBIX 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80240/80240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80240/80240_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2016-06-06 | View Edit Delete | ||||||||||||
| 707863 | 80241 | QUETIAPINA TARBIS 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TARBIS 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80241/80241_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80241/80241_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2019-10-17 | View Edit Delete | ||||||||||||
| 707865 | 80243 | QUETIAPINA TARBIS 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TARBIS 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80243/80243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80243/80243_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2019-10-17 | View Edit Delete | ||||||||||||
| 707866 | 80244 | QUETIAPINA TARBIS 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TARBIS 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80244/80244_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80244/80244_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2019-10-17 | View Edit Delete | ||||||||||||
| 707867 | 80245 | QUETIAPINA TARBIS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA TARBIS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80245/80245_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80245/80245_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2015-09-30 | 1 | 1 | 1 | 2015-09-30 | 2015-09-30 | 1 | 2019-10-17 | View Edit Delete | ||||||||||||
| 708015 | 80278 | DOCETAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION Y PERFUSION EFG | DOCETAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION Y PERFUSION EFG 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80278/80278_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80278/80278_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2015-10-07 | 1 | 1 | 1 | 2015-10-07 | 2015-10-07 | 1 | 2022-06-29 | View Edit Delete | ||||||||||||
| 708018 | 80278 | DOCETAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION Y PERFUSION EFG | DOCETAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION Y PERFUSION EFG 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80278/80278_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80278/80278_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2015-10-07 | 1 | 1 | 1 | 2015-10-07 | 2015-10-07 | 1 | 2021-08-24 | View Edit Delete | ||||||||||||
| 708297 | 72145 | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72145/72145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72145/72145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2015-10-21 | 1 | 2017-10-18 | View Edit Delete | ||||||||||||
| 708298 | 72146 | OMEPRAZOL AUROVITAS SPAIN 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL AUROVITAS SPAIN 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 56 cápsulas | 40 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72146/72146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72146/72146_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2015-10-21 | 1 | 2020-10-30 | View Edit Delete | ||||||||||||
| 708586 | 64730 | RHINOCORT 64 microgramos SUSPENSION PARA PULVERIZACION NASAL | RHINOCORT 64 microgramos SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 120 dosis | 64 microgramos/dosis | 34 | 120 | 31 | 1 envase pulverizador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64730/64730_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64730/64730_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2002-04-26 | 1 | 1 | 1 | 2002-04-26 | 2004-05-10 | 1 | 2011-10-24 | 727545 | View Edit Delete | |||||||||||
| 709194 | 80473 | AMLODIPINO/ATORVASTATINA NORMON 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/ATORVASTATINA NORMON 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80473/80473_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80473/80473_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2015-12-11 | 1 | 1 | 1 | 2015-12-11 | 2015-12-11 | 1 | 2016-02-12 | View Edit Delete | ||||||||||||
| 709195 | 80474 | AMLODIPINO/ATORVASTATINA NORMON 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/ATORVASTATINA NORMON 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80474/80474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80474/80474_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2015-12-11 | 1 | 1 | 1 | 2015-12-11 | 2015-12-11 | 1 | 2016-02-12 | View Edit Delete | ||||||||||||
| 709226 | 1151047001 | Blincyto 38,5mcg de polvo para concentrado y solucion para solucion para perfusion | Blincyto 38,5mcg de polvo para concentrado y solucion para solucion para perfusion 1 vial | 38,5 microgramos | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1151047001/1151047001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151047001/1151047001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 7884 | 41943 | 2015-12-16 | 1 | 1 | 1 | 2015-12-16 | 2015-12-16 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 709242 | 103256013 | Humira 40mg solucion inyectable en jeringa precargada | Humira 40mg solucion inyectable en jeringa precargada 2 jeringas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/103256013/103256013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/103256013/103256013_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2015-12-16 | 1 | 1 | 1 | 2015-12-16 | 2015-12-16 | 1 | 2017-01-01 | View Edit Delete | ||||||||||||
| 709247 | 1151040002 | Intuniv 1mg comprimidos de liberacion prolongada | Intuniv 1mg comprimidos de liberacion prolongada Blister de 28 comprimidos de liberación prolongada | 1 mg | 5 | 28 | 10 | Blister de 28 comprimidos de liberación prolongada | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1151040002/1151040002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151040002/1151040002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | 70973 | 2015-12-17 | 1 | 1 | 1 | 2015-12-17 | 2015-12-17 | 1 | 2016-12-15 | View Edit Delete | ||||||||||||
| 709248 | 1151040004 | Intuniv 2mg comprimidos de liberacion prolongada | Intuniv 2mg comprimidos de liberacion prolongada Blister 28 comprimidos de liberación prolongada | 2 mg | 5 | 28 | 10 | Blister 28 comprimidos de liberación prolongada | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1151040004/1151040004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151040004/1151040004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | 70973 | 2015-12-17 | 1 | 1 | 1 | 2015-12-17 | 2015-12-17 | 1 | 2016-12-15 | View Edit Delete | ||||||||||||
| 709249 | 1151040006 | Intuniv 3mg comprimidos de liberacion prolongada | Intuniv 3mg comprimidos de liberacion prolongada Blister 28 comprimidos de liberación prolongada | 3 mg | 5 | 28 | 10 | Blister 28 comprimidos de liberación prolongada | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1151040006/1151040006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151040006/1151040006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | 70973 | 2015-12-17 | 1 | 1 | 1 | 2015-12-17 | 2015-12-17 | 1 | 2016-12-15 | View Edit Delete | ||||||||||||
| 709250 | 1151040008 | Intuniv 4mg comprimidos de liberacion prolongada | Intuniv 4mg comprimidos de liberacion prolongada Blister 28 comprimidos de liberación prolongada | 4 mg | 5 | 28 | 10 | Blister 28 comprimidos de liberación prolongada | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1151040008/1151040008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151040008/1151040008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | 70973 | 2015-12-17 | 1 | 1 | 1 | 2015-12-17 | 2015-12-17 | 1 | 2016-12-15 | View Edit Delete | ||||||||||||
| 709252 | 80496 | CICLOPIROX OLAMINA ABAMED 15 MG/G CHAMPU | CICLOPIROX OLAMINA ABAMED 15 MG/G CHAMPU , 100 ml | 15 mg/g | 6 | 100 | 26 | 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80496/80496_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80496/80496_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41325 | 41325 | 2015-12-17 | 1 | 1 | 1 | 2015-12-17 | 2015-12-17 | 1 | 2016-03-14 | View Edit Delete | ||||||||||||
| 709410 | 98081003 | COMTAN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | COMTAN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98081003/98081003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98081003/98081003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 1999-01-01 | 1 | 1 | 1 | 1999-01-01 | 1999-01-01 | 1 | 2011-02-24 | View Edit Delete | ||||||||||||
| 709451 | 43906 | ANTICERUMEN LIADE | ANTICERUMEN LIADE, 1 frasco de 10 ml | 50 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5085 | 67189 | 1967-01-01 | 1 | 1 | 1 | 1967-01-01 | 1967-01-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 709452 | 103256017 | HUMIRA 40 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA | HUMIRA 40 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/103256017/103256017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/103256017/103256017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2016-01-11 | 1 | 1 | 1 | 2016-01-11 | 2016-01-11 | 1 | 2017-01-01 | View Edit Delete | ||||||||||||
| 709732 | 114970003 | Rixubis 1000UI/vial polvo y disolvente para solucion inyectable | Rixubis 1000UI/vial polvo y disolvente para solucion inyectable 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 1000 UI | 45 | 1 | 34 | 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114970003/114970003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114970003/114970003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | 70973 | 2016-01-18 | 1 | 1 | 1 | 2016-01-18 | 2016-01-18 | 1 | 2016-10-11 | View Edit Delete | ||||||||||||
| 709734 | 114970004 | Rixubis 2000UI/vial polvo y disolvente para solucion inyectable | Rixubis 2000UI/vial polvo y disolvente para solucion inyectable 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 2000 UI | 45 | 1 | 34 | 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114970004/114970004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114970004/114970004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | 70973 | 2016-01-18 | 1 | 1 | 1 | 2016-01-18 | 2016-01-18 | 1 | 2016-10-11 | View Edit Delete | ||||||||||||
| 709735 | 114970005 | Rixubis 3000UI/vial polvo y disolvente para solucion inyectable | Rixubis 3000UI/vial polvo y disolvente para solucion inyectable 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 3000 UI | 45 | 1 | 34 | 1 vial de polvo + 1 vial de disolvente + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114970005/114970005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114970005/114970005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | 70973 | 2016-01-18 | 1 | 1 | 1 | 2016-01-18 | 2016-01-18 | 1 | 2016-10-11 | View Edit Delete | ||||||||||||
| 709737 | 114980004 | COSENTYX 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | COSENTYX 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 150 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114980004/114980004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114980004/114980004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2016-01-19 | 1 | 1 | 1 | 2016-01-19 | 2016-01-19 | 1 | 2016-04-15 | View Edit Delete | ||||||||||||
| 709756 | 80572 | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal , 140 dosis | 50 microgramos/dosis | 6 | 140 | 30 | 140 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80572/80572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80572/80572_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2016-01-22 | 1 | 1 | 1 | 2016-01-22 | 2016-01-22 | 1 | 2016-06-15 | View Edit Delete | ||||||||||||
| 709813 | 80604 | DROSBELALLEFLEX 3 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DROSBELALLEFLEX 3 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 120 (5 x 24) comprimidos | 3 mg/0,02 mg | 5 | 120 | 10 | 120 (5 x 24) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80604/80604_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80604/80604_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2016-01-26 | 1 | 1 | 1 | 2016-05-31 | 2016-05-31 | 1 | 2016-10-24 | View Edit Delete | ||||||||||||
| 709818 | 63983 | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL CINFA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas (frasco) | 20 mg | 6 | 56 | 43 | 56 cápsulas (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63983/63983_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63983/63983_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2001-06-11 | 1 | 1 | 1 | 2001-06-11 | 2016-01-25 | 1 | 2016-01-27 | View Edit Delete | ||||||||||||
| 710049 | 1151016003 | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas | 140 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016003/1151016003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016003/1151016003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2016-02-24 | 1 | 1 | 1 | 2016-02-24 | 2016-02-24 | 1 | 2016-06-01 | View Edit Delete | ||||||||||||
| 710303 | 1151076008 | KOVALTRY 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 2000 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076008/1151076008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076008/1151076008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2016-03-11 | 1 | 2016-10-10 | View Edit Delete | ||||||||||||
| 710304 | 1151076010 | KOVALTRY 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 3000 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076010/1151076010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076010/1151076010_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2016-03-11 | 1 | 2016-10-10 | View Edit Delete | ||||||||||||
| 711045 | 69139 | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL COMBIX 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG,28 CÁPSULAS (frasco) | 20 mg | 6 | 28 | 43 | 28 CÁPSULAS | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69139/69139_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69139/69139_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2016-05-26 | 1 | 2017-01-04 | View Edit Delete | ||||||||||||
| 711070 | 1161088002 | EMPLICITI 400 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | EMPLICITI 400 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial | 400 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161088002/1161088002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161088002/1161088002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2016-05-30 | 1 | 1 | 1 | 2016-05-31 | 2016-05-30 | 1 | 2017-12-11 | View Edit Delete | ||||||||||||
| 711211 | 1151085001 | TALTZ 80 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | TALTZ 80 mg SOLUCION INYECTABLE, 1 pluma precargada de 1 ml | 80 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151085001/1151085001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151085001/1151085001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 37945 | 1673 | 2016-06-15 | 1 | 1 | 1 | 2016-06-16 | 2016-06-15 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 711212 | 1151085001 | TALTZ 80 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | TALTZ 80 mg SOLUCION INYECTABLE, 2 plumas precargadas de 1 ml | 80 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151085001/1151085001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151085001/1151085001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 37945 | 1673 | 2016-06-15 | 1 | 1 | 1 | 2016-06-16 | 2016-06-15 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 711213 | 1151085004 | TALTZ 80 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | TALTZ 80 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 80 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151085004/1151085004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151085004/1151085004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 37945 | 1673 | 2016-06-15 | 1 | 1 | 1 | 2016-06-16 | 2016-06-15 | 1 | 2016-11-11 | View Edit Delete | ||||||||||||
| 712075 | 96005005 | CELLCEPT 500 MG POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION | CELLCEPT 500 MG POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION, 4 viales | 500 mg | 45 | 4 | 34 | 4 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96005005/96005005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96005005/96005005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | 5458 | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 712215 | 81154 | QUETIAPINA CINFA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA CINFA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81154/81154_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81154/81154_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2016-08-16 | 1 | 1 | 1 | 2016-08-17 | 2016-08-16 | 1 | 2017-02-10 | View Edit Delete | ||||||||||||
| 712267 | 1161095003 | IDELVION 1000 UI polvo y disolvente para solucion inyectable | IDELVION 1000 UI polvo y disolvente para solucion inyectable, 1 vial+1 vial de disolvente | 1000 UI | 83 | 1 | 34 | 1 vial+1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161095003/1161095003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161095003/1161095003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 27753 | 37033 | 2016-08-30 | 1 | 1 | 1 | 2016-08-31 | 2016-08-30 | 1 | 2017-06-01 | View Edit Delete | ||||||||||||
| 712268 | 1161095004 | IDELVION 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | IDELVION 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 vial de disolvente | 2000 UI | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161095004/1161095004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161095004/1161095004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 27753 | 37033 | 2016-08-30 | 1 | 1 | 1 | 2016-08-31 | 2016-08-30 | 1 | 2017-06-01 | View Edit Delete | ||||||||||||
| 712269 | 1161095001 | IDELVION 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | IDELVION 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial + 1 vial de disolvente | 250 UI | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161095001/1161095001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161095001/1161095001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 27753 | 37033 | 2016-08-30 | 1 | 1 | 1 | 2016-08-31 | 2016-08-30 | 1 | 2017-06-01 | View Edit Delete | ||||||||||||
| 712270 | 1161095002 | IDELVION 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | IDELVION 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE 1 vial + 1 vial de disolvente | 500 UI | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161095002/1161095002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161095002/1161095002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 27753 | 37033 | 2016-08-30 | 1 | 1 | 1 | 2016-08-31 | 2016-08-30 | 1 | 2018-02-14 | View Edit Delete | ||||||||||||
| 712570 | 1151024002 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002/1151024002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002/1151024002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 1828 | 2016-09-23 | 1 | 1 | 1 | 2016-09-24 | 2016-09-23 | 1 | 2017-05-30 | View Edit Delete | ||||||||||||
| 712834 | 81274 | REMIDOL 650 MG/20 MG/4 MG GRANULADO PARA SOLUCION ORAL EFG | REMIDOL 650 MG/20 MG/4 MG GRANULADO PARA SOLUCION ORAL EFG, 10 sobres | 650 mg/4 mg/20 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81274/81274_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81274/81274_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | 5478 | 2016-10-06 | 1 | 1 | 1 | 2016-10-07 | 2016-10-06 | 1 | 2016-11-08 | View Edit Delete | ||||||||||||
| 712886 | 69487 | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 56 cápsulas (FRASCO) | 40 mg | 6 | 56 | 43 | 56 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69487/69487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69487/69487_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2007-12-21 | 1 | 1 | 1 | 2007-12-21 | 2016-10-10 | 1 | 2017-02-14 | View Edit Delete | ||||||||||||
| 712909 | 63908 | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG,56 cápsulas (frasco) | 20 mg | 6 | 56 | 43 | 56 cápsulas (frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63908/63908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63908/63908_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2016-10-11 | 1 | 2017-02-14 | View Edit Delete | ||||||||||||
| 713095 | 81311 | LANSOPRAZOL FLAS STADA 30MG COMPRIMIDOS BUCODISPERSABLES EFG | LANSOPRAZOL FLAS STADA 30MG COMPRIMIDOS BUCODISPERSABLES EFG 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81311/81311_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81311/81311_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2016-10-13 | 1 | 1 | 1 | 2017-02-22 | 2017-02-22 | 1 | 2017-07-21 | View Edit Delete | ||||||||||||
| 713432 | 108494004 | STELARA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | STELARA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108494004/108494004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108494004/108494004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2016-10-31 | 1 | 1 | 1 | 2016-11-01 | 2016-10-31 | 1 | 2017-06-05 | View Edit Delete | ||||||||||||
| 713508 | 81390 | HQUIN 40 MG/G CREMA | HQUIN 40 MG/G CREMA 1 tubo de 30 g | 40 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81390/81390_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81390/81390_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | 67780 | 2016-11-11 | 1 | 1 | 1 | 2016-11-12 | 2016-11-11 | 1 | 2018-05-11 | View Edit Delete | ||||||||||||
| 713694 | 81466 | TAMSULOSINA COMBIX 0,4 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TAMSULOSINA COMBIX 0,4 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81466/81466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81466/81466_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2016-12-05 | 1 | 1 | 1 | 2016-12-06 | 2016-12-05 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 713947 | 108494005 | STELARA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | STELARA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108494005/108494005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108494005/108494005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2016-12-13 | 1 | 1 | 1 | 2016-12-14 | 2016-12-13 | 1 | 2017-06-05 | View Edit Delete | ||||||||||||
| 714126 | 07410002 | BINOCRIT, 1000 UI/0,5 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 1000 UI/0,5 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,5 ml con protector de seguridad para la aguja | 1.000 UI inyectable 0,5 ml | 22 | 6 | 61 | 6 jeringas precargadas de 0,5 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410002/07410002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410002/07410002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714127 | 07410004 | BINOCRIT, 2000 UI/1 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 2000 UI/1 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 1 ml con protector de seguridad para la aguja | 2.000 UI inyectable 1 ml | 22 | 6 | 61 | 6 jeringas precargadas de 1 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410004/07410004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410004/07410004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714128 | 07410006 | BINOCRIT, 3000 UI/0,3 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 3000 UI/0,3 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,3 ml con protector de seguridad para la aguja | 3.000 UI inyectable 0,3 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,3 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410006/07410006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410006/07410006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714129 | 07410008 | BINOCRIT, 4000 UI/0,4 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 4000 UI/0,4 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,4 ml con protector de seguridad para la aguja | 4.000 UI inyectable 0,4 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,4 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410008/07410008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410008/07410008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714130 | 07410010 | BINOCRIT, 5000 UI/0,5 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 5000 UI/0,5 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,5 ml con protector de seguridad para la aguja | 5.000 UI inyectable 0,5 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,5 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410010/07410010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410010/07410010_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714131 | 07410012 | BINOCRIT, 6000 UI/0,6 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 6000 UI/0,6 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,6 ml con protector de seguridad para la aguja | 6.000 UI inyectable 0,6 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,6 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410012/07410012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410012/07410012_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714132 | 07410014 | BINOCRIT, 8000 UI/0,8 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 8000 UI/0,8 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,8 ml con protector de seguridad para la aguja | 8.000 UI inyectable 0,8 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,8 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410014/07410014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410014/07410014_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714133 | 07410016 | BINOCRIT, 10.000 UI/1 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT, 10.000 UI/1 ml, SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 1 ml con protector de seguridad para la aguja | 10.000 UI inyectable 1 ml | 33 | 6 | 61 | 6 jeringas precargadas de 1 ml con protector de seguridad para la aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410016/07410016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410016/07410016_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 8274 | 2008-02-18 | 1 | 1 | 1 | 2008-02-18 | 2016-12-28 | 1 | 2017-05-12 | View Edit Delete | ||||||||||||
| 714136 | 161138002 | VENCLYXTO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 10 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138002/161138002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138002/161138002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2017-01-05 | 1 | 1 | 1 | 2017-01-06 | 2017-01-05 | 1 | 2018-03-15 | View Edit Delete | ||||||||||||
| 714137 | 161138004 | VENCLYXTO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 7 comprimidos | 50 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138004/161138004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138004/161138004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2017-01-05 | 1 | 1 | 1 | 2017-01-06 | 2017-01-05 | 1 | 2018-03-15 | View Edit Delete | ||||||||||||
| 714138 | 161138005 | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 7 comprimidos | 100 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138005/161138005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138005/161138005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2017-01-05 | 1 | 1 | 1 | 2017-01-06 | 2017-01-05 | 1 | 2018-03-15 | View Edit Delete | ||||||||||||
| 714139 | 161138005 | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 100 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138005/161138005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138005/161138005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2017-01-05 | 1 | 1 | 1 | 2017-01-06 | 2017-01-05 | 1 | 2018-03-15 | View Edit Delete | ||||||||||||
| 714140 | 161138005 | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 100 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138005/161138005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138005/161138005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2017-01-05 | 1 | 1 | 1 | 2017-01-06 | 2017-01-05 | 1 | 2018-03-15 | View Edit Delete | ||||||||||||
| 714435 | 80737 | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 ml | 10 g inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80737/80737_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80737/80737_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2016-03-11 | 1 | 1 | 1 | 2017-01-25 | 2017-01-25 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 714973 | 81772 | TRINOMIA 100 MG/40 MG/2,5 MG CAPSULAS DURAS | TRINOMIA 100 MG/40 MG/2,5 MG CAPSULAS DURAS 28 cápsulas | 40 mg/100 mg/2,5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81772/81772_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81772/81772_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2017-02-20 | 1 | 1 | 1 | 2017-02-21 | 2017-02-20 | 1 | 2017-05-11 | View Edit Delete | ||||||||||||
| 714974 | 81773 | TRINOMIA 100 MG/40 MG/5 MG CAPSULAS DURAS | TRINOMIA 100 MG/40 MG/5 MG CAPSULAS DURAS 28 cápsulas | 40 mg/100 mg/5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81773/81773_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81773/81773_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2017-02-20 | 1 | 1 | 1 | 2017-02-21 | 2017-02-20 | 1 | 2017-05-11 | View Edit Delete | ||||||||||||
| 714975 | 81774 | TRINOMIA 100 MG/40 MG/10 MG CAPSULAS DURAS | TRINOMIA 100 MG/40 MG/10 MG CAPSULAS DURAS 28 cápsulas | 40 mg/100 mg/10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81774/81774_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81774/81774_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | 4115 | 2017-02-20 | 1 | 1 | 1 | 2017-02-21 | 2017-02-20 | 1 | 2017-05-11 | View Edit Delete | ||||||||||||
| 714991 | 81784 | IRBESARTAN AUROVITAS 75 MG COMPRIMIDOS EFG | IRBESARTAN AUROVITAS 75 MG COMPRIMIDOS EFG, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81784/81784_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81784/81784_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2017-02-21 | 1 | 1 | 1 | 2017-02-22 | 2017-02-21 | 1 | 2018-03-14 | View Edit Delete | ||||||||||||
| 714992 | 81785 | IRBESARTAN AUROVITAS 150 MG COMPRIMIDOS EFG | IRBESARTAN AUROVITAS 150 MG COMPRIMIDOS EFG, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81785/81785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81785/81785_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2017-02-21 | 1 | 1 | 1 | 2017-02-22 | 2017-02-21 | 1 | 2018-03-14 | View Edit Delete | ||||||||||||
| 714993 | 81786 | IRBESARTAN AUROVITAS 300 MG COMPRIMIDOS EFG | IRBESARTAN AUROVITAS 300 MG COMPRIMIDOS EFG, 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81786/81786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81786/81786_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2017-02-21 | 1 | 1 | 1 | 2017-02-22 | 2017-02-21 | 1 | 2018-03-14 | View Edit Delete | ||||||||||||
| 715016 | 81311 | LANSOPRAZOL FLAS STADA 30MG COMPRIMIDOS BUCODISPERSABLES EFG | LANSOPRAZOL FLAS STADA 30MG COMPRIMIDOS BUCODISPERSABLES EFG 56 comprimidos | 30 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81311/81311_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81311/81311_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2016-10-13 | 1 | 1 | 1 | 2017-02-22 | 2017-02-22 | 1 | 2018-11-05 | View Edit Delete | ||||||||||||
| 715032 | 81797 | ESOMEPRAZOL NORMON 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMON 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 28 cápsulas (Blister) | 20 mg | 5 | 28 | 43 | 28 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81797/81797_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81797/81797_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-04-05 | 1 | 1 | 1 | 2018-04-05 | 2018-04-05 | 1 | 2022-03-21 | View Edit Delete | ||||||||||||
| 715034 | 81797 | ESOMEPRAZOL NORMON 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMON 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 56 cápsulas (Blster) | 20 mg | 5 | 56 | 43 | 56 cápsulas (Blster) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81797/81797_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81797/81797_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-04-05 | 1 | 1 | 1 | 2018-04-05 | 2018-04-05 | 1 | 2022-03-21 | View Edit Delete | ||||||||||||
| 715058 | 81798 | ESOMEPRAZOL NORMON 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMON 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 28 cápsulas (Blister) | 40 mg | 5 | 28 | 43 | 28 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81798/81798_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81798/81798_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-04-05 | 1 | 1 | 1 | 2018-04-05 | 2018-04-05 | 1 | 2022-03-21 | View Edit Delete | ||||||||||||
| 715061 | 81798 | ESOMEPRAZOL NORMON 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMON 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 56 cápsulas (Blister) | 40 mg | 5 | 56 | 43 | 56 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81798/81798_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81798/81798_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-04-05 | 1 | 1 | 1 | 2018-04-05 | 2018-04-05 | 1 | 2022-03-21 | View Edit Delete | ||||||||||||
| 715083 | 81799 | ESOMEPRAZOL MABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81799/81799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81799/81799_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2018-01-17 | 1 | 1 | 1 | 2018-01-17 | 2018-01-17 | 1 | 2018-05-10 | View Edit Delete | ||||||||||||
| 715085 | 81799 | ESOMEPRAZOL MABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81799/81799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81799/81799_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2018-01-17 | 1 | 1 | 1 | 2018-01-17 | 2018-01-17 | 1 | 2018-05-10 | View Edit Delete | ||||||||||||
| 715109 | 81800 | ESOMEPRAZOL MABO 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81800/81800_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81800/81800_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2018-01-17 | 1 | 1 | 1 | 2018-01-17 | 2018-01-17 | 1 | 2018-05-10 | View Edit Delete | ||||||||||||
| 715111 | 81800 | ESOMEPRAZOL MABO 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG 56 cápsulas | 40 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81800/81800_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81800/81800_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2018-01-17 | 1 | 1 | 1 | 2018-01-17 | 2018-01-17 | 1 | 2018-05-10 | View Edit Delete | ||||||||||||
| 715334 | 61654 | ZARATOR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61654/61654_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61654/61654_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 1997-10-01 | 1 | 1 | 1 | 1997-10-01 | 2001-05-14 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 715504 | 80737 | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 20 ml | 2 g inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80737/80737_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80737/80737_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2016-03-11 | 1 | 1 | 1 | 2017-01-25 | 2017-03-27 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715505 | 80737 | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 50 ml | 5 g inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80737/80737_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80737/80737_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2016-03-11 | 1 | 1 | 1 | 2017-01-25 | 2017-03-27 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715506 | 80737 | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 200 ml | 20 g inyectable 200 ml | 45 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80737/80737_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80737/80737_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2016-03-11 | 1 | 1 | 1 | 2017-01-25 | 2017-03-27 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715578 | 81940 | ACTONEL SEMANAL 35 MG COMPRIMIDOS GASTRORRESISTENTES | ACTONEL SEMANAL 35 MG COMPRIMIDOS GASTRORRESISTENTES, 4 comprimidos | 35 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81940/81940_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81940/81940_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2017-04-06 | 1 | 1 | 1 | 2017-04-07 | 2017-04-06 | 1 | 2018-07-26 | View Edit Delete | ||||||||||||
| 715592 | 1161167001 | TRUXIMA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | TRUXIMA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161167001/1161167001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161167001/1161167001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2017-04-07 | 1 | 1 | 1 | 2017-04-08 | 2017-04-07 | 1 | 2017-06-14 | View Edit Delete | ||||||||||||
| 715773 | 72703 | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (OPA/AL/PVC/AL) | 20 mg | 5 | 56 | 43 | 56 cápsulas (OPA/AL/PVC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72703/72703_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72703/72703_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2017-04-18 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715774 | 72702 | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 capsulas (OPA/Al/PVC/Al) | 40 mg | 5 | 56 | 43 | 56 capsulas (OPA/Al/PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72702/72702_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72702/72702_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-08 | 1 | 1 | 1 | 2010-10-08 | 2017-04-18 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715775 | 72902 | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72902/72902_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72902/72902_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2017-04-18 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 715776 | 72903 | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL TEVA-RATIOPHARM 40 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 40 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72903/72903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72903/72903_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2017-04-18 | 1 | 2017-10-11 | View Edit Delete | ||||||||||||
| 716295 | R6898 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R6898/R6898_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 43579 | 2017-05-30 | 1 | 1 | 1 | 2017-05-31 | 2017-05-30 | 1 | 2017-11-03 | View Edit Delete | ||||||||||||
| 716325 | 842261102022012 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/842261102022012/842261102022012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3041 | 17193 | 2017-06-05 | 1 | 1 | 1 | 2017-06-06 | 2017-06-05 | 1 | 2018-02-08 | View Edit Delete | ||||||||||||
| 716326 | 4787IP | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/4787IP/4787IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 43579 | 2017-06-05 | 1 | 1 | 1 | 2017-06-06 | 2017-06-05 | 1 | 2017-11-03 | View Edit Delete | ||||||||||||
| 716638 | 04787IP | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/04787IP/04787IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 43579 | 2017-06-21 | 1 | 1 | 1 | 2017-06-22 | 2017-06-21 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 716654 | R-6898IP | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R-6898IP/R-6898IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 43579 | 2017-06-24 | 1 | 1 | 1 | 2017-06-25 | 2017-06-24 | 1 | 2017-11-03 | View Edit Delete | ||||||||||||
| 716658 | 1171185001 | RIXATHON 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RIXATHON 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 2 | 34 | 2 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171185001/1171185001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171185001/1171185001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2017-07-31 | 1 | 1 | 1 | 2017-08-01 | 2017-07-31 | 1 | 2018-05-17 | View Edit Delete | ||||||||||||
| 716659 | 1171185003 | RIXATHON 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RIXATHON 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171185003/1171185003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171185003/1171185003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2017-07-31 | 1 | 1 | 1 | 2017-08-01 | 2017-07-31 | 1 | 2018-05-17 | View Edit Delete | ||||||||||||
| 716783 | 1171200001 | BESPONSA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | BESPONSA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 1 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171200001/1171200001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171200001/1171200001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29446 | 11622 | 2017-07-21 | 1 | 1 | 1 | 2017-07-22 | 2017-07-21 | 1 | 2019-05-14 | View Edit Delete | ||||||||||||
| 716850 | 109564004 | ILARIS 150 MG/ML SOLUCION INYECTABLE | ILARIS 150 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml | 150 mg inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/109564004/109564004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/109564004/109564004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2017-07-24 | 1 | 1 | 1 | 2017-07-25 | 2017-07-24 | 1 | 2018-06-13 | View Edit Delete | ||||||||||||
| 716886 | 61716 | CARDYL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61716/61716_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61716/61716_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 1997-10-01 | 1 | 1 | 1 | 1997-10-01 | 2001-05-14 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 718786 | 82373 | RALOXIFENO AUROVITAS 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RALOXIFENO AUROVITAS 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82373/82373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82373/82373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2017-09-01 | 1 | 1 | 1 | 2017-09-02 | 2017-09-01 | 1 | 2018-04-24 | View Edit Delete | ||||||||||||
| 718831 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (Frasco) | 20 mg | 6 | 56 | 43 | 56 cápsulas (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2017-09-07 | 1 | 2018-01-08 | View Edit Delete | ||||||||||||
| 718834 | 67531 | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALMUS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Frasco) | 20 mg | 6 | 28 | 43 | 28 cápsulas (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67531/67531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67531/67531_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2006-02-02 | 1 | 1 | 1 | 2006-02-02 | 2017-09-07 | 1 | 2018-01-08 | View Edit Delete | ||||||||||||
| 719640 | 82566 | ACNEMIN 10 MG CAPSULAS BLANDAS EFG | ACNEMIN 10 MG CAPSULAS BLANDAS EFG, 50 cápsulas | 10 mg | 5 | 50 | 43 | 50 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82566/82566_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82566/82566_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3047 | 3047 | 2017-10-31 | 1 | 1 | 1 | 2017-11-01 | 2017-10-31 | 1 | 2025-07-29 | View Edit Delete | ||||||||||||
| 719642 | 82567 | ACNEMIN 20 MG CAPSULAS BLANDAS EFG | ACNEMIN 20 MG CAPSULAS BLANDAS EFG, 50 cápsulas | 20 mg | 5 | 50 | 43 | 50 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82567/82567_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82567/82567_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3047 | 3047 | 2017-10-31 | 1 | 1 | 1 | 2017-11-01 | 2017-10-31 | 1 | 2025-07-29 | View Edit Delete | ||||||||||||
| 719775 | 82607 | NEBIVOLOL AUROVITAS 5 MG COMPRIMIDOS EFG | NEBIVOLOL AUROVITAS 5 MG COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82607/82607_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82607/82607_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2017-11-15 | 1 | 1 | 1 | 2017-11-16 | 2017-11-15 | 1 | 2018-10-29 | View Edit Delete | ||||||||||||
| 720033 | 78896 | TISSEEL SOLUCIONES PARA ADHESIVO TISULAR | TISSEEL SOLUCIONES PARA ADHESIVO TISULAR,1 x 4 ml (sistema de jeringa Prima) | 91 mg/ml + 3.000 UIC/ml + 500 UI/ml + 40 micromol/ml | 33 | 1 | 61 | 1 x 4 ml (sistema de jeringa Prima) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78896/78896_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78896/78896_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | 7980 | 2014-11-07 | 1 | 1 | 1 | 2014-11-07 | 2017-12-11 | 1 | 2019-03-12 | View Edit Delete | ||||||||||||
| 720034 | 78896 | TISSEEL SOLUCIONES PARA ADHESIVO TISULAR | TISSEEL SOLUCIONES PARA ADHESIVO TISULAR,1 x 10 ml (sistema de jeringa Prima) | 91 mg/ml + 3.000 UIC/ml + 500 UI/ml + 10 micromol/ml | 33 | 1 | 61 | 1 x 10 ml (sistema de jeringa Prima) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78896/78896_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78896/78896_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | 7980 | 2014-11-07 | 1 | 1 | 1 | 2014-11-07 | 2017-12-11 | 1 | 2019-03-12 | View Edit Delete | ||||||||||||
| 720058 | 1171234001 | TREMFYA 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TREMFYA 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA 1 jeringa precargada de 1 ml | 100 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171234001/1171234001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171234001/1171234001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2017-12-14 | 1 | 1 | 1 | 2017-12-15 | 2017-12-14 | 1 | 2018-12-11 | View Edit Delete | ||||||||||||
| 720445 | 82795 | MOMCORT 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMCORT 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82795/82795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82795/82795_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-01-15 | 1 | 1 | 1 | 2018-01-16 | 2018-01-15 | 1 | 2018-07-10 | View Edit Delete | ||||||||||||
| 720536 | 82817 | NEBIVOLOL COMBIX 5 MG COMPRIMIDOS EFG | NEBIVOLOL COMBIX 5 MG COMPRIMIDOS EFG, 28 comprimidos (Blister Al/PVC/PVDC) | 5 mg | 5 | 28 | 10 | 28 comprimidos (Blister Al/PVC/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82817/82817_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82817/82817_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2018-01-24 | 1 | 1 | 1 | 2018-01-25 | 2018-01-24 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 720633 | 82847 | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (Blister) | 20 mg | 5 | 28 | 43 | 28 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82847/82847_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82847/82847_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2018-02-08 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720635 | 82847 | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas (Frasco) | 20 mg | 6 | 28 | 43 | 28 cápsulas (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82847/82847_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82847/82847_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2018-02-08 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720637 | 82848 | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Blister) | 40 mg | 5 | 28 | 43 | 28 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82848/82848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82848/82848_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2018-02-08 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720639 | 82848 | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Frasco) | 40 mg | 6 | 28 | 43 | 28 cápsulas (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82848/82848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82848/82848_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2018-02-08 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720760 | R6898IP1 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R6898IP1/R6898IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 41972 | 2018-02-19 | 1 | 1 | 1 | 2018-02-19 | 2018-02-19 | 1 | 2018-05-17 | View Edit Delete | ||||||||||||
| 720888 | 07434003IP4 | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07434003IP4/07434003IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07434003IP4/07434003IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14862 | 23628 | 2018-02-27 | 1 | 1 | 1 | 2018-02-28 | 2018-02-27 | 1 | 2018-10-08 | View Edit Delete | ||||||||||||
| 720932 | 82921 | ESOMEPRAZOL CINFA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Blister) | 20 mg | 5 | 28 | 43 | 28 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82921/82921_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82921/82921_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-03-07 | 1 | 1 | 1 | 2018-03-08 | 2018-03-07 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720933 | 82921 | ESOMEPRAZOL CINFA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (Blister) | 20 mg | 5 | 56 | 43 | 56 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82921/82921_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82921/82921_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-03-07 | 1 | 1 | 1 | 2018-03-08 | 2018-03-07 | 1 | 2023-06-07 | View Edit Delete | ||||||||||||
| 720940 | 82922 | ESOMEPRAZOL CINFA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Blster) | 40 mg | 5 | 28 | 43 | 28 cápsulas (Blster) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82922/82922_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82922/82922_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-03-07 | 1 | 1 | 1 | 2018-03-08 | 2018-03-07 | 1 | 2018-06-07 | View Edit Delete | ||||||||||||
| 720941 | 82922 | ESOMEPRAZOL CINFA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (Blister) | 40 mg | 5 | 56 | 43 | 56 cápsulas (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82922/82922_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82922/82922_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-03-07 | 1 | 1 | 1 | 2018-03-08 | 2018-03-07 | 1 | 2023-06-07 | View Edit Delete | ||||||||||||
| 721013 | 84225112-2-12 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/84225112-2-12/84225112-2-12_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71207 | 43579 | 2018-03-14 | 1 | 1 | 1 | 2018-03-14 | 2018-03-14 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 721350 | 1171262001 | CRYSVITA 10 MG SOLUCION INYECTABLE | CRYSVITA 10 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 10 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262001/1171262001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262001/1171262001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | 39714 | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 721351 | 1171262002 | CRYSVITA 20 MG SOLUCION INYECTABLE | CRYSVITA 20 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262002/1171262002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262002/1171262002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | 39714 | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 721352 | 1171262003 | CRYSVITA 30 MG SOLUCION INYECTABLE | CRYSVITA 30 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 30 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262003/1171262003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262003/1171262003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | 39714 | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 721421 | 75057 | ESOMEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL AUROVITAS SPAIN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos (blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75057/75057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75057/75057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2018-04-18 | 1 | 2024-02-22 | View Edit Delete | ||||||||||||
| 721422 | 75059 | ESOMEPRAZOL AUROVITAS SPAIN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL AUROVITAS SPAIN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (blister) | 40 mg | 5 | 56 | 10 | 56 comprimidos (blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75059/75059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75059/75059_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2018-04-18 | 1 | 2024-02-22 | View Edit Delete | ||||||||||||
| 721500 | 1-24293IP1 | SEBIPROX 15 MG/G CHAMPU | SEBIPROX 15 MG/G CHAMPU, 1 frasco de 100 ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25446 | 23628 | 2018-04-27 | 1 | 1 | 1 | 2018-04-28 | 2018-04-27 | 1 | 2018-10-08 | View Edit Delete | ||||||||||||
| 721902 | 07434003IP3 | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07434003IP3/07434003IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07434003IP3/07434003IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14862 | 26669 | 2018-05-28 | 1 | 1 | 1 | 2018-05-29 | 2018-05-28 | 1 | 2023-10-26 | View Edit Delete | ||||||||||||
| 721926 | 72679 | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL ALMUS 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas (Frasco HDPE) | 40 mg | 6 | 28 | 43 | 28 cápsulas (Frasco HDPE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72679/72679_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72679/72679_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2011-07-15 | 1 | 1 | 1 | 2011-07-15 | 2018-05-29 | 1 | 2018-09-10 | View Edit Delete | ||||||||||||
| 722044 | 3400935533951 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 (14 X 2) comprimidos | 40 mg | 5 | 28 | 10 | 28 (14 X 2) comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935533951%20/3400935533951__p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67217 | 43579 | 2018-06-12 | 1 | 1 | 1 | 2018-06-13 | 2018-06-12 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 722073 | 3400939239989 | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 43579 | 2018-06-13 | 1 | 1 | 1 | 2018-06-14 | 2018-06-13 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 722150 | 83226 | TENOFOVIR DISOPROXILO CIPLA 245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TENOFOVIR DISOPROXILO CIPLA 245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 245 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83226/83226_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83226/83226_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2018-10-24 | 1 | 1 | 1 | 2018-10-24 | 2018-10-24 | 1 | 2019-01-22 | View Edit Delete | ||||||||||||
| 722184 | 83244 | CETRAXAL PLUS 3 MG/ML + 0,25 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS | CETRAXAL PLUS 3 MG/ML + 0,25 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS, 15 envases unidosis | 0,25 mg/ml + 3 mg/ml | 37 | 15 | 51 | 15 envases unidosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83244/83244_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83244/83244_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2018-06-27 | 1 | 1 | 1 | 2018-06-28 | 2018-06-27 | 1 | 2020-04-15 | View Edit Delete | ||||||||||||
| 722306 | 1181280001 | ZESSLY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ZESSLY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181280001/1181280001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181280001/1181280001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2018-07-16 | 1 | 1 | 1 | 2018-07-17 | 2018-07-16 | 1 | 2019-02-11 | View Edit Delete | ||||||||||||
| 722344 | 36286-00-00 | OPIREN 30 MG CAPSULAS | OPIREN 30 MG CAPSULAS, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/36286-00-00/36286-00-00_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 43579 | 2018-07-06 | 1 | 1 | 1 | 2018-07-07 | 2018-07-06 | 1 | 2018-09-26 | View Edit Delete | ||||||||||||
| 722432 | 83300 | CARVEDILOL AUROVITAS 6,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CARVEDILOL AUROVITAS 6,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 6,25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83300/83300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83300/83300_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | 16109 | 2018-07-13 | 1 | 1 | 1 | 2018-07-14 | 2018-07-13 | 1 | 2019-06-24 | View Edit Delete | ||||||||||||
| 722433 | 83301 | CARVEDILOL AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CARVEDILOL AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83301/83301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83301/83301_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | 16109 | 2018-07-13 | 1 | 1 | 1 | 2018-07-14 | 2018-07-13 | 1 | 2019-06-24 | View Edit Delete | ||||||||||||
| 723316 | 57606 | FML 1 mg/ml colirio en suspensión | FML 1 mg/ml colirio en suspensión, 1 envase cuentagotas de 5 ml | 1 mg/ml | 6 | 5 | 26 | 1 envase cuentagotas de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57606/57606_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57606/57606_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16052 | 16052 | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 2018-09-14 | 1 | 2011-10-17 | 977504 | View Edit Delete | |||||||||||
| 723417 | 83376 | LUTRATE DEPOT TRIMESTRAL 22,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | LUTRATE DEPOT TRIMESTRAL 22,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 jeringa precargada de 2 ml | 22,5 mg | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83376/83376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83376/83376_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7882 | 7882 | 2019-04-02 | 1 | 1 | 1 | 2019-04-02 | 2019-04-02 | 1 | 2025-05-07 | View Edit Delete | ||||||||||||
| 723419 | 83377 | LUTRATE DEPOT MENSUAL 3,75 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | LUTRATE DEPOT MENSUAL 3,75 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE 1 vial + jeringa precargada de 2 ml | 3,75 mg | 80 | 1 | 61 | 1 vial + jeringa precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83377/83377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83377/83377_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7882 | 7882 | 2019-04-02 | 1 | 1 | 1 | 2019-04-02 | 2019-04-02 | 1 | 2021-01-13 | View Edit Delete | ||||||||||||
| 723426 | 83380 | FOSAPREPITANT ACCORD 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG | FOSAPREPITANT ACCORD 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83380/83380_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83380/83380_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2018-08-08 | 1 | 1 | 1 | 2018-08-09 | 2018-08-08 | 1 | 2022-11-10 | View Edit Delete | ||||||||||||
| 723530 | 83401 | ESOMEPRAZOL NORMOGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMOGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG 28 comprimidos (Blister OPA/Al/PE-Al/PE) | 20 mg | 5 | 28 | 10 | 28 comprimidos (Blister OPA/Al/PE-Al/PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83401/83401_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83401/83401_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-09-04 | 1 | 1 | 1 | 2018-09-05 | 2018-09-04 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 723531 | 83401 | ESOMEPRAZOL NORMOGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMOGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG 56 comprimidos (Blister OPA/Al/PE-Al/PE) | 20 mg | 5 | 56 | 10 | 56 comprimidos (Blister OPA/Al/PE-Al/PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83401/83401_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83401/83401_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-09-04 | 1 | 1 | 1 | 2018-09-05 | 2018-09-04 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 723537 | 83402 | ESOMEPRAZOL NORMOGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMOGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG 56 comprimidos (Blister OPA/Al/PE-Al/PE) | 40 mg | 5 | 56 | 10 | 56 comprimidos (Blister OPA/Al/PE-Al/PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83402/83402_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83402/83402_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-09-04 | 1 | 1 | 1 | 2018-09-05 | 2018-09-04 | 1 | 2019-10-22 | View Edit Delete | ||||||||||||
| 723552 | R6898IP2 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 23628 | 2018-09-04 | 1 | 1 | 1 | 2018-09-05 | 2018-09-04 | 1 | 2018-12-10 | View Edit Delete | ||||||||||||
| 723565 | R-6898IP1 | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 23628 | 2018-09-06 | 1 | 1 | 1 | 2018-09-07 | 2018-09-06 | 1 | 2018-12-10 | View Edit Delete | ||||||||||||
| 723573 | 77013 | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 15 MG CAPSULAS DURAS GASTRORRESISTENTES EFG,56 Cápsulas | 15 mg | 5 | 56 | 43 | 56 Cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77013/77013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77013/77013_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2018-09-12 | 1 | 2018-11-07 | View Edit Delete | ||||||||||||
| 723574 | 77014 | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL STADA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG ,56 cápsulas | 30 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77014/77014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77014/77014_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2018-09-12 | 1 | 2018-11-07 | View Edit Delete | ||||||||||||
| 723591 | 83417 | EPLERENONA KRKA 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA KRKA 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83417/83417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83417/83417_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2018-09-19 | 1 | 1 | 1 | 2018-09-20 | 2018-09-19 | 1 | 2018-11-12 | View Edit Delete | ||||||||||||
| 723592 | 83418 | EPLERENONA KRKA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EPLERENONA KRKA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83418/83418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83418/83418_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2018-09-19 | 1 | 1 | 1 | 2018-09-20 | 2018-09-19 | 1 | 2018-11-12 | View Edit Delete | ||||||||||||
| 723598 | 75075 | ESOMEPRAZOL PENSA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75075/75075_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75075/75075_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2018-09-17 | 1 | 2022-01-04 | View Edit Delete | ||||||||||||
| 723599 | 75076 | ESOMEPRAZOL PENSA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75076/75076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75076/75076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2018-09-17 | 1 | 2022-01-04 | View Edit Delete | ||||||||||||
| 723628 | 3400928005557 | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33992 | 43579 | 2018-09-21 | 1 | 1 | 1 | 2018-09-22 | 2018-09-21 | 1 | 2023-02-06 | View Edit Delete | ||||||||||||
| 723682 | 3400934306983 | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400934306983/3400934306983_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 43579 | 2018-09-27 | 1 | 1 | 1 | 2018-09-28 | 2018-09-27 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 723771 | 3400935557506 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506/3400935557506_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 43579 | 2018-10-10 | 1 | 1 | 1 | 2018-10-11 | 2018-10-10 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 723798 | 62825 | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ADIRO 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 30 comprimidos (PVC- Aluminio) | 100 mg | 5 | 30 | 10 | 30 comprimidos (PVC- Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62825/62825_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62825/62825_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11424 | 11424 | 1999-12-10 | 1 | 1 | 1 | 2012-08-07 | 2018-11-05 | 1 | 2018-11-12 | View Edit Delete | ||||||||||||
| 723810 | 3400928005786 | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71151 | 43579 | 2018-10-16 | 1 | 1 | 1 | 2018-10-17 | 2018-10-16 | 1 | 2023-02-06 | View Edit Delete | ||||||||||||
| 723846 | 4040 | LOBIVON 5 MG COMPRIMIDOS | LOBIVON 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/4040/4040_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 398 | 43579 | 2018-10-19 | 1 | 1 | 1 | 2018-10-20 | 2018-10-19 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 723962 | 4787IP1 | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 23628 | 2018-11-06 | 1 | 1 | 1 | 2018-11-07 | 2018-11-06 | 1 | 2019-02-12 | View Edit Delete | ||||||||||||
| 723963 | 4787IP2 | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 23628 | 2018-11-06 | 1 | 1 | 1 | 2018-11-07 | 2018-11-06 | 1 | 2019-02-12 | View Edit Delete | ||||||||||||
| 724431 | 83698 | NEOMYX 0,5 MG/0,4 MG CAPSULAS DURAS | NEOMYX 0,5 MG/0,4 MG CAPSULAS DURAS, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83698/83698_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83698/83698_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2018-12-26 | 1 | 1 | 1 | 2018-12-27 | 2018-12-26 | 1 | 2019-04-11 | View Edit Delete | ||||||||||||
| 724433 | 83700 | DUTASTERIDA/TAMSULOSINA TARBIS 0,5 MG/0,4 MG CAPSULAS DURAS | DUTASTERIDA/TAMSULOSINA TARBIS 0,5 MG/0,4 MG CAPSULAS DURAS, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83700/83700_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83700/83700_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2018-12-26 | 1 | 1 | 1 | 2018-12-27 | 2018-12-26 | 1 | 2021-06-14 | View Edit Delete | ||||||||||||
| 724434 | 83701 | DUTASTERIDA/TAMSULOSINA ALTER GENERICOS 0,5 MG/0,4 MG CAPSULAS DURAS | DUTASTERIDA/TAMSULOSINA ALTER GENERICOS 0,5 MG/0,4 MG CAPSULAS DURAS, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83701/83701_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83701/83701_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2018-12-26 | 1 | 1 | 1 | 2018-12-27 | 2018-12-26 | 1 | 2019-04-11 | View Edit Delete | ||||||||||||
| 724437 | 83704 | DUTASTERIDA/TAMSULOSINA ALMUS PHARMA 0,5 MG/0,4 MG CAPSULAS DURAS | DUTASTERIDA/TAMSULOSINA ALMUS PHARMA 0,5 MG/0,4 MG CAPSULAS DURAS, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83704/83704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83704/83704_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2018-12-26 | 1 | 1 | 1 | 2018-12-27 | 2018-12-26 | 1 | 2019-05-13 | View Edit Delete | ||||||||||||
| 724440 | 83707 | DUTASTERIDA/TAMSULOSINA QUALIGEN 0,5 MG/0,4 MG CAPSULAS DURAS | DUTASTERIDA/TAMSULOSINA QUALIGEN 0,5 MG/0,4 MG CAPSULAS DURAS , 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83707/83707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83707/83707_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2018-12-26 | 1 | 1 | 1 | 2018-12-27 | 2018-12-26 | 1 | 2019-04-12 | View Edit Delete | ||||||||||||
| 724622 | 36286-00-00IP | OPIREN 30 MG CAPSULAS | OPIREN 30 mg CAPSULAS, 14 cápsulas | 30 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 17193 | 2019-01-22 | 1 | 1 | 1 | 2019-01-23 | 2019-01-22 | 1 | 2020-02-24 | View Edit Delete | ||||||||||||
| 724623 | 36286-00-00IP | OPIREN 30 MG CAPSULAS | OPIREN 30 mg CAPSULAS, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 17193 | 2019-01-22 | 1 | 1 | 1 | 2019-01-23 | 2019-01-22 | 1 | 2020-02-24 | View Edit Delete | ||||||||||||
| 724667 | 83402 | ESOMEPRAZOL NORMOGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL NORMOGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG 28 comprimidos (Blister OPA/Al/PE-Al/PE) | 40 mg | 5 | 28 | 10 | 28 comprimidos (Blister OPA/Al/PE-Al/PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83402/83402_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83402/83402_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2018-09-04 | 1 | 1 | 1 | 2018-09-05 | 2019-01-24 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 724795 | R-2948IP | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos | 6 | 120 | 30 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 43579 | 2019-02-14 | 1 | 1 | 1 | 2019-02-15 | 2019-02-14 | 1 | 2026-03-27 | View Edit Delete | ||||||||||||
| 724796 | 3400927563119 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400927563119/3400927563119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28538 | 43579 | 2019-02-14 | 1 | 1 | 1 | 2019-02-15 | 2019-02-14 | 1 | 2023-09-05 | View Edit Delete | ||||||||||||
| 725085 | 64492 | OMEPRAZOL KRKA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL KRKA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64492/64492_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64492/64492_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2002-01-02 | 1 | 1 | 1 | 2002-01-02 | 2002-01-02 | 1 | 2014-05-31 | View Edit Delete | ||||||||||||
| 725243 | 83990 | ANIDULAFUNGINA NORMON 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ANIDULAFUNGINA NORMON 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83990/83990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83990/83990_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2019-04-02 | 1 | 1 | 1 | 2019-04-03 | 2019-04-02 | 1 | 2019-05-13 | View Edit Delete | ||||||||||||
| 725335 | 1191358001 | AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1,5 ml | 225 mg inyectable 1,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191358001/1191358001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191358001/1191358001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16246 | 34492 | 2019-05-14 | 1 | 1 | 1 | 2019-05-15 | 2019-05-16 | 1 | 2020-07-08 | View Edit Delete | ||||||||||||
| 725624 | 1181293004 | AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA | AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 140 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181293004/1181293004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181293004/1181293004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2019-06-13 | 1 | 1 | 1 | 2019-06-14 | 2019-06-13 | 1 | 2019-10-14 | View Edit Delete | ||||||||||||
| 725667 | 65570 | OMEPRAZOL CINFAMED 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL CINFAMED 40 mg CAPSULAS DURAS GASTRORRESISTENTES,56 cápsulas (Frasco) | 40 MG | 6 | 56 | 43 | 56 cápsulas (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65570/65570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65570/65570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2003-09-05 | 1 | 1 | 1 | 2003-09-05 | 2019-05-09 | 1 | 2019-08-29 | View Edit Delete | ||||||||||||
| 725777 | 1191358001 | AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 3 jeringas precargadas de 1,5 ml | 225 mg inyectable 1,5 ml | 33 | 3 | 61 | 3 jeringas precargadas de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191358001/1191358001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191358001/1191358001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16246 | 34492 | 2019-05-14 | 1 | 1 | 1 | 2019-05-15 | 2019-05-16 | 1 | 2020-09-14 | View Edit Delete | ||||||||||||
| 725778 | 1181335001 | POTELIGEO 4 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | POTELIGEO 4 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 4 mg/ml inyectable perfusión 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181335001/1181335001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181335001/1181335001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | 39714 | 2019-06-05 | 1 | 1 | 1 | 2019-06-06 | 2019-06-05 | 1 | 2021-06-14 | View Edit Delete | ||||||||||||
| 725797 | 71289 | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71289/71289_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71289/71289_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2009-11-10 | 1 | 1 | 1 | 2009-11-10 | 2019-05-20 | 1 | 2020-01-09 | View Edit Delete | ||||||||||||
| 725825 | 70025 | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70025/70025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70025/70025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2019-05-21 | 1 | 2020-04-08 | View Edit Delete | ||||||||||||
| 725826 | 70026 | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL SANDOZ 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70026/70026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70026/70026_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2008-08-08 | 1 | 1 | 1 | 2008-08-08 | 2019-05-21 | 1 | 2020-04-08 | View Edit Delete | ||||||||||||
| 725963 | 1191356002 | IDACIO 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | IDACIO 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,8 ml | 40 mg inyectable 0.8 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0.8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191356002/1191356002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191356002/1191356002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2019-10-29 | View Edit Delete | ||||||||||||
| 725964 | 1191356003 | IDACIO 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | IDACIO 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,8 ml | 40 mg inyectable 0.8 ml | 66 | 2 | 49 | 2 plumas precargadas de 0,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191356003/1191356003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191356003/1191356003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2019-10-29 | View Edit Delete | ||||||||||||
| 726298 | 1191376001 | LIBTAYO 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | LIBTAYO 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191376001/1191376001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191376001/1191376001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36484 | 73186 | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2022-04-04 | View Edit Delete | ||||||||||||
| 726370 | 84347 | ATORVASTATINA OPKO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA OPKO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84347/84347_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84347/84347_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51042 | 51042 | 2019-07-16 | 1 | 1 | 1 | 2022-07-06 | 2022-07-06 | 1 | 2024-04-05 | View Edit Delete | ||||||||||||
| 726500 | 1191374001 | ESPEROCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 500 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374001/1191374001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374001/1191374001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726501 | 1191374003 | ESPEROCT 1500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 1500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 1500 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374003/1191374003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374003/1191374003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726502 | 1191374004 | ESPEROCT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 2000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374004/1191374004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374004/1191374004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 726503 | 1191374005 | ESPEROCT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 3000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374005/1191374005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374005/1191374005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726604 | 66145 | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG, 14 cápsulas | 30 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66145/66145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66145/66145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-06-16 | 1 | 1 | 1 | 2004-06-16 | 2004-06-16 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 726625 | 1181344002 | ZIRABEV 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ZIRABEV 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 25 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181344002/1181344002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181344002/1181344002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2019-09-30 | 1 | 1 | 1 | 2019-10-01 | 2019-09-30 | 1 | 2020-06-09 | View Edit Delete | ||||||||||||
| 726626 | 1181344001 | ZIRABEV 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ZIRABEV 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181344001/1181344001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181344001/1181344001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2019-09-30 | 1 | 1 | 1 | 2019-10-01 | 2019-09-30 | 1 | 2020-06-09 | View Edit Delete | ||||||||||||
| 726677 | 84452 | FOSAPREPITANT ZENTIVA 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG | FOSAPREPITANT ZENTIVA 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84452/84452_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84452/84452_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 67398 | 2019-09-09 | 1 | 1 | 1 | 2019-09-10 | 2019-09-09 | 1 | 2020-09-07 | View Edit Delete | ||||||||||||
| 726684 | 1151043005 | NUCALA 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | NUCALA 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 100 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151043005/1151043005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151043005/1151043005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2019-09-27 | 1 | 1 | 1 | 2019-09-28 | 2019-09-27 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 726685 | 1151043003 | NUCALA 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | NUCALA 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 100 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151043003/1151043003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151043003/1151043003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2019-09-27 | 1 | 1 | 1 | 2019-09-28 | 2019-09-27 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 726727 | 36286-00-00IP1 | OPIREN 30 MG CAPSULAS | OPIREN 30 MG CAPSULAS, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 23628 | 2019-09-12 | 1 | 1 | 1 | 2019-09-13 | 2019-09-12 | 1 | 2025-01-09 | View Edit Delete | ||||||||||||
| 726753 | 84466 | DUTASTERIDA/TAMSULOSINA COMBIX PHARMA 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA COMBIX PHARMA 0,5 MG/0,4 MG CAPSULAS DURAS EFG 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84466/84466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84466/84466_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2020-02-07 | 1 | 1 | 1 | 2020-02-07 | 2020-02-07 | 1 | 2021-10-01 | View Edit Delete | ||||||||||||
| 726865 | 1191374002 | ESPEROCT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 1000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374002/1191374002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374002/1191374002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726889 | 34009288005557IP | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38215 | 23628 | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2020-05-14 | View Edit Delete | ||||||||||||
| 726933 | 3400935557506IP | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506IP/3400935557506IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 23628 | 2019-10-10 | 1 | 1 | 1 | 2019-10-11 | 2019-10-10 | 1 | 2020-02-14 | View Edit Delete | ||||||||||||
| 726950 | 66145 | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66145/66145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66145/66145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-06-16 | 1 | 1 | 1 | 2004-06-16 | 2004-06-16 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 726951 | 3400928005557IP1 | ORVATEZ 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORVATEZ 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38215 | 23628 | 2019-10-15 | 1 | 1 | 1 | 2019-10-16 | 2019-10-15 | 1 | 2020-05-14 | View Edit Delete | ||||||||||||
| 726992 | 66146 | LANSOPRAZOL CINFA 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFA 15 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66146/66146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66146/66146_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-06-15 | 1 | 1 | 1 | 2004-06-15 | 2004-06-15 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 727090 | 1151024002IP | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP/1151024002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP/1151024002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 29145 | 2019-10-17 | 1 | 1 | 1 | 2019-10-18 | 2019-10-17 | 1 | 2020-03-19 | View Edit Delete | ||||||||||||
| 727254 | 84603 | SLINDA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SLINDA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84603/84603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84603/84603_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2019-10-25 | 1 | 1 | 1 | 2019-10-26 | 2019-10-25 | 1 | 2020-01-15 | View Edit Delete | ||||||||||||
| 727257 | 84603 | SLINDA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SLINDA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 (3 x 28) comprimidos | 4 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84603/84603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84603/84603_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2019-10-25 | 1 | 1 | 1 | 2019-10-26 | 2019-10-25 | 1 | 2021-02-03 | View Edit Delete | ||||||||||||
| 727309 | 1171229010 | DUPIXENT 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | DUPIXENT 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 1,14 ml | 200 mg inyectable 1,14 ml | 33 | 2 | 61 | 2 jeringas precargadas de 1,14 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171229010/1171229010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171229010/1171229010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2019-12-10 | 1 | 1 | 1 | 2019-12-11 | 2019-12-10 | 1 | 2022-06-07 | View Edit Delete | ||||||||||||
| 727329 | 1151014002IP | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP/1151014002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP/1151014002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 29145 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-03-31 | View Edit Delete | ||||||||||||
| 727433 | 66146 | LANSOPRAZOL CINFA 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFA 15 mg CAPSULAS GASTRORRESISTENTES EFG, 56 cápsulas | 15 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66146/66146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66146/66146_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-06-15 | 1 | 1 | 1 | 2004-06-15 | 2019-11-26 | 1 | 2020-07-09 | View Edit Delete | ||||||||||||
| 727434 | 66145 | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFA 30 mg CAPSULAS GASTRORRESISTENTES EFG,56 cápsulas | 30 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66145/66145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66145/66145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2004-06-16 | 1 | 1 | 1 | 2004-06-16 | 2019-11-26 | 1 | 2020-07-09 | View Edit Delete | ||||||||||||
| 727435 | 75071 | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos (BLISTER) | 20 mg | 5 | 56 | 10 | 56 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75071/75071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75071/75071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2019-11-26 | 1 | 2020-06-30 | View Edit Delete | ||||||||||||
| 727437 | 75074 | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL CINFA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos (BLISTER) | 40 mg | 5 | 56 | 10 | 56 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75074/75074_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75074/75074_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2019-11-26 | 1 | 2020-06-30 | View Edit Delete | ||||||||||||
| 727554 | 84718 | DUTASTERIDA/TAMSULOSINA TEVA-RATIO 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA TEVA-RATIO 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84718/84718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84718/84718_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2019-12-10 | 1 | 1 | 1 | 2019-12-11 | 2019-12-10 | 1 | 2020-11-13 | View Edit Delete | ||||||||||||
| 727706 | 66128 | LANSOPRAZOL SANDOZ 30 MG CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL SANDOZ 30 MG CAPSULAS GASTRORRESISTENTES EFG 56 cápsulas | 30 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66128/66128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66128/66128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2004-05-28 | 1 | 1 | 1 | 2004-05-28 | 2020-01-08 | 1 | 2020-04-08 | View Edit Delete | ||||||||||||
| 727713 | 114957003IP | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957003IP/114957003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957003IP/114957003IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20183 | 29145 | 2020-01-14 | 1 | 1 | 1 | 2020-01-15 | 2020-01-14 | 1 | 2020-05-15 | View Edit Delete | ||||||||||||
| 727871 | 1130853012 | REMSIMA 120 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REMSIMA 120 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml + 2 almohadillas con alcohol | 120 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml + 2 almohadillas con alcohol | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1130853012/1130853012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1130853012/1130853012_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2020-02-14 | 1 | 1 | 1 | 2020-02-15 | 2020-02-14 | 1 | 2021-02-12 | View Edit Delete | ||||||||||||
| 728062 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 14 cápsulas | 90 mg/50 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2022-11-08 | View Edit Delete | ||||||||||||
| 728063 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 42 cápsulas | 90 mg/50 mg | 5 | 42 | 43 | 42 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2023-09-01 | View Edit Delete | ||||||||||||
| 728064 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 84 cápsulas | 90 mg/50 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2025-10-03 | View Edit Delete | ||||||||||||
| 728099 | 1191417 | BEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | BEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,165 ml | 120 mg/ml inyectable 0,165 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,165 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191417/1191417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191417/1191417_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2020-02-28 | 1 | 1 | 1 | 2020-02-29 | 2020-02-28 | 1 | 2022-04-11 | View Edit Delete | ||||||||||||
| 728143 | 1151014001IP | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP/1151014001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP/1151014001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 29145 | 2020-03-04 | 1 | 1 | 1 | 2020-03-05 | 2020-03-04 | 1 | 2020-05-18 | View Edit Delete | ||||||||||||
| 728298 | 84998 | DULOXETINA KERN PHARMA 60 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA KERN PHARMA 60 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG 28 cápsulas (Blister PVC-PVDC/Al) | 60 mg | 5 | 28 | 43 | 28 cápsulas (Blister PVC-PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84998/84998_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84998/84998_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2020-05-14 | 1 | 1 | 1 | 2020-05-14 | 2020-05-14 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 728299 | 84998 | DULOXETINA KERN PHARMA 60 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA KERN PHARMA 60 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG 56 cápsulas (Blister PVC-PVDC/Al) | 60 mg | 5 | 56 | 43 | 56 cápsulas (Blister PVC-PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84998/84998_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84998/84998_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2020-05-14 | 1 | 1 | 1 | 2020-05-14 | 2020-05-14 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 728334 | 85010 | DUTASTERIDA/TAMSULOSINA MABO 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA MABO 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85010/85010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85010/85010_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2020-04-13 | 1 | 1 | 1 | 2020-04-14 | 2020-04-13 | 1 | 2020-09-15 | View Edit Delete | ||||||||||||
| 728339 | 1201431001 | RUXIENCE 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RUXIENCE 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201431001/1201431001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201431001/1201431001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2020-04-26 | 1 | 1 | 1 | 2020-04-27 | 2020-04-26 | 1 | 2020-08-11 | View Edit Delete | ||||||||||||
| 728340 | 1201431002 | RUXIENCE 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RUXIENCE 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201431002/1201431002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201431002/1201431002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2020-04-26 | 1 | 1 | 1 | 2020-04-27 | 2020-04-26 | 1 | 2020-08-11 | View Edit Delete | ||||||||||||
| 728346 | 85018 | BISOPROLOL/HIDROCLOROTIAZIDA AUROVITAS 10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BISOPROLOL/HIDROCLOROTIAZIDA AUROVITAS 10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85018/85018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85018/85018_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2020-04-17 | 1 | 1 | 1 | 2020-04-18 | 2020-04-17 | 1 | 2022-02-08 | View Edit Delete | ||||||||||||
| 728347 | 85018 | BISOPROLOL/HIDROCLOROTIAZIDA AUROVITAS 10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BISOPROLOL/HIDROCLOROTIAZIDA AUROVITAS 10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 10 mg/25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85018/85018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85018/85018_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2020-04-17 | 1 | 1 | 1 | 2020-04-18 | 2020-04-17 | 1 | 2022-02-08 | View Edit Delete | ||||||||||||
| 728401 | 85040 | DUTASTERIDA/TAMSULOSINA CINFALAB 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA CINFALAB 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85040/85040_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85040/85040_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2020-04-26 | 1 | 1 | 1 | 2020-04-27 | 2020-04-26 | 1 | 2023-03-29 | View Edit Delete | ||||||||||||
| 728405 | 73591 | LEVOFLOXACINO MABO-FARMA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOFLOXACINO MABO-FARMA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,14 comprimidos | 500 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73591/73591_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73591/73591_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2019-12-11 | 1 | 1 | 1 | 2019-12-11 | 2020-04-27 | 1 | 2020-10-06 | View Edit Delete | ||||||||||||
| 728409 | 85041 | DUTASTERIDA/TAMSULOSINA VIATRIS 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA VIATRIS 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85041/85041_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85041/85041_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2020-04-29 | 1 | 1 | 1 | 2020-04-30 | 2020-04-29 | 1 | 2021-02-10 | View Edit Delete | ||||||||||||
| 728424 | 85050 | NEBIVOLOL TARBIS 5 MG COMPRIMIDOS EFG | NEBIVOLOL TARBIS 5 MG COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85050/85050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85050/85050_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2020-04-29 | 1 | 1 | 1 | 2020-04-30 | 2020-04-29 | 1 | 2021-07-26 | View Edit Delete | ||||||||||||
| 728432 | 85054 | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos | 40 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85054/85054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85054/85054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2020-05-04 | 1 | 1 | 1 | 2020-05-05 | 2020-05-04 | 1 | 2022-03-08 | View Edit Delete | ||||||||||||
| 728433 | 85054 | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85054/85054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85054/85054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2020-05-04 | 1 | 1 | 1 | 2020-05-05 | 2020-05-04 | 1 | 2022-03-08 | View Edit Delete | ||||||||||||
| 728434 | 85054 | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85054/85054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85054/85054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2020-05-04 | 1 | 1 | 1 | 2020-05-05 | 2020-05-04 | 1 | 2022-03-08 | View Edit Delete | ||||||||||||
| 728473 | 09546005IP1 | SIMPONI 100 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | SIMPONI 100 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 100 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09546005IP1/09546005IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09546005IP1/09546005IP1_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11369 | 29145 | 2020-05-08 | 1 | 1 | 1 | 2020-05-09 | 2020-05-08 | 1 | 2020-06-30 | View Edit Delete | ||||||||||||
| 728509 | 84999 | DULOXETINA KERN PHARMA 30 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA KERN PHARMA 30 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (Blister PVC/PVDC-Al) | 30 mg | 5 | 28 | 43 | 28 cápsulas (Blister PVC/PVDC-Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84999/84999_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84999/84999_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2020-05-14 | 1 | 1 | 1 | 2020-05-14 | 2020-05-14 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 728622 | 1927421 | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS, 30 chicles | 2 mg | 5 | 30 | 9 | 30 chicles | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32623 | 17193 | 2020-05-29 | 1 | 1 | 1 | 2020-05-30 | 2020-05-29 | 1 | 2022-07-06 | View Edit Delete | ||||||||||||
| 728623 | 1927421 | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE FRESHFRUIT 2 mg CHICLES MEDICAMENTOSOS, 105 chicles | 2 mg | 5 | 105 | 9 | 105 chicles | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32623 | 17193 | 2020-05-29 | 1 | 1 | 1 | 2020-05-30 | 2020-05-29 | 1 | 2022-07-06 | View Edit Delete | ||||||||||||
| 728787 | 77767 | TRAMADOL/PARACETAMOL AUROVITAS 37,5 MG / 325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL AUROVITAS 37,5 MG / 325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (PVC/PVDC-ALUMINIO) | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos (PVC/PVDC-ALUMINIO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77767/77767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77767/77767_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2013-07-17 | 1 | 1 | 1 | 2013-07-17 | 2020-06-15 | 1 | 2021-09-29 | View Edit Delete | ||||||||||||
| 728789 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728790 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728791 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728802 | 1201435001 | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201435001/1201435001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201435001/1201435001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2020-07-06 | 1 | 1 | 1 | 2020-07-07 | 2020-07-06 | 1 | 2022-04-06 | View Edit Delete | ||||||||||||
| 728803 | 1201435001 | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201435001/1201435001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201435001/1201435001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2020-07-06 | 1 | 1 | 1 | 2020-07-07 | 2020-07-06 | 1 | 2022-04-06 | View Edit Delete | ||||||||||||
| 728834 | 85203 | DUPROST 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUPROST 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85203/85203_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85203/85203_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 1 | 2020-09-14 | View Edit Delete | ||||||||||||
| 728853 | 3400928005786IP | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71151 | 23628 | 2020-06-30 | 1 | 1 | 1 | 2020-07-01 | 2020-06-30 | 1 | 2022-12-21 | View Edit Delete | ||||||||||||
| 728860 | 3400928005786IP1 | ORVATEZ 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORVATEZ 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71151 | 23628 | 2020-06-30 | 1 | 1 | 1 | 2020-07-01 | 2020-06-30 | 1 | 2022-12-21 | View Edit Delete | ||||||||||||
| 728861 | 23462-04-04-2012 | LOBIVON 5 mg COMPRIMIDOS | LOBIVON 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 17193 | 2020-06-30 | 1 | 1 | 1 | 2020-07-01 | 2020-06-30 | 1 | 2021-03-15 | View Edit Delete | ||||||||||||
| 728863 | 85219 | BUDENA 0,25 MG/ML SUSPENSION PARA INHALACION POR NEBULIZADOR | BUDENA 0,25 MG/ML SUSPENSION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2 ml | 0,5 mg | 1 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85219/85219_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85219/85219_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | 16620 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2022-08-08 | View Edit Delete | ||||||||||||
| 728864 | 85220 | BUDENA 0,5 MG/ML SUSPENSION PARA INHALACION POR NEBULIZADOR | BUDENA 0,5 MG/ML SUSPENSION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2 ml | 1 mg | 1 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85220/85220_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85220/85220_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | 16620 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2022-08-08 | View Edit Delete | ||||||||||||
| 728873 | 85225 | ANIDULAFUNGINA REIG JOFRE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ANIDULAFUNGINA REIG JOFRE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial (30 ml) | 100 mg | 45 | 1 | 34 | 1 vial (30 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85225/85225_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85225/85225_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2023-06-28 | View Edit Delete | ||||||||||||
| 728878 | 1201452001 | REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE | REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE, 1 vial | 25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201452001/1201452001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201452001/1201452001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31892 | 37363 | 2020-08-18 | 1 | 1 | 1 | 2020-08-20 | 2020-08-18 | 1 | 2023-08-03 | View Edit Delete | ||||||||||||
| 728879 | 1201452002 | REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE | REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE, 1 vial | 75 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201452002/1201452002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201452002/1201452002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31892 | 37363 | 2020-08-18 | 1 | 1 | 1 | 2020-08-20 | 2020-08-18 | 1 | 2023-08-03 | View Edit Delete | ||||||||||||
| 728882 | 3400935533951IP | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67217 | 23628 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2023-12-19 | View Edit Delete | ||||||||||||
| 728883 | 85227 | CABAZITAXEL DR. REDDYS 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG | CABAZITAXEL DR. REDDYS 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG, 1 vial + 1 vial de disolvente | 60 mg inyectable 1,5 ml | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85227/85227_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85227/85227_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2021-03-12 | View Edit Delete | ||||||||||||
| 728920 | 85240 | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 20 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85240/85240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85240/85240_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-07-13 | 1 | 1 | 1 | 2020-07-14 | 2020-07-13 | 1 | 2021-07-28 | View Edit Delete | ||||||||||||
| 728921 | 85240 | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 8 comprimidos | 20 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85240/85240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85240/85240_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-07-13 | 1 | 1 | 1 | 2020-07-14 | 2020-07-13 | 1 | 2021-07-28 | View Edit Delete | ||||||||||||
| 728924 | 85243 | TADALAFILO STADAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TADALAFILO STADAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85243/85243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85243/85243_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-07-13 | 1 | 1 | 1 | 2020-07-14 | 2020-07-13 | 1 | 2021-07-28 | View Edit Delete | ||||||||||||
| 728931 | 114923005 | ENTYVIO 108 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | ENTYVIO 108 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 108 mg inyectable 0,68 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114923005/114923005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114923005/114923005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | 70973 | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2020-07-29 | 1 | 2021-12-02 | View Edit Delete | ||||||||||||
| 728989 | PA229-010-001 | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34753 | 17193 | 2020-07-24 | 1 | 1 | 1 | 2020-07-25 | 2020-07-24 | 1 | 2021-03-15 | View Edit Delete | ||||||||||||
| 729010 | PA2229-010-002 | PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34753 | 17193 | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-03-15 | View Edit Delete | ||||||||||||
| 729166 | 1181340004 | TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 2 ml | 300 mg | 33 | 1 | 61 | 1 jeringa precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181340004/1181340004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181340004/1181340004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42050 | 70973 | 2020-09-09 | 1 | 1 | 1 | 2020-09-10 | 2020-09-09 | 1 | 2021-02-03 | View Edit Delete | ||||||||||||
| 729182 | BE190854IP | NASONEX 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | NASONEX 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL 1 envase pulverizador de 140 dosis | 50 microgramos/dosis | 6 | 140 | 31 | 1 envase pulverizador de 140 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71392 | 43579 | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2020-12-06 | View Edit Delete | ||||||||||||
| 729185 | BE190854 | NASONEX 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | NASONEX 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 140 dosis | 50 microgramos/dosis | 6 | 140 | 31 | 1 envase pulverizador de 140 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71392 | 17193 | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2021-03-15 | View Edit Delete | ||||||||||||
| 729187 | PA2229-010-001IP | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34753 | 17193 | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2022-07-25 | View Edit Delete | ||||||||||||
| 729191 | LT-1-98-3805-025 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT-1-98-3805-025/LT-1-98-3805-025_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 43579 | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2020-12-06 | View Edit Delete | ||||||||||||
| 729193 | LT-1-98-3805-025IP | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 43579 | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2020-12-06 | View Edit Delete | ||||||||||||
| 729226 | 06348001IP2 | ROTATEQ SOLUCION ORAL | ROTATEQ SOLUCION ORAL, 1 tubo de 2 ml | N/A (vacuna) | 44 | 1 | 17 | 1 tubo de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06348001IP2/06348001IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06348001IP2/06348001IP2_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24170 | 23628 | 2020-09-09 | 1 | 1 | 1 | 2020-09-10 | 2020-09-09 | 1 | 2020-10-05 | View Edit Delete | ||||||||||||
| 729297 | 1201448001 | CABAZITAXEL ACCORD 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL ACCORD 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 60 mg inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201448001/1201448001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201448001/1201448001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2020-10-20 | 1 | 1 | 1 | 2020-10-21 | 2020-10-20 | 1 | 2021-04-12 | View Edit Delete | ||||||||||||
| 729304 | 1181272001 | SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | SHINGRIX POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 1 vial (polvo) y 1 vial (suspensión) | N/A (vacuna) | 83 | 1 | 34 | 1 vial (polvo) y 1 vial (suspensión) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181272001/1181272001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181272001/1181272001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | 3732 | 2020-10-16 | 1 | 1 | 1 | 2020-10-17 | 2020-10-16 | 1 | 2021-06-11 | View Edit Delete | ||||||||||||
| 729375 | LT-1-98-3805-025_IP | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 23628 | 2020-10-07 | 1 | 1 | 1 | 2020-10-08 | 2020-10-07 | 1 | 2023-12-19 | View Edit Delete | ||||||||||||
| 729376 | 3400934306983IP | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400934306983IP/3400934306983IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 23628 | 2020-10-07 | 1 | 1 | 1 | 2020-10-08 | 2020-10-07 | 1 | 2023-12-19 | View Edit Delete | ||||||||||||
| 729514 | 34009_355_575_0_6IP | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/34009_355_575_0_6IP/34009_355_575_0_6IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 43579 | 2020-10-16 | 1 | 1 | 1 | 2020-10-17 | 2020-10-16 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 729515 | 3400934306983IP1 | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400934306983IP1%20/3400934306983IP1__p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 43579 | 2020-10-16 | 1 | 1 | 1 | 2020-10-17 | 2020-10-16 | 1 | 2022-12-29 | View Edit Delete | ||||||||||||
| 729563 | 85505 | DUTASTERIDA/TAMSULOSINA NORMOGEN 0,5 MG/0,4 MG CAPSULAS DURAS EFG | DUTASTERIDA/TAMSULOSINA NORMOGEN 0,5 MG/0,4 MG CAPSULAS DURAS EFG, 30 cápsulas | 0,5 mg/0,4 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85505/85505_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85505/85505_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2020-10-21 | 1 | 1 | 1 | 2020-10-22 | 2020-10-21 | 1 | 2021-08-11 | View Edit Delete | ||||||||||||
| 729565 | 21649-13-23-04-2014 | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS, 30 chicles | 2 mg | 5 | 30 | 9 | 30 chicles | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32623 | 17193 | 2020-10-21 | 1 | 1 | 1 | 2020-10-22 | 2020-10-21 | 1 | 2022-07-06 | View Edit Delete | ||||||||||||
| 729567 | 21649-13-23-04-2014 | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS | NICORETTE ICE MINT 2 mg CHICLES MEDICAMENTOSOS, 105 chicles | 2 mg | 5 | 105 | 9 | 105 chicles | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32623 | 17193 | 2020-10-21 | 1 | 1 | 1 | 2020-10-22 | 2020-10-21 | 1 | 2022-07-06 | View Edit Delete | ||||||||||||
| 729612 | 3400935533432 | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935533432/3400935533432_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43584 | 23628 | 2020-10-27 | 1 | 1 | 1 | 2020-10-28 | 2020-10-27 | 1 | 2023-12-19 | View Edit Delete | ||||||||||||
| 729711 | PA2229-010-002IP | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34753 | 17193 | 2020-11-06 | 1 | 1 | 1 | 2020-11-07 | 2020-11-06 | 1 | 2024-04-25 | View Edit Delete | ||||||||||||
| 729775 | 75061 | ESOMEPRAZOL ALTER 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALTER 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75061/75061_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75061/75061_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2020-11-17 | 1 | 2021-06-01 | View Edit Delete | ||||||||||||
| 729776 | 75067 | ESOMEPRAZOL ALTER 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALTER 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG,56 comprimidos (Blister) | 40 mg | 5 | 56 | 10 | 56 comprimidos (Blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75067/75067_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75067/75067_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2020-11-17 | 1 | 2021-06-01 | View Edit Delete | ||||||||||||
| 729914 | 114980010 | COSENTYX 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | COSENTYX 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 2 ml | 300 mg inyectable 2 ml | 66 | 1 | 49 | 1 pluma precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114980010/114980010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114980010/114980010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2020-12-16 | 1 | 1 | 1 | 2020-12-17 | 2020-12-16 | 1 | 2021-08-13 | View Edit Delete | ||||||||||||
| 729917 | 66428 | LANSOPRAZOL NORMON 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL NORMON 15 mg CAPSULAS GASTRORRESISTENTES EFG,56 capsulas | 15 mg | 5 | 56 | 43 | 56 capsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66428/66428_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66428/66428_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2004-11-03 | 1 | 1 | 1 | 2004-11-03 | 2020-11-30 | 1 | 2021-05-11 | View Edit Delete | ||||||||||||
| 729918 | 66486 | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL NORMON 30 mg CAPSULAS GASTRORRESISTENTES EFG,56 capsulas | 30 mg | 5 | 56 | 43 | 56 capsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66486/66486_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66486/66486_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2004-11-23 | 1 | 1 | 1 | 2004-11-23 | 2020-11-30 | 1 | 2021-05-11 | View Edit Delete | ||||||||||||
| 730017 | 85655 | FARSICOLD 650 MG/20 MG/4 MG GRANULADO PARA SOLUCION ORAL EFG | FARSICOLD 650 MG/20 MG/4 MG GRANULADO PARA SOLUCION ORAL EFG, 10 sobres | 650 mg/4 mg/20 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85655/85655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85655/85655_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | 5478 | 2020-12-17 | 1 | 1 | 1 | 2020-12-18 | 2020-12-17 | 1 | 2023-07-20 | View Edit Delete | ||||||||||||
| 730018 | 85656 | TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION | TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 3 ml | 15 microgramos/ml + 5 mg/ml | 6 | 3 | 26 | 1 frasco de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85656/85656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85656/85656_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2020-12-17 | 1 | 1 | 1 | 2020-12-18 | 2020-12-17 | 1 | 2024-01-08 | View Edit Delete | ||||||||||||
| 730086 | 109522003IP | ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA | ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA, 1 comprimido | 30 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/109522003IP/109522003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/109522003IP/109522003IP_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30116 | 17193 | 2021-01-08 | 1 | 1 | 1 | 2021-01-09 | 2021-01-08 | 1 | 2023-12-04 | View Edit Delete | ||||||||||||
| 730217 | 85714 | CABAZITAXEL EVER PHARMA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL EVER PHARMA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 6 ml | 60 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial de 6 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85714/85714_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85714/85714_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23345 | 38524 | 2021-01-20 | 1 | 1 | 1 | 2021-01-21 | 2021-01-20 | 1 | 2021-08-12 | View Edit Delete | ||||||||||||
| 730318 | 1201508001 | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201508001/1201508001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201508001/1201508001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8400 | 39736 | 2021-03-20 | 1 | 1 | 1 | 2021-03-21 | 2021-03-20 | 1 | 2022-11-11 | View Edit Delete | ||||||||||||
| 730327 | 5304019IP | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/5304019IP/5304019IP_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32357 | 43579 | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2021-10-19 | View Edit Delete | ||||||||||||
| 730328 | 5304019IP | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 3 mg/0,03 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/5304019IP/5304019IP_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32357 | 43579 | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2021-10-19 | View Edit Delete | ||||||||||||
| 730334 | 1161095009 | IDELVION 3.500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | IDELVION 3.500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 vial de disolvente | 3.500 UI | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161095009/1161095009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161095009/1161095009_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 27753 | 37033 | 2021-02-23 | 1 | 1 | 1 | 2021-02-24 | 2021-02-23 | 1 | 2021-09-06 | View Edit Delete | ||||||||||||
| 730386 | 1151024002IP1 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP1/1151024002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP1/1151024002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 23628 | 2021-02-15 | 1 | 1 | 1 | 2021-02-16 | 2021-02-15 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 730462 | 72145 | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72145/72145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72145/72145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2021-02-22 | 1 | 2021-09-15 | View Edit Delete | ||||||||||||
| 730463 | 72145 | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL AUROVITAS SPAIN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72145/72145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72145/72145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2010-05-04 | 1 | 1 | 1 | 2010-05-04 | 2021-02-22 | 1 | 2021-09-15 | View Edit Delete | ||||||||||||
| 730479 | 85810 | ABACAVIR/LAMIVUDINA MACLEODS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ABACAVIR/LAMIVUDINA MACLEODS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister Al/Al) | 600 mg/300 mg | 5 | 30 | 10 | 30 comprimidos (Blister Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85810/85810_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85810/85810_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 67266 | 67266 | 2021-02-24 | 1 | 1 | 1 | 2021-02-25 | 2021-02-24 | 1 | 2023-12-22 | View Edit Delete | ||||||||||||
| 730481 | 01172008 | KALETRA 200 mg/50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KALETRA 200 mg/50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 120 comprimidos | 200 mg/50 mg | 6 | 120 | 10 | 120 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01172008/01172008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01172008/01172008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2010-10-21 | 1 | 1 | 1 | 2010-10-21 | 2021-02-24 | 1 | 2022-05-30 | View Edit Delete | ||||||||||||
| 730614 | 1201513010 | YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas + 2 toallitas con alcohol | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas precargadas + 2 toallitas con alcohol | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201513010/1201513010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201513010/1201513010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2021-03-31 | 1 | 1 | 1 | 2021-04-01 | 2021-03-31 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 730629 | R-6898IP2 | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R-6898IP2/R-6898IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 26669 | 2021-03-26 | 1 | 1 | 1 | 2021-03-27 | 2021-03-26 | 1 | 2021-06-09 | View Edit Delete | ||||||||||||
| 730631 | 4787IP4 | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 26669 | 2021-03-26 | 1 | 1 | 1 | 2021-03-27 | 2021-03-26 | 1 | 2021-06-09 | View Edit Delete | ||||||||||||
| 730650 | 4787IP3 | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 26669 | 2021-03-26 | 1 | 1 | 1 | 2021-03-27 | 2021-03-26 | 1 | 2021-06-09 | View Edit Delete | ||||||||||||
| 730651 | R6898IP3 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28100 | 26669 | 2021-03-26 | 1 | 1 | 1 | 2021-03-27 | 2021-03-26 | 1 | 2021-06-09 | View Edit Delete | ||||||||||||
| 730757 | 1-21520 | LOBIVON 5 MG COMPRIMIDOS | LOBIVON 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 23628 | 2021-04-06 | 1 | 1 | 1 | 2021-04-07 | 2021-04-06 | 1 | 2021-06-29 | View Edit Delete | ||||||||||||
| 730772 | 106346002 | TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 1ml | 150 mg | 33 | 2 | 61 | 2 jeringas precargadas de 1ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/106346002/106346002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/106346002/106346002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | 19066 | 2021-04-21 | 1 | 1 | 1 | 2021-04-22 | 2021-04-21 | 1 | 2021-12-05 | View Edit Delete | ||||||||||||
| 730776 | 85902 | ATORVASTATINA ALTER GENERICOS 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA ALTER GENERICOS 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 30 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85902/85902_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85902/85902_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 730778 | 85903 | ATORVASTATINA ALTER GENERICOS 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALTER GENERICOS 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 40 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85903/85903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85903/85903_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-12-10 | View Edit Delete | ||||||||||||
| 730780 | 85904 | ATORVASTATINA ALTER GENERICOS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALTER GENERICOS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 10 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85904/85904_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85904/85904_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-12-10 | View Edit Delete | ||||||||||||
| 730782 | 85905 | ATORVASTATINA ALTER GENERICOS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALTER GENERICOS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 20 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85905/85905_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85905/85905_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-12-10 | View Edit Delete | ||||||||||||
| 730784 | 85906 | ATORVASTATINA ALTER GENERICOS 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA ALTER GENERICOS 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 80 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85906/85906_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85906/85906_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 730786 | 85907 | ATORVASTATINA ALTER GENERICOS 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA ALTER GENERICOS 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 60 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85907/85907_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85907/85907_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-13 | 1 | 1 | 1 | 2021-04-14 | 2021-04-13 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 730792 | 85908 | CABAZITAXEL ZENTIVA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG | CABAZITAXEL ZENTIVA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG, 1 vial + 1 vial de disolvente | 60 mg inyectable 1,5 ml | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85908/85908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85908/85908_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 67398 | 2021-11-02 | 1 | 1 | 1 | 2021-11-02 | 2021-11-02 | 1 | 2023-01-10 | View Edit Delete | ||||||||||||
| 730797 | 121532003 | KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,4 ml | 20 mg inyectable 0,4 ml | 66 | 1 | 49 | 1 pluma precargada de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/121532003/121532003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/121532003/121532003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 1 | 2022-10-13 | View Edit Delete | ||||||||||||
| 730817 | 85919 | ESOMEPRAZOL COMBIX 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL COMBIX 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (OPA/Al/PE-PE/Al) | 20 mg | 5 | 28 | 10 | 28 comprimidos (OPA/Al/PE-PE/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85919/85919_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85919/85919_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 730818 | 85919 | ESOMEPRAZOL COMBIX 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL COMBIX 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (OPA/Al/PE-PE/Al) | 20 mg | 5 | 56 | 10 | 56 comprimidos (OPA/Al/PE-PE/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85919/85919_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85919/85919_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 730824 | 85920 | ESOMEPRAZOL COMBIX 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL COMBIX 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (OPA/Al/PE-PE/Al) | 40 mg | 5 | 28 | 10 | 28 comprimidos (OPA/Al/PE-PE/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85920/85920_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85920/85920_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2022-04-04 | View Edit Delete | ||||||||||||
| 730825 | 85920 | ESOMEPRAZOL COMBIX 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL COMBIX 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (OPA/Al/PE-PE/Al) | 40 mg | 5 | 56 | 10 | 56 comprimidos (OPA/Al/PE-PE/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85920/85920_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85920/85920_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2022-04-04 | View Edit Delete | ||||||||||||
| 730840 | 85925 | THERVAN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | THERVAN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 10 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85925/85925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85925/85925_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-11-12 | View Edit Delete | ||||||||||||
| 730842 | 85926 | THERVAN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | THERVAN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 20 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85926/85926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85926/85926_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-11-12 | View Edit Delete | ||||||||||||
| 730844 | 85927 | THERVAN 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | THERVAN 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 30 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85927/85927_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85927/85927_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 730847 | 85928 | THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 40 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85928/85928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85928/85928_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-11-12 | View Edit Delete | ||||||||||||
| 730849 | 85929 | THERVAN 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | THERVAN 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 60 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85929/85929_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85929/85929_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 730851 | 85930 | THERVAN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | THERVAN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 80 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PVDC/PVC-Aluminio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85930/85930_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85930/85930_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2021-11-12 | View Edit Delete | ||||||||||||
| 730904 | 85946 | BUTILESCOPOLAMINA AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS EFG | BUTILESCOPOLAMINA AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS EFG, 60 comprimidos | 10 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85946/85946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85946/85946_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2021-04-23 | 1 | 1 | 1 | 2021-04-24 | 2021-04-23 | 1 | 2022-03-07 | View Edit Delete | ||||||||||||
| 730927 | 1211538001 | JEMPERLI 500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | JEMPERLI 500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 500 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211538001/1211538001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211538001/1211538001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2021-05-25 | 1 | 1 | 1 | 2021-05-26 | 2021-05-25 | 1 | 2023-03-09 | View Edit Delete | ||||||||||||
| 730993 | 02218009IP | AXURA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | AXURA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 10 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02218009IP/02218009IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02218009IP/02218009IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1839 | 17193 | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 1 | 2023-01-19 | View Edit Delete | ||||||||||||
| 731022 | 114957001IP | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957001IP/114957001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957001IP/114957001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20183 | 29145 | 2021-05-18 | 1 | 1 | 1 | 2021-05-19 | 2021-05-18 | 1 | 2021-08-11 | View Edit Delete | ||||||||||||
| 731044 | 06348001IP3 | ROTATEQ SOLUCION ORAL | ROTATEQ SOLUCION ORAL, 1 tubo | N/A (Vacuna) | 44 | 1 | 17 | 1 tubo | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06348001IP3/06348001IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06348001IP3/06348001IP3_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24170 | 29145 | 2021-05-21 | 1 | 1 | 1 | 2021-05-22 | 2021-05-21 | 1 | 2021-08-12 | View Edit Delete | ||||||||||||
| 731061 | 1151076004 | KOVALTRY 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 500 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076004/1151076004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076004/1151076004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 731062 | 1151076006 | KOVALTRY 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 1.000 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076006/1151076006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076006/1151076006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2024-01-11 | View Edit Delete | ||||||||||||
| 731063 | 1151076002 | KOVALTRY 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa de 2,5 ml (capacidad de 5 ml) | 250 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076002/1151076002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076002/1151076002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 731120 | 1191371002 | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 3 ml | 100 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371002/1191371002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371002/1191371002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | 71490 | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 731121 | 1191371003 | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 11 ml | 100 mg/ml inyectable 11 ml | 45 | 1 | 34 | 1 vial de 11 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371003/1191371003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371003/1191371003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | 71490 | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 731146 | 86016 | IBUDOL PEDIATRICO 20 MG/ML SUSPENSION ORAL | IBUDOL PEDIATRICO 20 MG/ML SUSPENSION ORAL EFG, 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86016/86016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86016/86016_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2021-06-14 | 1 | 1 | 1 | 2021-06-15 | 2021-06-14 | 1 | 2023-04-14 | View Edit Delete | ||||||||||||
| 731262 | 1151014002IP1 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP1/1151014002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP1/1151014002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 23628 | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 731263 | 1151014001IP1 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 10 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP1/1151014001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP1/1151014001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 23628 | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 731271 | 86059 | RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 30 ml (240 pulverizaciones) | 25 microgramos/600 microgramos/dosis | 6 | 240 | 31 | 1 frasco de 30 ml (240 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86059/86059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86059/86059_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10539 | 1803 | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2022-12-12 | View Edit Delete | ||||||||||||
| 731332 | 07410049 | BINOCRIT 30.000 UI/0,75 ML SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA | BINOCRIT 30.000 UI/0,75 ML SOLUCION INYECTABLE EN UNA JERINGA PRECARGADA, 6 jeringas precargadas de 0,75 ml | 30.000 UI inyectable 0,75 ml | 33 | 6 | 61 | 6 jeringas precargadas de 0,75 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07410049/07410049_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07410049/07410049_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 1092 | 2011-03-23 | 1 | 1 | 1 | 2011-03-28 | 2021-07-08 | 1 | 2022-04-08 | View Edit Delete | ||||||||||||
| 731413 | 1140980012 | COSENTYX 75 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | COSENTYX 75 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada 0,5 ml | 75 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1140980012/1140980012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1140980012/1140980012_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 1945 | 2021-09-03 | 1 | 1 | 1 | 2021-09-04 | 2021-09-03 | 1 | 2021-12-10 | View Edit Delete | ||||||||||||
| 731445 | 86127 | SILODOSINA VIVANTA 4 MG CAPSULAS DURAS EFG | SILODOSINA VIVANTA 4 MG CAPSULAS DURAS EFG, 30 cápsulas | 4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86127/86127_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86127/86127_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27271 | 68134 | 2021-08-05 | 1 | 1 | 1 | 2021-08-06 | 2021-08-05 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 731446 | 86128 | SILODOSINA VIVANTA 8 MG CAPSULAS DURAS EFG | SILODOSINA VIVANTA 8 MG CAPSULAS DURAS EFG, 30 cápsulas | 8 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86128/86128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86128/86128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27271 | 68134 | 2021-08-05 | 1 | 1 | 1 | 2021-08-06 | 2021-08-05 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 731530 | 86170 | ALLUZIENCE 200 UNIDADES SPEYWOOD/ML SOLUCION INYECTABLE | ALLUZIENCE 200 UNIDADES SPEYWOOD/ML SOLUCION INYECTABLE, 2 viales de 125 unidades | 125 U inyectable 0,625 ml | 45 | 2 | 34 | 2 viales de 125 unidades | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86170/86170_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86170/86170_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71122 | 23643 | 2021-12-09 | 1 | 1 | 1 | 2021-12-09 | 2021-12-09 | 1 | 2022-04-20 | View Edit Delete | ||||||||||||
| 731543 | PA1740-1-4 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 41972 | 2021-08-24 | 1 | 1 | 1 | 2021-08-25 | 2021-08-24 | 1 | 2022-01-10 | View Edit Delete | ||||||||||||
| 731801 | 1191358003 | AJOVY 225 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AJOVY 225 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 225 mg inyectable 1,5 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191358003/1191358003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191358003/1191358003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16246 | 34492 | 2021-10-19 | 1 | 1 | 1 | 2021-10-20 | 2021-10-19 | 1 | 2022-02-12 | View Edit Delete | ||||||||||||
| 731803 | 1191358003 | AJOVY 225 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AJOVY 225 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 3 plumas precargadas | 225 mg inyectable 1,5 ml | 66 | 3 | 49 | 3 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191358003/1191358003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191358003/1191358003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16246 | 34492 | 2021-10-19 | 1 | 1 | 1 | 2021-10-20 | 2021-10-19 | 1 | 2022-03-14 | View Edit Delete | ||||||||||||
| 731805 | 86256 | ATORDUO 10 MG/10 MG CAPSULAS DURAS | ATORDUO 10 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 10 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86256/86256_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86256/86256_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 72805 | 2021-10-26 | 1 | 1 | 1 | 2021-10-26 | 2021-10-26 | 1 | 2023-09-04 | View Edit Delete | ||||||||||||
| 731813 | 86257 | ATORDUO 20 MG/10 MG CAPSULAS DURAS | ATORDUO 20 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 20 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86257/86257_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86257/86257_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 72805 | 2021-10-26 | 1 | 1 | 1 | 2021-10-26 | 2021-10-26 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731820 | 86258 | ATORDUO 40 MG/10 MG CAPSULAS DURAS | ATORDUO 40 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 40 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86258/86258_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86258/86258_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 72805 | 2021-10-26 | 1 | 1 | 1 | 2021-10-26 | 2021-10-26 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731848 | 86274 | ABECLIN 2 MG COMPRIMIDOS EFG | ABECLIN 2 MG COMPRIMIDOS EFG, 20 comprimidos | 2 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86274/86274_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86274/86274_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27712 | 27712 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2025-12-19 | View Edit Delete | ||||||||||||
| 731856 | 86280 | DULOXETINA CINFAMED 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA CINFAMED 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 7 cápsulas | 30 mg | 5 | 7 | 43 | 7 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86280/86280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86280/86280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2022-05-11 | View Edit Delete | ||||||||||||
| 731857 | 86280 | DULOXETINA CINFAMED 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA CINFAMED 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86280/86280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86280/86280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2022-05-11 | View Edit Delete | ||||||||||||
| 731859 | 86282 | DULOXETINA CINFAMED 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA CINFAMED 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 60 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86282/86282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86282/86282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2022-05-11 | View Edit Delete | ||||||||||||
| 731860 | 86282 | DULOXETINA CINFAMED 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | DULOXETINA CINFAMED 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 60 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86282/86282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86282/86282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2022-05-11 | View Edit Delete | ||||||||||||
| 731878 | 1211575002 | BIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | BIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas | 160 mg inyectable 1 ml | 33 | 1 | 61 | 2 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211575002/1211575002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211575002/1211575002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2021-10-27 | 1 | 1 | 1 | 2021-10-28 | 2021-10-27 | 1 | 2022-11-04 | View Edit Delete | ||||||||||||
| 731879 | 1211575006 | BIMZELX 160 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | BIMZELX 160 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas | 160 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211575006/1211575006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211575006/1211575006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2021-10-27 | 1 | 1 | 1 | 2021-10-28 | 2021-10-27 | 1 | 2022-11-04 | View Edit Delete | ||||||||||||
| 731932 | 86315 | ASACOL 1.600 MG COMPRIMIDOS GASTRORRESISTENTES | ASACOL 1.600 MG COMPRIMIDOS GASTRORRESISTENTES, 90 comprimidos | 1.600 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86315/86315_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86315/86315_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 71054 | 71054 | 2021-10-15 | 1 | 1 | 1 | 2021-10-16 | 2021-10-15 | 1 | 2022-04-11 | View Edit Delete | ||||||||||||
| 732085 | 114946024 | ACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA | ACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA, 5 jeringas precargadas | 12 millones U inyectable 0,2 ml | 33 | 5 | 61 | 5 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946024/114946024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946024/114946024_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2021-10-22 | 1 | 1 | 1 | 2021-10-23 | 2021-10-22 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 732086 | 114946033 | ACCOFIL 70 MU/0,73 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA | ACCOFIL 70 MU/0,73 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA, 5 jeringas precargadas | 70 millones U inyectable 0,73 ml | 33 | 5 | 61 | 5 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114946033/114946033_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114946033/114946033_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2021-10-22 | 1 | 1 | 1 | 2021-10-23 | 2021-10-22 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 732129 | 1201471001 | IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 11 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201471001/1201471001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201471001/1201471001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35295 | 35295 | 2021-12-09 | 1 | 1 | 1 | 2021-12-10 | 2021-12-09 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 732130 | 1201471001 | IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales | 11 mg | 45 | 2 | 34 | 2 viales | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201471001/1201471001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201471001/1201471001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35295 | 35295 | 2021-12-09 | 1 | 1 | 1 | 2021-12-10 | 2021-12-09 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 732168 | 86382 | FOSAPREPITANT HIKMA 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG | FOSAPREPITANT HIKMA 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86382/86382_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86382/86382_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | 50666 | 2021-11-11 | 1 | 1 | 1 | 2021-11-12 | 2021-11-11 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 732201 | 86400 | ETOPOSIDO HIKMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ETOPOSIDO HIKMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86400/86400_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86400/86400_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | 50666 | 2021-11-18 | 1 | 1 | 1 | 2021-11-19 | 2021-11-18 | 1 | 2024-08-20 | View Edit Delete | ||||||||||||
| 732216 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 732217 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 732220 | 1211592001 | TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211592001/1211592001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211592001/1211592001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16632 | 88172 | 2021-11-26 | 1 | 1 | 1 | 2021-11-27 | 2021-11-26 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 732364 | 86429 | OMEPRAZOL FARMAMABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL FARMAMABO 20 MG CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86429/86429_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86429/86429_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2021-12-09 | 1 | 1 | 1 | 2021-12-10 | 2021-12-09 | 1 | 2022-02-21 | View Edit Delete | ||||||||||||
| 732451 | 3400927563119IP1 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30019 | 26669 | 2021-12-15 | 1 | 1 | 1 | 2021-12-16 | 2021-12-15 | 1 | 2022-02-11 | View Edit Delete | ||||||||||||
| 732454 | 3400934306983IP2 | PREVENCOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 23628 | 2021-12-15 | 1 | 1 | 1 | 2021-12-16 | 2021-12-15 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 732464 | BE190854IP1 | NASONEX 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 140 dosis | 50 microgramos/dosis | 6 | 140 | 31 | 1 envase pulverizador de 140 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71392 | 23628 | 2021-12-21 | 1 | 1 | 1 | 2021-12-22 | 2021-12-21 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 732485 | 1211594001 | RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 7 ml | 350 mg inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211594001/1211594001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211594001/1211594001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2022-01-12 | 1 | 1 | 1 | 2022-01-13 | 2022-01-12 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 732536 | 86472 | DIARFIN FLAS 2 MG LIOFILIZADO ORAL | DIARFIN FLAS 2 MG LIOFILIZADO ORAL, 12 liofilizados | 2 mg | 5 | 12 | 10 | 12 liofilizados | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86472/86472_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86472/86472_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2021-12-21 | 1 | 1 | 1 | 2021-12-22 | 2021-12-21 | 1 | 2023-06-13 | View Edit Delete | ||||||||||||
| 732547 | 86474 | OMEPRAZOL VIATRIS PHARMACEUTICALS 20 MG CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL VIATRIS PHARMACEUTICALS 20 MG CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86474/86474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86474/86474_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2021-12-23 | 1 | 1 | 1 | 2021-12-24 | 2021-12-23 | 1 | 2023-11-24 | View Edit Delete | ||||||||||||
| 732550 | 340039239989IP | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 23628 | 2021-12-23 | 1 | 1 | 1 | 2021-12-24 | 2021-12-23 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 732553 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 20 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2021-12-21 | 1 | 2022-02-10 | View Edit Delete | ||||||||||||
| 732554 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2021-12-22 | 1 | 2022-02-10 | View Edit Delete | ||||||||||||
| 732555 | 64375 | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64375/64375_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64375/64375_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2001-11-16 | 1 | 1 | 1 | 2001-11-16 | 2021-12-22 | 1 | 2022-02-10 | View Edit Delete | ||||||||||||
| 732557 | 1211577002 | VOXZOGO 0,56 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | VOXZOGO 0,56 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0,56 mg | 80 | 10 | 34 | 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211577002/1211577002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211577002/1211577002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 20700 | 28157 | 2022-01-20 | 1 | 1 | 1 | 2022-01-21 | 2022-01-20 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 732558 | 1211577001 | VOXZOGO 0,4 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | VOXZOGO 0,4 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0,4 mg | 80 | 10 | 34 | 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211577001/1211577001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211577001/1211577001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 20700 | 28157 | 2022-01-20 | 1 | 1 | 1 | 2022-01-21 | 2022-01-20 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 732559 | 1211577003 | VOXZOGO 1,2 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | VOXZOGO 1,2 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 1,2 mg | 80 | 10 | 34 | 10 viales, 10 jeringas precargadas y 10 jeringas para administracion | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211577003/1211577003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211577003/1211577003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 20700 | 28157 | 2022-01-20 | 1 | 1 | 1 | 2022-01-21 | 2022-01-20 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 732581 | 842261102022012IP | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67789 | 23628 | 2022-01-12 | 1 | 1 | 1 | 2022-01-13 | 2022-01-12 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 732646 | 3400934292293 | NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL | NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 120 dosis | 55 microgramos/dosis | 25 | 120 | 31 | 1 envase pulverizador de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44525 | 43579 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2022-03-20 | View Edit Delete | ||||||||||||
| 732686 | 86518 | EZETIMIBA/ATORVASTATINA TEVA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA TEVA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86518/86518_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86518/86518_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2022-07-15 | View Edit Delete | ||||||||||||
| 732687 | 86519 | EZETIMIBA/ATORVASTATINA TEVA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA TEVA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86519/86519_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86519/86519_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2022-07-15 | View Edit Delete | ||||||||||||
| 732688 | 86520 | EZETIMIBA/ATORVASTATINA TEVA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA TEVA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86520/86520_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86520/86520_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2022-07-15 | View Edit Delete | ||||||||||||
| 732689 | 86521 | EZETIMIBA/ATORVASTATINA TEVA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA TEVA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86521/86521_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86521/86521_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2022-07-15 | View Edit Delete | ||||||||||||
| 732714 | 82847 | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82847/82847_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82847/82847_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2022-01-21 | 1 | 2022-05-27 | View Edit Delete | ||||||||||||
| 732715 | 82848 | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | ESOMEPRAZOL PENSA 40 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 40 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82848/82848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82848/82848_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-02-08 | 1 | 1 | 1 | 2018-02-09 | 2022-01-21 | 1 | 2022-05-27 | View Edit Delete | ||||||||||||
| 732721 | 70914 | ARTISS SOLUCIONES PARA ADHESIVO TISULAR, ULTRACONGELADAS | ARTISS SOLUCIONES PARA ADHESIVO TISULAR, ULTRACONGELADAS, 1 jeringa precargada de doble cámara (4 ml) (Jeringa PRIMA) | 91 mg/ml + 3.000 UIC/ml + 4 UI/ml + 40 micromol/ml | 33 | 1 | 61 | 1 jeringa precargada de doble cámara (4 ml) (Jeringa PRIMA) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70914/70914_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70914/70914_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | 7980 | 2009-05-08 | 1 | 1 | 1 | 2009-05-08 | 2022-01-27 | 1 | 2022-09-06 | View Edit Delete | ||||||||||||
| 732751 | 86544 | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 5 ml | 200 mg/ml inyectable 5 ml | 45 | 1 | 34 | vial de 5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/86544/86544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86544/86544_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2022-03-03 | 1 | 1 | 1 | 2022-03-03 | 2022-03-03 | 1 | 2023-05-10 | View Edit Delete | ||||||||||||
| 732752 | 86544 | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 10 ml | 200 mg/ml inyectable 10 ml | 45 | 1 | 34 | vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/86544/86544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86544/86544_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2022-03-03 | 1 | 1 | 1 | 2022-03-03 | 2022-03-03 | 1 | 2023-05-10 | View Edit Delete | ||||||||||||
| 732753 | 86544 | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 20 ml | 4 g inyectable 20 ml | 45 | 1 | 34 | vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/86544/86544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86544/86544_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2022-03-03 | 1 | 1 | 1 | 2022-03-03 | 2022-03-03 | 1 | 2023-05-10 | View Edit Delete | ||||||||||||
| 732754 | 86544 | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, vial de 50 ml | 200 mg/ml inyectable 50 ml | 45 | 1 | 34 | vial de 50 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/86544/86544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86544/86544_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2022-03-03 | 1 | 1 | 1 | 2022-03-03 | 2022-03-03 | 1 | 2023-05-10 | View Edit Delete | ||||||||||||
| 732787 | 1171247016 | ADYNOVI 3000 UI/5 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ADYNOVI 3000 UI/5 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial+1 vial de disolvente | 3.000 UI | 83 | 1 | 34 | 1 vial+1 vial de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1171247016/1171247016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171247016/1171247016_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | 70973 | 2022-02-21 | 1 | 1 | 1 | 2022-02-22 | 2022-02-21 | 1 | 2022-07-27 | View Edit Delete | ||||||||||||
| 732827 | 86571 | PAZOPANIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86571/86571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86571/86571_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-02-21 | 1 | 1 | 1 | 2022-02-22 | 2022-02-21 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 732829 | 86572 | PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86572/86572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86572/86572_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-02-21 | 1 | 1 | 1 | 2022-02-22 | 2022-02-21 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 732854 | 85240 | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TADALAFILO STADAGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 12 comprimidos | 20 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85240/85240_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85240/85240_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-07-13 | 1 | 1 | 1 | 2020-07-14 | 2022-02-21 | 1 | 2022-06-08 | View Edit Delete | ||||||||||||
| 732858 | 1211623001 | SAPHNELO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | SAPHNELO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2 ml | 300 mg inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211623001/1211623001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211623001/1211623001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34774 | 41965 | 2022-03-18 | 1 | 1 | 1 | 2022-03-19 | 2022-03-18 | 1 | 2023-05-05 | View Edit Delete | ||||||||||||
| 732860 | 1211612002 | PREVENAR 20 SUSPENSION INYECTABLE EN JERINGA PRECARGADA | PREVENAR 20 SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | N/A (más de 4 PA) | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211612002/1211612002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211612002/1211612002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2022-03-23 | 1 | 1 | 1 | 2022-03-24 | 2022-03-23 | 1 | 2022-08-01 | View Edit Delete | ||||||||||||
| 733207 | 86488 | ABACAVIR/LAMIVUDINA TARBIS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ABACAVIR/LAMIVUDINA TARBIS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (OPA/Al/PVC/Al) | 600 mg/300 mg | 5 | 30 | 10 | 30 comprimidos (OPA/Al/PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86488/86488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86488/86488_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-03-23 | 1 | 1 | 1 | 2022-03-23 | 2022-03-23 | 1 | 2023-01-31 | View Edit Delete | ||||||||||||
| 733208 | 86488 | ABACAVIR/LAMIVUDINA TARBIS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ABACAVIR/LAMIVUDINA TARBIS 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (PVC/PVDC/Al) | 600 mg/300 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86488/86488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86488/86488_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-03-23 | 1 | 1 | 1 | 2022-03-23 | 2022-03-23 | 1 | 2023-01-31 | View Edit Delete | ||||||||||||
| 733268 | 1211605002 | TAVNEOS 10 MG CAPSULAS DURAS | TAVNEOS 10 MG CAPSULAS DURAS, 180 cápsulas | 10 mg | 6 | 180 | 43 | 180 cápsulas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211605002/1211605002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211605002/1211605002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 68189 | 23756 | 2022-04-28 | 1 | 1 | 1 | 2022-04-29 | 2022-04-28 | 1 | 2023-07-19 | View Edit Delete | ||||||||||||
| 733342 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 120 dosis | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2022-03-31 | 1 | 2022-10-13 | View Edit Delete | ||||||||||||
| 733733 | 86752 | LIFOG 50 MICROGRAMOS/ML COLIRIO EN SOLUCION | LIFOG 50 MICROGRAMOS/ML COLIRIO EN SOLUCION, 1 frasco de 7,5 ml | 50 microgramos/ml | 6 | 7,5 | 26 | 1 frasco de 7,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86752/86752_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86752/86752_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44573 | 44573 | 2022-04-05 | 1 | 1 | 1 | 2022-04-06 | 2022-04-05 | 1 | 2023-08-14 | View Edit Delete | ||||||||||||
| 733758 | 1201513015 | YUFLYMA 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | YUFLYMA 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,8 ml + 2 toallitas con alcohol | 80 mg inyectable 0,8 ml | 66 | 1 | 49 | 1 pluma precargada de 0,8 ml + 2 toallitas con alcohol | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201513015/1201513015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201513015/1201513015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2022-04-21 | 1 | 1 | 1 | 2022-04-22 | 2022-04-22 | 1 | 2022-08-08 | View Edit Delete | ||||||||||||
| 734014 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 734040 | 86793 | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86793/86793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86793/86793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734041 | 86793 | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimdos | 80 mg | 6 | 28 | 10 | 28 comprimdos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86793/86793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86793/86793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734042 | 86794 | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86794/86794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86794/86794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734043 | 86794 | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86794/86794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86794/86794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734044 | 86795 | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86795/86795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86795/86795_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734045 | 86795 | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86795/86795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86795/86795_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734046 | 86796 | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86796/86796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86796/86796_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734047 | 86796 | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86796/86796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86796/86796_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734052 | 86532 | STREFEN 8,75 MG PASTILLAS PARA CHUPAR SABOR MIEL Y EUCALIPTO | STREFEN 8,75 MG PASTILLAS PARA CHUPAR SABOR MIEL Y EUCALIPTO, 16 pastillas | 8,75 | 5 | 16 | 29 | 16 pastillas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86532/86532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86532/86532_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7742 | 7742 | 2022-04-04 | 1 | 1 | 1 | 2022-04-04 | 2022-04-04 | 1 | 2024-07-09 | View Edit Delete | ||||||||||||
| 734276 | 70295 | PANTOPRAZOL TECNIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TECNIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70295/70295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70295/70295_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2022-04-07 | 1 | 2022-04-13 | View Edit Delete | ||||||||||||
| 734277 | 70298 | PANTOPRAZOL TECNIGEN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TECNIGEN 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70298/70298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70298/70298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2008-12-10 | 1 | 1 | 1 | 2008-12-10 | 2022-04-07 | 1 | 2022-04-13 | View Edit Delete | ||||||||||||
| 734281 | 86818 | SERTRALINA TARBIS FARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TARBIS FARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (PVC/PVDC/Al) | 100 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86818/86818_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86818/86818_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-04-12 | 1 | 1 | 1 | 2022-04-13 | 2022-04-12 | 1 | 2023-04-09 | View Edit Delete | ||||||||||||
| 734282 | 86818 | SERTRALINA TARBIS FARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TARBIS FARMA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (PVC/PVDC/Al) | 100 mg | 5 | 60 | 10 | 60 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86818/86818_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86818/86818_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-04-12 | 1 | 1 | 1 | 2022-04-13 | 2022-04-12 | 1 | 2023-04-09 | View Edit Delete | ||||||||||||
| 734286 | 86819 | SERTRALINA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (PVC/PVDC/Al) | 50 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86819/86819_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86819/86819_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-04-12 | 1 | 1 | 1 | 2022-04-13 | 2022-04-12 | 1 | 2023-04-09 | View Edit Delete | ||||||||||||
| 734287 | 86819 | SERTRALINA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (PVC/PVDC/Al) | 50 mg | 5 | 60 | 10 | 60 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86819/86819_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86819/86819_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-04-12 | 1 | 1 | 1 | 2022-04-13 | 2022-04-12 | 1 | 2023-04-09 | View Edit Delete | ||||||||||||
| 735100 | 64512 | EXOREX EMULSION | EXOREX EMULSION, 1 frasco de 100 ml | 10 mg/g | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64512/64512_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64512/64512_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2939 | 4202 | 2002-01-10 | 1 | 1 | 1 | 2002-01-10 | 2002-01-10 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 735118 | 64512 | EXOREX EMULSION | EXOREX EMULSION, 1 frasco de 250 ml | 10 mg/g | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64512/64512_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64512/64512_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2939 | 4202 | 2002-01-10 | 1 | 1 | 1 | 2002-01-10 | 2002-01-10 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 738278 | 60537 | BUDESONIDA ALCON 100 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA ALCON 100 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60537/60537_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60537/60537_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29808 | 945 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1999-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 738328 | 59533 | BUDESONIDA ALCON 50 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA ALCON 50 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 200 dosis | 50 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59533/59533_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59533/59533_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29808 | 945 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1999-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 738567 | 59897 | LACIMEN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LACIMEN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59897/59897_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59897/59897_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | 3732 | 1993-06-01 | 1 | 1 | 1 | 1993-06-01 | 1993-06-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 738823 | 59785 | OPIREN 30 mg CAPSULAS | OPIREN 30 mg CAPSULAS , 14 cápsulas | 30 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59785/59785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59785/59785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 1993-06-01 | 1 | 1 | 1 | 1993-06-01 | 1993-06-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 740022 | 87089 | BARNIDIPINO TEVA 10 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | BARNIDIPINO TEVA 10 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 28 cápsulas | 10 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87089/87089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87089/87089_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-05-05 | 1 | 1 | 1 | 2022-05-06 | 2022-05-05 | 1 | 2025-06-13 | View Edit Delete | ||||||||||||
| 740023 | 87089 | BARNIDIPINO TEVA 10 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | BARNIDIPINO TEVA 10 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 56 cápsulas | 10 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87089/87089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87089/87089_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-05-05 | 1 | 1 | 1 | 2022-05-06 | 2022-05-05 | 1 | 2025-06-13 | View Edit Delete | ||||||||||||
| 740024 | 87090 | BARNIDIPINO TEVA 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | BARNIDIPINO TEVA 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87090/87090_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87090/87090_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-05-05 | 1 | 1 | 1 | 2022-05-06 | 2022-05-05 | 1 | 2025-06-13 | View Edit Delete | ||||||||||||
| 740025 | 87090 | BARNIDIPINO TEVA 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | BARNIDIPINO TEVA 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87090/87090_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87090/87090_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-05-05 | 1 | 1 | 1 | 2022-05-06 | 2022-05-05 | 1 | 2025-06-13 | View Edit Delete | ||||||||||||
| 741412 | 1211599001 | VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg inyectable 1 ml | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211599001/1211599001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211599001/1211599001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1250 | 1710 | 2022-05-26 | 1 | 1 | 1 | 2022-05-27 | 2022-05-26 | 1 | 2023-02-15 | View Edit Delete | ||||||||||||
| 741629 | 46983 | DEPO-PROGEVERA 150 mg/ml SUSPENSION INYECTABLE | DEPO-PROGEVERA 150 mg/ml SUSPENSION INYECTABLE, 1 vial de 1 ml | 150 mg | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/46983/46983_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/46983/46983_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11622 | 11622 | 1968-12-01 | 1 | 1 | 1 | 1968-12-01 | 1968-12-01 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 742098 | 64529 | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64529/64529_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64529/64529_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2002-01-24 | 1 | 1 | 1 | 2002-01-24 | 2002-01-24 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 742247 | 64530 | GONAPEPTYL DEPOT 3,75 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE | GONAPEPTYL DEPOT 3,75 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE, 1 jeringa precargada + 1 jeringa precargada de disolvente | 3,75 mg | 33 | 1 | 61 | 1 jeringa precargada + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64530/64530_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64530/64530_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31840 | 31840 | 2002-05-29 | 1 | 1 | 1 | 2002-05-29 | 2002-05-29 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 742367 | 87198 | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87198/87198_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87198/87198_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-05-11 | 1 | 1 | 1 | 2022-05-12 | 2022-05-11 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 742368 | 87199 | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87199/87199_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87199/87199_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-05-11 | 1 | 1 | 1 | 2022-05-12 | 2022-05-11 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 742369 | 87200 | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EZETIMIBA/ATORVASTATINA STADAFARMA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87200/87200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87200/87200_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-05-11 | 1 | 1 | 1 | 2022-05-12 | 2022-05-11 | 1 | 2022-09-05 | View Edit Delete | ||||||||||||
| 744070 | 87265 | ESCITALOPRAM TARBIS FARMA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87265/87265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87265/87265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744071 | 87265 | ESCITALOPRAM TARBIS FARMA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 15 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87265/87265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87265/87265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744072 | 87266 | ESCITALOPRAM TARBIS FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87266/87266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87266/87266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744073 | 87266 | ESCITALOPRAM TARBIS FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87266/87266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87266/87266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744074 | 87267 | ESCITALOPRAM TARBIS FARMA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87267/87267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87267/87267_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744075 | 87268 | ESCITALOPRAM TARBIS FARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87268/87268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87268/87268_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744076 | 87268 | ESCITALOPRAM TARBIS FARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM TARBIS FARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87268/87268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87268/87268_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2023-04-10 | View Edit Delete | ||||||||||||
| 744080 | 87270 | ATORVASTATINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87270/87270_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87270/87270_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 744081 | 87270 | ATORVASTATINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos (Frasco) | 30 mg | 6 | 28 | 10 | 28 comprimidos (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87270/87270_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87270/87270_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 744082 | 87271 | ATORVASTATINA NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87271/87271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87271/87271_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 744083 | 87271 | ATORVASTATINA NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos (Frasco) | 60 mg | 6 | 28 | 10 | 28 comprimidos (Frasco) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87271/87271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87271/87271_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-05-17 | 1 | 1 | 1 | 2022-05-18 | 2022-05-17 | 1 | 2022-06-15 | View Edit Delete | ||||||||||||
| 747956 | 02221006 | PEGASYS, 135 microgramos, SOLUCION INYECTABLE EN JERINGA PRECARGADA | PEGASYS, 135 microgramos, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,5 ml | 135 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02221006/02221006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02221006/02221006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44015 | 2488 | 2002-07-04 | 1 | 1 | 1 | 2002-07-04 | 2002-07-04 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 748095 | 02221008 | PEGASYS, 180 microgramos, SOLUCION INYECTABLE EN JERINGA PRECARGADA | PEGASYS, 180 microgramos, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,5 ml | 180 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02221008/02221008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02221008/02221008_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44015 | 2488 | 2002-07-29 | 1 | 1 | 1 | 2002-07-29 | 2002-07-29 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 748649 | 1181323003 | ILUMETRI 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | ILUMETRI 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 2 ml | 200 mg inyectable 2 ml | 33 | 1 | 61 | 1 jeringa precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181323003/1181323003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181323003/1181323003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2022-06-06 | 1 | 1 | 1 | 2022-06-07 | 2022-06-06 | 1 | 2023-08-08 | View Edit Delete | ||||||||||||
| 749364 | 87533 | RISEDRONATO SEMANAL COMBIX 35 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISEDRONATO SEMANAL COMBIX 35 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 35 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87533/87533_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87533/87533_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2022-05-30 | 1 | 1 | 1 | 2022-05-31 | 2022-05-30 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 749365 | 87534 | RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISEDRONATO COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 2 comprimidos | 75 mg | 5 | 2 | 10 | 2 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87534/87534_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87534/87534_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2022-05-30 | 1 | 1 | 1 | 2022-05-31 | 2022-05-30 | 1 | 2022-11-24 | View Edit Delete | ||||||||||||
| 749770 | 02226001 | INDUCTOS 1,5 MG/ML POLVO, DISOLVENTE Y MATRIZ PARA MATRIZ DE IMPLANTACIÓN | INDUCTOS 1,5 MG/ML POLVO, DISOLVENTE Y MATRIZ PARA MATRIZ DE IMPLANTACIÓN 1 vial + 1 vial de disolvente | 12 mg | 45 | 1 | 23 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02226001/02226001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02226001/02226001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12599 | 12599 | 2003-03-28 | 1 | 1 | 1 | 2003-03-28 | 2003-03-28 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 756825 | 59466 | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 14 comprimidos | 20 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59466/59466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59466/59466_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1992-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 757195 | 59468 | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 20 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59468/59468_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59468/59468_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1992-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 758027 | 1171229014 | DUPIXENT 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | DUPIXENT 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 1,14 ml | 200 mg inyectable 1,14 ml | 66 | 2 | 49 | 2 plumas precargadas de 1,14 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171229014/1171229014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171229014/1171229014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2019-12-10 | 1 | 1 | 1 | 2019-12-11 | 2022-07-13 | 1 | 2023-01-10 | View Edit Delete | ||||||||||||
| 758028 | 1171229018 | DUPIXENT 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | DUPIXENT 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 2 ml | 300 mg inyectable 2 ml | 66 | 2 | 49 | 2 plumas precargadas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171229018/1171229018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171229018/1171229018_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2019-12-10 | 1 | 1 | 1 | 2019-12-11 | 2022-07-13 | 1 | 2023-01-10 | View Edit Delete | ||||||||||||
| 758052 | 87986 | MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO ALTER GENERICOS 50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 140 pulsaciones | 50 microgramos/dosis | 6 | 140 | 31 | 140 pulsaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87986/87986_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87986/87986_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2022-07-19 | 1 | 1 | 1 | 2022-07-20 | 2022-07-19 | 1 | 2023-11-06 | View Edit Delete | ||||||||||||
| 758062 | 1211602001 | UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | UPLIZNA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 3 viales de 10 ml | 100 mg inyectable 10 ml | 45 | 3 | 34 | 3 viales de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211602001/1211602001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211602001/1211602001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2022-07-22 | 1 | 1 | 1 | 2022-07-23 | 2022-07-22 | 1 | 2023-02-09 | View Edit Delete | ||||||||||||
| 758091 | 88000 | CABAZITAXEL VIVANTA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG | CABAZITAXEL VIVANTA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG, 1 vial de concentrado de 1,5 ml y 1 vial de disolvente de 4,5 ml | 60 mg inyectable 1,5 ml | 45 | 1 | 34 | 1 vial de concentrado de 1,5 ml y 1 vial de disolvente de 4,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88000/88000_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88000/88000_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | 67529 | 2023-01-23 | 1 | 1 | 1 | 2023-01-23 | 2023-01-23 | 1 | 2024-09-12 | View Edit Delete | ||||||||||||
| 758145 | 88028 | DULOXETINA NORMON 90 MG CAPSULAS DURAS GASTRORRESISTENTES | DULOXETINA NORMON 90 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 90 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88028/88028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88028/88028_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-08-08 | 1 | 1 | 1 | 2022-08-09 | 2022-08-08 | 1 | 2024-04-15 | View Edit Delete | ||||||||||||
| 758146 | 88029 | DULOXETINA NORMON 120 MG CAPSULAS DURAS GASTRORRESISTENTES | DULOXETINA NORMON 120 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 120 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88029/88029_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88029/88029_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-08-08 | 1 | 1 | 1 | 2022-08-09 | 2022-08-08 | 1 | 2024-04-15 | View Edit Delete | ||||||||||||
| 758156 | 88035 | CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN | CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial de 6 ml | 60 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial de 6 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88035/88035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88035/88035_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-08-17 | 1 | 1 | 1 | 2022-08-18 | 2022-08-17 | 1 | 2022-11-11 | View Edit Delete | ||||||||||||
| 758175 | 88047 | LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 140 (2 x 70) comprimidos | 250 mg | 5 | 140 | 10 | 140 (2 x 70) comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88047/88047_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88047/88047_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-08-25 | 1 | 1 | 1 | 2022-08-26 | 2022-08-25 | 1 | 2023-11-01 | View Edit Delete | ||||||||||||
| 758183 | 1211579001 | NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211579001/1211579001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211579001/1211579001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42448 | 40842 | 2022-09-07 | 1 | 1 | 1 | 2022-09-08 | 2022-09-07 | 1 | 2024-02-15 | View Edit Delete | ||||||||||||
| 758186 | 88052 | FUMARATO DE DIMETILO KERN PHARMA 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO KERN PHARMA 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 120 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88052/88052_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88052/88052_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-08-30 | 1 | 1 | 1 | 2022-08-31 | 2022-08-30 | 1 | 2025-01-14 | View Edit Delete | ||||||||||||
| 758187 | 88053 | FUMARATO DE DIMETILO KERN PHARMA 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO KERN PHARMA 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 240 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88053/88053_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88053/88053_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-08-30 | 1 | 1 | 1 | 2022-08-31 | 2022-08-30 | 1 | 2025-01-14 | View Edit Delete | ||||||||||||
| 758197 | 1221674001 | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial de 20 ml | 20 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221674001/1221674001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221674001/1221674001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41147 | 71016 | 2022-09-29 | 1 | 1 | 1 | 2022-09-30 | 2022-09-29 | 1 | 2023-11-13 | View Edit Delete | ||||||||||||
| 758570 | 1151043009 | NUCALA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | NUCALA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 40 mg inyectable 0,4 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151043009/1151043009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151043009/1151043009_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2022-10-18 | 1 | 1 | 1 | 2022-10-19 | 2022-10-18 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 758613 | 88175 | BUPROPION SANDOZ 300 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BUPROPION SANDOZ 300 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG , 30 comprimidos | 300 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88175/88175_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88175/88175_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2022-10-10 | 1 | 1 | 1 | 2022-10-11 | 2022-10-10 | 1 | 2024-08-14 | View Edit Delete | ||||||||||||
| 758644 | 88189 | ESPIRONOLACTONA ORION 25 MG COMPRIMIDOS EFG | ESPIRONOLACTONA ORION 25 MG COMPRIMIDOS EFG, 30 comprimidos | 25 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88189/88189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88189/88189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42344 | 43535 | 2023-03-31 | 1 | 1 | 1 | 2023-03-31 | 2023-03-31 | 1 | 2023-12-02 | View Edit Delete | ||||||||||||
| 758651 | 88191 | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG, 30 comprimidos | 100 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88191/88191_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88191/88191_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42344 | 9915 | 2023-03-31 | 1 | 1 | 1 | 2023-03-31 | 2023-03-31 | 1 | 2023-12-02 | View Edit Delete | ||||||||||||
| 758717 | 44901 | TRIGON DEPOT 40 mg/ml SUSPENSIÓN INYECTABLE | TRIGON DEPOT 40 mg/ml SUSPENSIÓN INYECTABLE, 3 viales de 1 ml | 40 mg/ml inyectable 1 ml | 45 | 3 | 34 | 3 viales de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/44901/44901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/44901/44901_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37363 | 37363 | 1967-09-01 | 1 | 1 | 1 | 1967-09-01 | 2022-10-14 | 1 | 2023-12-22 | View Edit Delete | ||||||||||||
| 758828 | 88232 | ESOMEPRAZOL TECNIGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL TECNIGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88232/88232_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88232/88232_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2022-10-26 | 1 | 1 | 1 | 2022-10-27 | 2022-10-26 | 1 | 2022-10-27 | View Edit Delete | ||||||||||||
| 758829 | 88232 | ESOMEPRAZOL TECNIGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL TECNIGEN 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88232/88232_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88232/88232_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2022-10-26 | 1 | 1 | 1 | 2022-10-27 | 2022-10-26 | 1 | 2022-10-27 | View Edit Delete | ||||||||||||
| 758831 | 88233 | ESOMEPRAZOL TECNIGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL TECNIGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88233/88233_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88233/88233_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2022-10-26 | 1 | 1 | 1 | 2022-10-27 | 2022-10-26 | 1 | 2022-10-27 | View Edit Delete | ||||||||||||
| 758832 | 88233 | ESOMEPRAZOL TECNIGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL TECNIGEN 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG , 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88233/88233_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88233/88233_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2022-10-26 | 1 | 1 | 1 | 2022-10-27 | 2022-10-26 | 1 | 2022-10-27 | View Edit Delete | ||||||||||||
| 759123 | 88265 | ESOMEPRAZOL MABO-FARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO-FARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (Al/Al) | 20 mg | 5 | 28 | 10 | 28 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88265/88265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88265/88265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2022-11-03 | 1 | 1 | 1 | 2022-11-04 | 2022-11-03 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 759124 | 88265 | ESOMEPRAZOL MABO-FARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO-FARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (Al/Al) | 20 mg | 5 | 56 | 10 | 56 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88265/88265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88265/88265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2022-11-03 | 1 | 1 | 1 | 2022-11-04 | 2022-11-03 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 759127 | 88266 | ESOMEPRAZOL MABO-FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO-FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (Al/Al) | 40 mg | 5 | 28 | 10 | 28 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88266/88266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88266/88266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2022-11-03 | 1 | 1 | 1 | 2022-11-04 | 2022-11-03 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 759128 | 88266 | ESOMEPRAZOL MABO-FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL MABO-FARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (Al/Al) | 40 mg | 5 | 56 | 10 | 56 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88266/88266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88266/88266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | 68134 | 2022-11-03 | 1 | 1 | 1 | 2022-11-04 | 2022-11-03 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 759162 | 06348001IP4 | ROTATEQ SOLUCION ORAL | ROTATEQ SOLUCION ORAL, 1 tubo | N/A (vacuna) | 44 | 1 | 17 | 1 tubo | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06348001IP4/06348001IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06348001IP4/06348001IP4_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | 26669 | 2022-11-08 | 1 | 1 | 1 | 2022-11-09 | 2022-11-08 | 1 | 2022-11-16 | View Edit Delete | ||||||||||||
| 759175 | 52047 | FORDIURAN 1 mg COMPRIMIDOS | FORDIURAN 1 mg COMPRIMIDOS, 20 comprimidos | 1 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52047/52047_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52047/52047_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30007 | 67885 | 1974-01-01 | 1 | 1 | 1 | 1974-01-01 | 1974-01-01 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 759257 | BE465822 | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 43579 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2022-11-21 | 1 | 2025-07-04 | View Edit Delete | ||||||||||||
| 759259 | BE465813 | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 43579 | 2022-11-25 | 1 | 1 | 1 | 2022-11-26 | 2022-11-25 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 759288 | BE465804 | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465804/BE465804_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 43579 | 2022-11-22 | 1 | 1 | 1 | 2022-11-23 | 2022-11-22 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 759296 | 1221664001 | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 1 mg (45.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664001/1221664001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664001/1221664001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759310 | 1221664002 | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 2 mg (90.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664002/1221664002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664002/1221664002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759311 | 1221664003 | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 5 mg (225.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664003/1221664003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664003/1221664003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | 28192 | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759443 | 88344 | FOSAPREPITANT TARBIS 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG | FOSAPREPITANT TARBIS 150 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88344/88344_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88344/88344_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2022-11-30 | 1 | 1 | 1 | 2022-12-01 | 2022-11-30 | 1 | 2023-06-12 | View Edit Delete | ||||||||||||
| 759673 | 88361 | CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 60 mg inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88361/88361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88361/88361_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2022-12-09 | 1 | 1 | 1 | 2022-12-10 | 2022-12-09 | 1 | 2023-01-23 | View Edit Delete | ||||||||||||
| 759676 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | 16109 | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2022-12-02 | 1 | 2023-09-20 | View Edit Delete | ||||||||||||
| 760017 | 49269 | FRENADOL COMPLEX GRANULADO PARA SOLUCION ORAL | FRENADOL COMPLEX GRANULADO PARA SOLUCION ORAL , 10 sobres | N/A (más de 4 PA) | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49269/49269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49269/49269_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 1971-03-01 | 1 | 1 | 1 | 1971-03-01 | 1971-03-01 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 760298 | 59466 | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59466/59466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59466/59466_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1992-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 760314 | 59468 | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59468/59468_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59468/59468_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1992-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 761748 | 842261102022012IP1 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/842261102022012IP1/842261102022012IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29532 | 26669 | 2023-01-23 | 1 | 1 | 1 | 2023-01-24 | 2023-01-23 | 1 | 2023-02-17 | View Edit Delete | ||||||||||||
| 761879 | 47546 | ESTILSONA 7 mg/ml GOTAS ORALES EN SUSPENSIÓN | ESTILSONA 7 mg/ml GOTAS ORALES EN SUSPENSIÓN, 1 frasco de 30 ml | 7 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/47546/47546_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/47546/47546_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 88185 | 945 | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2023-01-27 | 1 | 2023-06-13 | View Edit Delete | ||||||||||||
| 761978 | 1221713002 | IMJUDO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | IMJUDO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 20 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221713002/1221713002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221713002/1221713002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34774 | 41965 | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2024-04-12 | View Edit Delete | ||||||||||||
| 762267 | 1181323004 | ILUMETRI 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | ILUMETRI 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma | 100 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181323004/1181323004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181323004/1181323004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 88187 | 88187 | 2023-02-23 | 1 | 1 | 1 | 2023-02-24 | 2023-02-23 | 1 | 2023-08-08 | View Edit Delete | ||||||||||||
| 762275 | 4238496C | VALTREX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VALTREX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 42 comprimidos | 500 mg | 5 | 42 | 10 | 42 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/4238496C/4238496C_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 23628 | 2023-02-20 | 1 | 1 | 1 | 2023-02-21 | 2023-02-20 | 1 | 2023-04-25 | View Edit Delete | ||||||||||||
| 762343 | 88698 | NORMOGRIP ANTITUSIVO GRANULADO PARA SOLUCION ORAL | NORMOGRIP ANTITUSIVO GRANULADO PARA SOLUCION ORAL, 10 sobres | 650 mg/4 mg/20 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88698/88698_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88698/88698_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2023-05-12 | View Edit Delete | ||||||||||||
| 762347 | 88699 | NORMOGRIP ANTITUSIVO JUNIOR GRANULADO PARA SOLUCION ORAL | NORMOGRIP ANTITUSIVO JUNIOR GRANULADO PARA SOLUCION ORAL, 10 sobres | 300 mg/2 mg/15 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88699/88699_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88699/88699_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-03-01 | 1 | 1 | 1 | 2023-03-02 | 2023-03-01 | 1 | 2023-05-12 | View Edit Delete | ||||||||||||
| 762356 | 1221677003 | TEZSPIRE 210 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | TEZSPIRE 210 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 210 mg inyectable 1,91 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221677003/1221677003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221677003/1221677003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34774 | 41965 | 2023-03-08 | 1 | 1 | 1 | 2023-03-09 | 2023-03-08 | 1 | 2023-09-11 | View Edit Delete | ||||||||||||
| 762357 | 88704 | ACNIDUO 1 MG/G + 25 MG/G GEL | ACNIDUO 1 MG/G + 25 MG/G GEL, 1 frasco de 60 g | 1 mg/g + 25 mg/g | 6 | 60 | 21 | 1 frasco de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88704/88704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88704/88704_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | 67780 | 2023-03-07 | 1 | 1 | 1 | 2023-03-08 | 2023-03-07 | 1 | 2023-09-22 | View Edit Delete | ||||||||||||
| 762384 | 08462003IP | RANEXA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 500 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462003IP/08462003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462003IP/08462003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 26669 | 2023-03-08 | 1 | 1 | 1 | 2023-03-09 | 2023-03-08 | 1 | 2023-03-09 | View Edit Delete | ||||||||||||
| 762385 | 1211551001 | EVKEEZA 150 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | EVKEEZA 150 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2,3 ml | 150 mg/ml inyectable 2,3 ml | 45 | 1 | 34 | 1 vial de 2,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211551001/1211551001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211551001/1211551001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35117 | 35117 | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2024-07-15 | View Edit Delete | ||||||||||||
| 762387 | 08462001IP | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 375 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462001IP/08462001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462001IP/08462001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 26669 | 2023-03-09 | 1 | 1 | 1 | 2023-03-10 | 2023-03-09 | 1 | 2023-04-11 | View Edit Delete | ||||||||||||
| 762396 | 1171193004 | REFIXIA 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | REFIXIA 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada | 300 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1171193004/1171193004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171193004/1171193004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2023-03-23 | 1 | 1 | 1 | 2023-03-24 | 2023-03-23 | 1 | 2024-01-12 | View Edit Delete | ||||||||||||
| 762403 | 1221689001 | BEYFORTUS 50 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | BEYFORTUS 50 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 50 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221689001/1221689001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221689001/1221689001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2023-03-27 | 1 | 1 | 1 | 2023-03-28 | 2023-03-27 | 1 | 2023-06-13 | View Edit Delete | ||||||||||||
| 762405 | 1221689004 | BEYFORTUS 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | BEYFORTUS 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 100 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221689004/1221689004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221689004/1221689004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2023-03-27 | 1 | 1 | 1 | 2023-03-28 | 2023-03-27 | 1 | 2023-06-13 | View Edit Delete | ||||||||||||
| 762408 | 3400935557506IP1 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506IP1/3400935557506IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38087 | 26669 | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2023-04-11 | View Edit Delete | ||||||||||||
| 762414 | 88729 | OXITRIL 120 MG CAPSULAS DURAS GASTRORRESISTENTES | OXITRIL 120 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 120 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88729/88729_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88729/88729_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | 16612 | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 762415 | 88730 | OXITRIL 90 MG CAPSULAS DURAS GASTRORRESISTENTES | OXITRIL 90 MG CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 90 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88730/88730_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88730/88730_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | 16612 | 2023-03-15 | 1 | 1 | 1 | 2023-03-16 | 2023-03-15 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 762427 | 62503 | GEMFIBROZILO TARBIS 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | GEMFIBROZILO TARBIS 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 600 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62503/62503_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62503/62503_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2876 | 2876 | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 1 | 2015-01-13 | View Edit Delete | ||||||||||||
| 762466 | 88189 | ESPIRONOLACTONA ORION 25 MG COMPRIMIDOS EFG | ESPIRONOLACTONA ORION 25 MG COMPRIMIDOS EFG, 50 comprimidos | 25 mg | 6 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88189/88189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88189/88189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42344 | 43535 | 2023-03-31 | 1 | 1 | 1 | 2023-03-31 | 2023-03-31 | 1 | 2023-12-02 | View Edit Delete | ||||||||||||
| 762473 | 1181286010 | HYRIMOZ 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,8 ml | 80 mg inyectable 0,8 ml | 113 | 1 | 49 | 1 pluma precargada de 0,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286010/1181286010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286010/1181286010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-12-15 | View Edit Delete | ||||||||||||
| 762474 | 1231727001 | BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 30 ml | 300 mg inyectable 30 ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231727001/1231727001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231727001/1231727001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2023-04-27 | 1 | 1 | 1 | 2023-04-28 | 2023-04-27 | 1 | 2023-06-13 | View Edit Delete | ||||||||||||
| 762475 | 1181286015 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 1 | 49 | 1 pluma precargada de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286015/1181286015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286015/1181286015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-22 | View Edit Delete | ||||||||||||
| 762476 | 1181286015 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286015/1181286015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286015/1181286015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-22 | View Edit Delete | ||||||||||||
| 762508 | 1221714001 | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 105 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221714001/1221714001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221714001/1221714001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37607 | 71277 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2024-02-05 | View Edit Delete | ||||||||||||
| 762509 | 1221714001 | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales | 105 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221714001/1221714001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221714001/1221714001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37607 | 71277 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2024-02-05 | View Edit Delete | ||||||||||||
| 762510 | 1221714001 | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 25 viales | 105 mg | 45 | 25 | 34 | 25 viales | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221714001/1221714001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221714001/1221714001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37607 | 71277 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2024-02-05 | View Edit Delete | ||||||||||||
| 762540 | 1181286012 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286012/1181286012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286012/1181286012_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-28 | View Edit Delete | ||||||||||||
| 762747 | 1231740001 | AREXVY POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | AREXVY POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 1 vial de polvo + 1 vial con suspensión | N/A (vacuna) | 83 | 1 | 34 | 1 vial de polvo + 1 vial con suspensión | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231740001/1231740001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231740001/1231740001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | 3732 | 2023-06-12 | 1 | 1 | 1 | 2023-06-13 | 2023-06-12 | 1 | 2024-03-21 | View Edit Delete | ||||||||||||
| 762804 | 3400939239989IP1 | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400939239989IP1/3400939239989IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34756 | 26669 | 2023-05-26 | 1 | 1 | 1 | 2023-05-27 | 2023-05-26 | 1 | 2023-06-21 | View Edit Delete | ||||||||||||
| 762839 | 842261102022012IP2 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/842261102022012IP2/842261102022012IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71207 | 43579 | 2023-06-01 | 1 | 1 | 1 | 2023-06-02 | 2023-06-01 | 1 | 2025-01-15 | View Edit Delete | ||||||||||||
| 762855 | 69370 | BEKUNIS 5 mg COMPRIMIDOS GASTRORRESISTENTES | BEKUNIS 5 mg COMPRIMIDOS GASTRORRESISTENTES, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69370/69370_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69370/69370_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71139 | 5101 | 2007-10-29 | 1 | 1 | 1 | 2018-02-06 | 2023-06-02 | 1 | 2024-12-05 | View Edit Delete | ||||||||||||
| 762901 | 3400934306983IP3 | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400934306983IP3/3400934306983IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 26669 | 2023-06-08 | 1 | 1 | 1 | 2023-06-09 | 2023-06-08 | 1 | 2023-06-21 | View Edit Delete | ||||||||||||
| 762949 | 1231735001 | EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 30 ml | 300 mg inyectable 30 ml | 45 | 1 | 59 | 1 vial de 30 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231735001/1231735001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231735001/1231735001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29985 | 29985 | 2023-06-20 | 1 | 1 | 1 | 2023-06-21 | 2023-06-20 | 1 | 2023-08-10 | View Edit Delete | ||||||||||||
| 762979 | 1231736001 | OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 300 mg inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231736001/1231736001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231736001/1231736001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71735 | 1673 | 2023-06-27 | 1 | 1 | 1 | 2023-06-28 | 2023-06-27 | 1 | 2024-04-05 | View Edit Delete | ||||||||||||
| 762981 | 1080494006 | STELARA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | STELARA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 45 mg inyectable 0,5 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1080494006/1080494006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1080494006/1080494006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2023-06-27 | 1 | 1 | 1 | 2023-06-28 | 2023-06-27 | 1 | 2023-09-11 | View Edit Delete | ||||||||||||
| 762982 | 1080494007 | STELARA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | STELARA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada | 90 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1080494007/1080494007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1080494007/1080494007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2023-06-27 | 1 | 1 | 1 | 2023-06-28 | 2023-06-27 | 1 | 2023-09-11 | View Edit Delete | ||||||||||||
| 762989 | 1231752001 | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial (polvo) + 1 jeringa precargda (disolvente) + 1 adaptador del vial + 1 aguja | N/A (vacuna) | 80 | 1 | 34 | 1 vial (polvo) + 1 jeringa precargda (disolvente) + 1 adaptador del vial + 1 aguja | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231752001/1231752001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231752001/1231752001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2023-09-01 | 1 | 1 | 1 | 2023-09-02 | 2023-09-01 | 1 | 2023-11-10 | View Edit Delete | ||||||||||||
| 763180 | 1231754001 | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754001/1231754001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754001/1231754001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763181 | 1231754001 | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 4 viales de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 4 | 34 | 4 viales de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754001/1231754001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754001/1231754001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763182 | 1231754001 | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754001/1231754001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754001/1231754001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763183 | 1231754001 | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 4 viales de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 4 | 34 | 4 viales de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754001/1231754001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754001/1231754001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763184 | 1231754001 | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 20 ml | 20 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754001/1231754001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754001/1231754001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2025-12-19 | View Edit Delete | ||||||||||||
| 763187 | 1231754010 | TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 4 plumas precargadas 0,9 ml | 162 mg inyectable 0,9 ml | 66 | 4 | 49 | 4 plumas precargadas 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754010/1231754010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754010/1231754010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763190 | 1231754007 | TYENNE 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TYENNE 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas 0,9 ml | 162 mg inyectable 0,9 ml | 33 | 4 | 61 | 4 jeringas precargadas 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231754007/1231754007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231754007/1231754007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 763192 | 1231745001 | TYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | TYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 300 mg | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231745001/1231745001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231745001/1231745001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | 23615 | 2023-09-29 | 1 | 1 | 1 | 2023-09-30 | 2023-09-29 | 1 | 2024-02-13 | View Edit Delete | ||||||||||||
| 763215 | R-2948IP2 | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R-2948IP2/R-2948IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 23628 | 2023-07-31 | 1 | 1 | 1 | 2023-08-01 | 2023-07-31 | 1 | 2023-09-13 | View Edit Delete | ||||||||||||
| 763291 | 89018 | PAROXETINA NORMON 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAROXETINA NORMON 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89018/89018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89018/89018_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-08-16 | 1 | 1 | 1 | 2023-08-17 | 2023-08-16 | 1 | 2023-10-14 | View Edit Delete | ||||||||||||
| 763293 | 89019 | PAROXETINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAROXETINA NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89019/89019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89019/89019_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-08-16 | 1 | 1 | 1 | 2023-08-17 | 2023-08-16 | 1 | 2023-10-14 | View Edit Delete | ||||||||||||
| 763294 | 89020 | PAROXETINA NORMON 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PAROXETINA NORMON 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89020/89020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89020/89020_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-08-16 | 1 | 1 | 1 | 2023-08-17 | 2023-08-16 | 1 | 2023-10-14 | View Edit Delete | ||||||||||||
| 763295 | 2293101IP | LOBIVON 5 MG COMPRIMIDOS | LOBIVON 5 MG COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/2293101IP/2293101IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 26669 | 2023-08-16 | 1 | 1 | 1 | 2023-08-17 | 2023-08-16 | 1 | 2023-08-29 | View Edit Delete | ||||||||||||
| 763297 | BE190854IP2 | NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL | NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 140 dosis | 50 microgramos/dosis | 6 | 140 | 31 | 1 envase pulverizador de 140 dosis | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE190854IP2/BE190854IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71392 | 26669 | 2023-08-18 | 1 | 1 | 1 | 2023-08-19 | 2023-08-18 | 1 | 2023-08-29 | View Edit Delete | ||||||||||||
| 763303 | LT1983805044 | ZARATOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805044/LT1983805044_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 23628 | 2023-08-22 | 1 | 1 | 1 | 2023-08-23 | 2023-08-22 | 1 | 2023-09-13 | View Edit Delete | ||||||||||||
| 763322 | BE465804IP | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465804IP/BE465804IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 23628 | 2023-08-25 | 1 | 1 | 1 | 2023-08-26 | 2023-08-25 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 763372 | 1231759001 | TEPKINLY 4 MG/0,8 ML SOLUCION INYECTABLE | TEPKINLY 4 MG/0,8 ML SOLUCION INYECTABLE, 1 vial de 0,8 ml | 5 mg/ml inyectable 0,8 ml | 45 | 1 | 34 | 1 vial de 0,8 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231759001/1231759001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231759001/1231759001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2023-10-04 | 1 | 1 | 1 | 2023-10-05 | 2023-10-04 | 1 | 2024-12-10 | View Edit Delete | ||||||||||||
| 763378 | BE465813IP | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465813IP/BE465813IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 23628 | 2023-09-14 | 1 | 1 | 1 | 2023-09-15 | 2023-09-14 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 763379 | BE465822IP | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465822IP/BE465822IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 23628 | 2023-09-14 | 1 | 1 | 1 | 2023-09-15 | 2023-09-14 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 763383 | BE465804IP1 | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465804IP1/BE465804IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2023-09-14 | 1 | 1 | 1 | 2023-09-15 | 2023-09-14 | 1 | 2024-03-05 | View Edit Delete | ||||||||||||
| 763385 | BE465813IP1 | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465813IP1/BE465813IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2023-09-14 | 1 | 1 | 1 | 2023-09-15 | 2023-09-14 | 1 | 2024-02-21 | View Edit Delete | ||||||||||||
| 763386 | BE465822IP1 | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465822IP1/BE465822IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2023-09-14 | 1 | 1 | 1 | 2023-09-15 | 2023-09-14 | 1 | 2025-05-06 | View Edit Delete | ||||||||||||
| 763390 | 1211554004 | ADTRALZA 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | ADTRALZA 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 2 ml | 300 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211554004/1211554004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211554004/1211554004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8764 | 34965 | 2023-09-25 | 1 | 1 | 1 | 2023-09-26 | 2023-09-25 | 1 | 2024-04-11 | View Edit Delete | ||||||||||||
| 763393 | 84225112-2-12IP1 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/84225112-2-12IP1/84225112-2-12IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67789 | 23628 | 2023-09-21 | 1 | 1 | 1 | 2023-09-22 | 2023-09-21 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 763455 | 08462001IP1 | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 375 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462001IP1/08462001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462001IP1/08462001IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 17193 | 2023-09-29 | 1 | 1 | 1 | 2023-09-30 | 2023-09-29 | 1 | 2024-04-02 | View Edit Delete | ||||||||||||
| 763461 | 96022010IP1 | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96022010IP1/96022010IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96022010IP1/96022010IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20183 | 17193 | 2023-09-29 | 1 | 1 | 1 | 2023-09-30 | 2023-09-29 | 1 | 2024-02-21 | View Edit Delete | ||||||||||||
| 763542 | 1231759002 | TEPKINLY 48 MG SOLUCION INYECTABLE | TEPKINLY 48 MG SOLUCION INYECTABLE, 1 vial de 0,8 ml | 48 mg inyectable 0,8 ml | 45 | 1 | 34 | 1 vial de 0,8 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231759002/1231759002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231759002/1231759002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41086 | 16052 | 2023-10-09 | 1 | 1 | 1 | 2023-10-10 | 2023-10-09 | 1 | 2024-12-10 | View Edit Delete | ||||||||||||
| 763547 | 84225112-2-12IP2 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/84225112-2-12IP2/84225112-2-12IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29532 | 26669 | 2023-10-09 | 1 | 1 | 1 | 2023-10-10 | 2023-10-09 | 1 | 2023-10-26 | View Edit Delete | ||||||||||||
| 763554 | 84225112-2-12IP3 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/84225112-2-12IP3/84225112-2-12IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35212 | 17193 | 2023-10-11 | 1 | 1 | 1 | 2023-10-12 | 2023-10-11 | 1 | 2024-02-21 | View Edit Delete | ||||||||||||
| 763640 | 4238496CIP1 | VALTREX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VALTREX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 42 comprimidos | 500 mg | 5 | 42 | 10 | 42 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/4238496CIP1/4238496CIP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 41972 | 2023-10-27 | 1 | 1 | 1 | 2023-10-30 | 2023-10-27 | 1 | 2024-02-19 | View Edit Delete | ||||||||||||
| 763751 | 1231730001 | BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 150 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231730001/1231730001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231730001/1231730001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 43544 | 30261 | 2023-11-14 | 1 | 1 | 1 | 2023-11-15 | 2023-11-14 | 1 | 2024-06-12 | View Edit Delete | ||||||||||||
| 763756 | 35146012IP | BARNIX 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA | BARNIX 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28885 | 17193 | 2023-11-15 | 1 | 1 | 1 | 2023-11-16 | 2023-11-15 | 1 | 2024-05-06 | View Edit Delete | ||||||||||||
| 763762 | 4207416072010 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/4207416072010%20/4207416072010__p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38197 | 43579 | 2023-11-20 | 1 | 1 | 1 | 2023-11-21 | 2023-11-20 | 1 | 2025-02-12 | View Edit Delete | ||||||||||||
| 763795 | 1211537001 | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 8 comprimidos | 20 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211537001/1211537001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211537001/1211537001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41866 | 44506 | 2023-11-28 | 1 | 1 | 1 | 2023-11-29 | 2023-11-28 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 763796 | 1211537001 | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 12 comprimidos | 20 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211537001/1211537001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211537001/1211537001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41866 | 44506 | 2023-11-28 | 1 | 1 | 1 | 2023-11-29 | 2023-11-28 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 763799 | 1211537001 | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211537001/1211537001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211537001/1211537001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41866 | 44506 | 2023-11-28 | 1 | 1 | 1 | 2023-11-29 | 2023-11-28 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 763918 | 1231770001 | ELREXFIO 40 MG/ML SOLUCION INYECTABLE | ELREXFIO 40 MG/ML SOLUCION INYECTABLE, un vial de 1,1 ml | 40 mg/ml inyectable 1,1 ml | 45 | 1 | 34 | un vial de 1,1 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231770001/1231770001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231770001/1231770001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2023-12-18 | 1 | 1 | 1 | 2023-12-19 | 2023-12-18 | 1 | 2024-04-12 | View Edit Delete | ||||||||||||
| 763919 | 1231770001 | ELREXFIO 40 MG/ML SOLUCION INYECTABLE | ELREXFIO 40 MG/ML SOLUCION INYECTABLE, un vial de 1,9 ml | 40 mg/ml inyecatble 1,9 ml | 45 | 1 | 34 | un vial de 1,9 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231770001/1231770001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231770001/1231770001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2023-12-18 | 1 | 1 | 1 | 2023-12-19 | 2023-12-18 | 1 | 2024-04-12 | View Edit Delete | ||||||||||||
| 763994 | 89224 | EPLERENONA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EPLERENONA TARBIS FARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos (PVC/Al) | 50 mg | 5 | 30 | 10 | 30 comprimidos (PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89224/89224_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89224/89224_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2024-01-09 | 1 | 1 | 1 | 2024-01-10 | 2024-01-09 | 1 | 2024-08-14 | View Edit Delete | ||||||||||||
| 763997 | 89225 | EPLERENONA TARBIS FARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EPLERENONA TARBIS FARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos (PVC/Al) | 25 mg | 5 | 30 | 10 | 30 comprimidos (PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89225/89225_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89225/89225_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2024-01-09 | 1 | 1 | 1 | 2024-01-10 | 2024-01-09 | 1 | 2024-08-14 | View Edit Delete | ||||||||||||
| 764008 | 89231 | TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA | TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA, 60 ml | 1 mg/ml | 6 | 60 | 26 | 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89231/89231_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89231/89231_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | 30008 | 2024-01-09 | 1 | 1 | 1 | 2024-01-10 | 2024-01-09 | 1 | 2025-11-11 | View Edit Delete | ||||||||||||
| 764018 | 89235 | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89235/89235_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89235/89235_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2024-01-11 | 1 | 1 | 1 | 2024-01-12 | 2024-01-11 | 1 | 2024-08-23 | View Edit Delete | ||||||||||||
| 764019 | 89236 | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89236/89236_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89236/89236_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2024-01-11 | 1 | 1 | 1 | 2024-01-12 | 2024-01-11 | 1 | 2024-08-23 | View Edit Delete | ||||||||||||
| 764020 | 89237 | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA TECNIGEN 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 ng | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89237/89237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89237/89237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2024-01-11 | 1 | 1 | 1 | 2024-01-12 | 2024-01-11 | 1 | 2024-08-23 | View Edit Delete | ||||||||||||
| 764023 | 1231784001 | UZPRUVO 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | UZPRUVO 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231784001/1231784001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231784001/1231784001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2787 | 6220 | 2024-01-11 | 1 | 1 | 1 | 2024-01-12 | 2024-01-11 | 1 | 2024-06-11 | View Edit Delete | ||||||||||||
| 764024 | 1231784004 | UZPRUVO 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | UZPRUVO 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa de 1 ml | 90 mg inyecatble 1 ml | 33 | 1 | 61 | 1 jeringa de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231784004/1231784004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231784004/1231784004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2787 | 6220 | 2024-01-11 | 1 | 1 | 1 | 2024-01-12 | 2024-01-11 | 1 | 2024-06-11 | View Edit Delete | ||||||||||||
| 764037 | 89246 | EZETIMIBA/ATORVASTATINA ALTER 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA ALTER 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89246/89246_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89246/89246_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2024-10-14 | View Edit Delete | ||||||||||||
| 764038 | 89247 | EZETIMIBA/ATORVASTATINA ALTER 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA ALTER 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89247/89247_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89247/89247_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2025-01-14 | View Edit Delete | ||||||||||||
| 764039 | 89245 | EZETIMIBA/ATORVASTATINA ALTER 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA ALTER 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89245/89245_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89245/89245_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2024-10-14 | View Edit Delete | ||||||||||||
| 764040 | 89248 | THERVAN PLUS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | THERVAN PLUS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89248/89248_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89248/89248_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2024-10-14 | View Edit Delete | ||||||||||||
| 764041 | 89249 | THERVAN PLUS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | THERVAN PLUS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89249/89249_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89249/89249_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-18 | 1 | 1 | 1 | 2024-01-19 | 2024-01-18 | 1 | 2024-10-14 | View Edit Delete | ||||||||||||
| 764042 | 89250 | THERVAN PLUS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | THERVAN PLUS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89250/89250_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89250/89250_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-01-15 | 1 | 1 | 1 | 2024-01-16 | 2024-01-15 | 1 | 2024-10-14 | View Edit Delete | ||||||||||||
| 764082 | 1181340007 | TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa de 1 ml | 150 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181340007/1181340007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181340007/1181340007_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42050 | 70973 | 2024-01-18 | 1 | 1 | 1 | 2024-01-19 | 2024-01-18 | 1 | 2025-02-12 | View Edit Delete | ||||||||||||
| 764119 | 1231775001 | REZZAYO 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | REZZAYO 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231775001/1231775001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231775001/1231775001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 39782 | 11860 | 2024-01-25 | 1 | 1 | 1 | 2024-01-26 | 2024-01-25 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 764123 | 3400934306983IP4 | ZARATOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400934306983IP4/3400934306983IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 26669 | 2024-01-25 | 1 | 1 | 1 | 2024-01-26 | 2024-01-25 | 1 | 2024-02-05 | View Edit Delete | ||||||||||||
| 764127 | 3400935557506IP2 | ZARATOR 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935557506IP2/3400935557506IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | 26669 | 2024-01-26 | 1 | 1 | 1 | 2024-01-27 | 2024-01-26 | 1 | 2024-02-05 | View Edit Delete | ||||||||||||
| 764130 | 819420150119 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/819420150119/819420150119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2024-01-30 | 1 | 1 | 1 | 2024-01-31 | 2024-01-30 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764131 | 819520150119 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/819520150119/819520150119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2024-02-01 | 1 | 1 | 1 | 2024-02-02 | 2024-02-01 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764175 | 89280 | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89280/89280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89280/89280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67225 | 67225 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2025-03-26 | View Edit Delete | ||||||||||||
| 764176 | 89281 | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89281/89281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89281/89281_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67225 | 67225 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2025-03-26 | View Edit Delete | ||||||||||||
| 764177 | 89282 | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA OLPHA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89282/89282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89282/89282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67225 | 67225 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2025-03-26 | View Edit Delete | ||||||||||||
| 764189 | 1231780001 | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 2 ml | 140 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231780001/1231780001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231780001/1231780001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 8910 | 21333 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2025-04-02 | View Edit Delete | ||||||||||||
| 764299 | 89343 | CARDYL PLUS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | CARDYL PLUS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89343/89343_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89343/89343_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 764300 | 89344 | CARDYL PLUS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | CARDYL PLUS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89344/89344_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89344/89344_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 764301 | 89345 | CARDYL PLUS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | CARDYL PLUS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89345/89345_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89345/89345_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 764310 | 1201435001IP | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 25 ml | 20 mg/ml inyctable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201435001IP/1201435001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201435001IP/1201435001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 37912 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-04-30 | View Edit Delete | ||||||||||||
| 764311 | 1201435001IP1 | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201435001IP1/1201435001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201435001IP1/1201435001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 37912 | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-04-30 | View Edit Delete | ||||||||||||
| 764314 | 89350 | PAZOPANIB ACCORD 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB ACCORD 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89350/89350_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89350/89350_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2025-11-10 | View Edit Delete | ||||||||||||
| 764315 | 89351 | PAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89351/89351_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89351/89351_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2025-11-10 | View Edit Delete | ||||||||||||
| 764316 | 89346 | EZETIMIBA/ATORVASTATINA STADA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA STADA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89346/89346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89346/89346_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 764317 | 89347 | EZETIMIBA/ATORVASTATINA STADA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA STADA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89347/89347_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89347/89347_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 764318 | 89348 | EZETIMIBA/ATORVASTATINA STADA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA STADA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89348/89348_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89348/89348_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 764319 | 89349 | EZETIMIBA/ATORVASTATINA STADA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA STADA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89349/89349_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89349/89349_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 764345 | BE215826 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215826/BE215826_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 23628 | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 764358 | BE215887 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215887/BE215887_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 23628 | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 764380 | 89376 | OMEREFLUX 20 MG CÁPSULAS DURAS GASTRORRESISTENTES | OMEREFLUX 20 MG CÁPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89376/89376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89376/89376_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2024-02-21 | 1 | 1 | 1 | 2024-02-22 | 2024-02-21 | 1 | 2024-04-02 | View Edit Delete | ||||||||||||
| 764383 | 89378 | EZETIMIBA/ATORVASTATINA PENSA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA PENSA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89378/89378_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89378/89378_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2024-02-23 | 1 | 1 | 1 | 2024-02-24 | 2024-02-23 | 1 | 2024-08-01 | View Edit Delete | ||||||||||||
| 764384 | 89379 | EZETIMIBA/ATORVASTATINA PENSA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA PENSA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89379/89379_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89379/89379_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2024-02-23 | 1 | 1 | 1 | 2024-02-24 | 2024-02-23 | 1 | 2024-08-01 | View Edit Delete | ||||||||||||
| 764385 | 89380 | EZETIMIBA/ATORVASTATINA PENSA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA PENSA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89380/89380_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89380/89380_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2024-02-23 | 1 | 1 | 1 | 2024-02-24 | 2024-02-23 | 1 | 2024-08-01 | View Edit Delete | ||||||||||||
| 764425 | 1231763001 | CATIOLANZE 50 MICROGRAMOS/ML COLIRIO EN EMULSION | CATIOLANZE 50 MICROGRAMOS/ML COLIRIO EN EMULSION, 30 envases unidosis de 0,3 ml | 50 microgramos/ml | 37 | 30 | 16 | 30 envases unidosis de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1231763001/1231763001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231763001/1231763001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2024-02-27 | 1 | 1 | 1 | 2024-02-28 | 2024-02-27 | 1 | 2024-07-26 | View Edit Delete | ||||||||||||
| 764535 | 89443 | AZELASTINA/FLUTICASONA TEVA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AZELASTINA/FLUTICASONA TEVA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89443/89443_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89443/89443_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-03-13 | 1 | 1 | 1 | 2024-03-14 | 2024-03-13 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 764544 | 034972442 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972442/034972442_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 23628 | 2024-03-18 | 1 | 1 | 1 | 2024-03-19 | 2024-03-18 | 1 | 2024-06-13 | View Edit Delete | ||||||||||||
| 764545 | 034972291 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972291/034972291_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 23628 | 2024-03-15 | 1 | 1 | 1 | 2024-03-16 | 2024-03-15 | 1 | 2024-06-13 | View Edit Delete | ||||||||||||
| 764611 | 983805025IP | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/983805025IP/983805025IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 23628 | 2024-03-27 | 1 | 1 | 1 | 2024-03-28 | 2024-03-27 | 1 | 2024-07-16 | View Edit Delete | ||||||||||||
| 764651 | 8194201508 | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8194201508/8194201508_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2024-04-02 | 1 | 1 | 1 | 2024-04-03 | 2024-04-02 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 764652 | 8195201508 | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8195201508/8195201508_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2024-04-02 | 1 | 1 | 1 | 2024-04-03 | 2024-04-02 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 764709 | 89496 | TRAMADOL/PARACETAMOL ALTER 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL ALTER 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 20 comprimidos (PVC/PVDC/Al) | 75 mg/650 mg | 5 | 20 | 10 | 20 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89496/89496_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89496/89496_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-04-12 | 1 | 1 | 1 | 2024-04-13 | 2024-04-12 | 1 | 2024-09-13 | View Edit Delete | ||||||||||||
| 764710 | 89496 | TRAMADOL/PARACETAMOL ALTER 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TRAMADOL/PARACETAMOL ALTER 75 MG/650 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos (PVC/PVDC/Al) | 75 mg/650 mg | 5 | 60 | 10 | 60 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89496/89496_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89496/89496_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-04-12 | 1 | 1 | 1 | 2024-04-13 | 2024-04-12 | 1 | 2024-09-13 | View Edit Delete | ||||||||||||
| 764766 | 842261102022012IP3 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/842261102022012IP3/842261102022012IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29532 | 29145 | 2024-04-19 | 1 | 1 | 1 | 2024-04-20 | 2024-04-19 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 764795 | 89519 | TUSSAL 35,4 MG JARABE EN SOBRES | TUSSAL 35,4 MG JARABE EN SOBRES, 20 sobres de 10 ml | 35,4 mg | 35 | 20 | 64 | 20 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89519/89519_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89519/89519_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2024-04-25 | 1 | 1 | 1 | 2024-04-26 | 2024-04-25 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764827 | 1241801003 | PYZCHIVA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | PYZCHIVA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801003/1241801003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801003/1241801003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2024-04-30 | 1 | 1 | 1 | 2024-05-01 | 2024-04-30 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764828 | 1241801002 | PYZCHIVA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | PYZCHIVA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801002/1241801002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801002/1241801002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2024-04-30 | 1 | 1 | 1 | 2024-05-01 | 2024-04-30 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764830 | 1241801001 | PYZCHIVA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | PYZCHIVA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801001/1241801001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801001/1241801001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2024-04-30 | 1 | 1 | 1 | 2024-05-01 | 2024-04-30 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764876 | 75974 | NICORETTE SUPERMINT 2 mg COMPRIMIDOS PARA CHUPAR EFG | NICORETTE SUPERMINT 2 mg COMPRIMIDOS PARA CHUPAR EFG, 40 comprimidos (1x40) | 2 mg | 7 | 40 | 10 | 40 comprimidos (1x40) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75974/75974_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75974/75974_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2012-05-28 | 1 | 1 | 1 | 2013-12-03 | 2024-05-07 | 1 | 2024-10-01 | View Edit Delete | ||||||||||||
| 764877 | 75974 | NICORETTE SUPERMINT 2 mg COMPRIMIDOS PARA CHUPAR EFG | NICORETTE SUPERMINT 2 mg COMPRIMIDOS PARA CHUPAR EFG, 80 comprimidos (2x40) | 2 mg | 7 | 80 | 10 | 80 comprimidos (2x40) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75974/75974_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75974/75974_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2012-05-28 | 1 | 1 | 1 | 2013-12-03 | 2024-05-07 | 1 | 2024-10-01 | View Edit Delete | ||||||||||||
| 764879 | 75972 | NICORETTE SUPERMINT 4 mg COMPRIMIDOS PARA CHUPAR EFG | NICORETTE SUPERMINT 4 mg COMPRIMIDOS PARA CHUPAR EFG, 40 comprimidos (1x40) | 4 mg | 7 | 40 | 10 | 40 comprimidos (1x40) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75972/75972_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75972/75972_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2012-05-28 | 1 | 1 | 1 | 2013-12-03 | 2024-05-07 | 1 | 2024-10-01 | View Edit Delete | ||||||||||||
| 764895 | 89553 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89553/89553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89553/89553_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2025-06-13 | View Edit Delete | ||||||||||||
| 764901 | 89554 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89554/89554_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89554/89554_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2025-12-12 | View Edit Delete | ||||||||||||
| 764903 | 89555 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89555/89555_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89555/89555_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 764904 | 89556 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89556/89556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89556/89556_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2025-12-14 | View Edit Delete | ||||||||||||
| 764968 | 89582 | EZETIMIBA/ATORVASTATINA CINFA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA CINFA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89582/89582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89582/89582_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2024-05-22 | 1 | 1 | 1 | 2024-05-23 | 2024-05-22 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 764970 | 89583 | EZETIMIBA/ATORVASTATINA CINFA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA CINFA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89583/89583_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89583/89583_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2024-05-22 | 1 | 1 | 1 | 2024-05-23 | 2024-05-22 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 764971 | 89584 | EZETIMIBA/ATORVASTATINA CINFA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA CINFA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89584/89584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89584/89584_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2024-05-22 | 1 | 1 | 1 | 2024-05-23 | 2024-05-22 | 1 | 2024-11-11 | View Edit Delete | ||||||||||||
| 764976 | 89586 | KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA | KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 2 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89586/89586_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89586/89586_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2024-05-23 | 1 | 1 | 1 | 2024-05-24 | 2024-05-23 | 1 | 2026-05-14 | View Edit Delete | ||||||||||||
| 765014 | 102221017IP | PEGASYS 90 MICROGRAMOS SOLUCION INYECTABLE EN JERINGA PRECARGADA | PEGASYS 90 MICROGRAMOS SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada y 1 aguja | 90 microgramos 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada y 1 aguja | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/102221017IP/102221017IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/102221017IP/102221017IP_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44015 | 37912 | 2024-05-29 | 1 | 1 | 1 | 2024-05-30 | 2024-05-29 | 1 | 2024-07-05 | View Edit Delete | ||||||||||||
| 765050 | 1151016003IP | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas | 140 mg inyectable 1 ml | 66 | 2 | 49 | 2 plumas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151016003IP/1151016003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151016003IP/1151016003IP_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7884 | 37912 | 2024-05-30 | 1 | 1 | 1 | 2024-05-31 | 2024-05-30 | 1 | 2024-07-20 | View Edit Delete | ||||||||||||
| 765081 | 7164IP | OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA | OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43818 | 43579 | 2024-06-03 | 1 | 1 | 1 | 2024-06-04 | 2024-06-03 | 1 | 2024-11-07 | View Edit Delete | ||||||||||||
| 765099 | 1161164012 | AMGEVITA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AMGEVITA 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,4 ml (100 mg/ml) | 40 mg inyectable 0,4 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,4 ml (100 mg/ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161164012/1161164012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161164012/1161164012_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2024-06-07 | 1 | 1 | 1 | 2024-06-08 | 2024-06-07 | 1 | 2024-10-10 | View Edit Delete | ||||||||||||
| 765100 | 1161164015 | AMGEVITA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AMGEVITA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,4 ml (100 mg/ml) | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas precargadas de 0,4 ml (100 mg/ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161164015/1161164015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161164015/1161164015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2024-06-07 | 1 | 1 | 1 | 2024-06-08 | 2024-06-07 | 1 | 2024-10-10 | View Edit Delete | ||||||||||||
| 765101 | 1161164010 | AMGEVITA 20 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AMGEVITA 20 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,2 ml (100 mg/ml) | 20 mg inyectable 0,2 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,2 ml (100 mg/ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161164010/1161164010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161164010/1161164010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2024-06-07 | 1 | 1 | 1 | 2024-06-08 | 2024-06-07 | 1 | 2024-10-10 | View Edit Delete | ||||||||||||
| 765192 | 1241824001 | ALTUVOCT 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 250 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824001/1241824001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824001/1241824001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765193 | 1241824002 | ALTUVOCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 500 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824002/1241824002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824002/1241824002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765195 | 1241824007 | ALTUVOCT 4 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 4 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 4.000 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824007/1241824007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824007/1241824007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765196 | 1241824004 | ALTUVOCT 1 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 1 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 1.000 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824004/1241824004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824004/1241824004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765197 | 1241824006 | ALTUVOCT 3 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 3 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 3.000 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824006/1241824006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824006/1241824006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765199 | 1241824005 | ALTUVOCT 2 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ALTUVOCT 2 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de 3 ml | 2.000 UI | 80 | 1 | 34 | 1 vial + 1 jeringa precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241824005/1241824005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241824005/1241824005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 15522 | 30717 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-11-08 | View Edit Delete | ||||||||||||
| 765200 | 89648 | FUMARATO DE DIMETILO VIVANTA 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO VIVANTA 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 120 mg | 110 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89648/89648_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89648/89648_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | 67529 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2025-02-06 | View Edit Delete | ||||||||||||
| 765201 | 89647 | FUMARATO DE DIMETILO VIVANTA 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO VIVANTA 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 240 mg | 110 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89647/89647_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89647/89647_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | 67529 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2025-02-06 | View Edit Delete | ||||||||||||
| 765202 | BE184064 | PREVENCOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE184064/BE184064_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47564 | 17193 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-09-19 | View Edit Delete | ||||||||||||
| 765203 | BE232933 | PREVENCOR 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE232933/BE232933_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47564 | 17193 | 2024-06-20 | 1 | 1 | 1 | 2024-06-21 | 2024-06-20 | 1 | 2024-09-19 | View Edit Delete | ||||||||||||
| 765233 | 89660 | BITUROL 5 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BITUROL 5 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 5 mg/5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89660/89660_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89660/89660_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2024-06-24 | 1 | 1 | 1 | 2024-06-25 | 2024-06-24 | 1 | 2025-01-02 | View Edit Delete | ||||||||||||
| 765251 | 1241823004 | WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823004/1241823004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823004/1241823004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 765252 | 1241823003 | WEZENLA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | WEZENLA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823003/1241823003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823003/1241823003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 765253 | 1241823002 | WEZENLA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | WEZENLA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823002/1241823002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823002/1241823002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 765254 | 1241823001 | WEZENLA 45 MG SOLUCION INYECTABLE | WEZENLA 45 MG SOLUCION INYECTABLE, 1 vial de 0,5 ml | 45 mg inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823001/1241823001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823001/1241823001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-08-09 | View Edit Delete | ||||||||||||
| 765320 | 89682 | TAMSULOSINA PENSA PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA PENSA PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89682/89682_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89682/89682_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2024-07-04 | 1 | 1 | 1 | 2024-07-05 | 2024-07-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 765337 | 89694 | FLUTICASONA TEVA 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLUTICASONA TEVA 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89694/89694_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89694/89694_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-07-09 | 1 | 1 | 1 | 2024-07-10 | 2024-07-09 | 1 | 2025-03-14 | View Edit Delete | ||||||||||||
| 765382 | 89698 | TAMSULOSINA KERN PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA KERN PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89698/89698_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89698/89698_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2024-07-12 | 1 | 1 | 1 | 2024-07-13 | 2024-07-12 | 1 | 2025-03-14 | View Edit Delete | ||||||||||||
| 765427 | 28600056 | OPIREN 30 mg CAPSULAS DURAS GASTRORRESISTENTES | OPIREN 30 mg CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/28600056/28600056_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29766 | 17193 | 2024-07-19 | 1 | 1 | 1 | 2024-07-20 | 2024-07-19 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 765534 | 103260036 | STALEVO 175 MG/43,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 175 MG/43,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 175 mg/43,75 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/103260036/103260036_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/103260036/103260036_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2024-08-02 | 1 | 1 | 1 | 2024-08-03 | 2024-08-02 | 1 | 2025-02-18 | View Edit Delete | ||||||||||||
| 765551 | 89758 | RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE | RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE, 1 vial de 1,5 ml | 100 unidades/ml inyectable 1,5 ml | 45 | 1 | 34 | 1 vial de 1,5 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/89758/89758_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89758/89758_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71122 | 23643 | 2024-09-13 | 1 | 1 | 1 | 2024-09-13 | 2024-09-13 | 1 | 2024-10-30 | View Edit Delete | ||||||||||||
| 765553 | 89758 | RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE | RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE, 10 viales de 1,5 ml | 100 unidades/ml inyectable 1,5 ml | 45 | 10 | 34 | 10 viales de 1,5 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/89758/89758_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89758/89758_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71122 | 23643 | 2024-09-13 | 1 | 1 | 1 | 2024-09-13 | 2024-09-13 | 1 | 2024-10-30 | View Edit Delete | ||||||||||||
| 765583 | 89773 | FUMARATO DE DIMETILO DR. REDDYS 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO DR. REDDYS 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 120 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89773/89773_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89773/89773_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2024-08-16 | 1 | 1 | 1 | 2024-08-17 | 2024-08-16 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 765584 | 89774 | FUMARATO DE DIMETILO DR. REDDYS 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | FUMARATO DE DIMETILO DR. REDDYS 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas | 240 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89774/89774_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89774/89774_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2024-08-16 | 1 | 1 | 1 | 2024-08-17 | 2024-08-16 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 765607 | 89779 | AVANCORT 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | AVANCORT 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 15 ml (120 pulverizaciones) | 27,5 microgramos/dosis | 6 | 120 | 30 | 1 frasco de 15 ml (120 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89779/89779_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89779/89779_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2024-08-21 | 1 | 1 | 1 | 2024-08-22 | 2024-08-21 | 1 | 2025-04-11 | View Edit Delete | ||||||||||||
| 765613 | 1181286001IP | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,8 ml | 40 mg inyectable 0,8 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286001IP/1181286001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286001IP/1181286001IP_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | 37912 | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 1 | 2024-10-01 | View Edit Delete | ||||||||||||
| 765616 | 89786 | PAZOPANIB GLENMARK 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB GLENMARK 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89786/89786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89786/89786_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2024-12-16 | 1 | 1 | 1 | 2024-12-16 | 2024-12-16 | 1 | 2025-11-14 | View Edit Delete | ||||||||||||
| 765623 | 89787 | PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89787/89787_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89787/89787_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2024-12-16 | 1 | 1 | 1 | 2024-12-16 | 2024-12-16 | 1 | 2025-11-14 | View Edit Delete | ||||||||||||
| 765630 | PA23055017002 | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/PA23055017002/PA23055017002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 43579 | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 1 | 2025-02-05 | View Edit Delete | ||||||||||||
| 765631 | PA23055017003 | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/PA23055017003/PA23055017003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 43579 | 2024-08-22 | 1 | 1 | 1 | 2024-08-23 | 2024-08-22 | 1 | 2025-02-05 | View Edit Delete | ||||||||||||
| 765662 | 1241850003 | WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada 1,3 ml | 60 mg | 80 | 1 | 61 | 1 vial + 1 jeringa precargada 1,3 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241850003/1241850003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241850003/1241850003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 34945 | 69623 | 2024-09-02 | 1 | 1 | 1 | 2024-09-03 | 2024-09-02 | 1 | 2025-07-08 | View Edit Delete | ||||||||||||
| 765663 | 1241850003 | WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 2 viales + 2 jeringas precargadas 1,3 ml | 60 mg | 80 | 2 | 61 | 2 viales + 2 jeringas precargadas 1,3 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241850003/1241850003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241850003/1241850003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 34945 | 69623 | 2024-09-02 | 1 | 1 | 1 | 2024-09-03 | 2024-09-02 | 1 | 2025-10-08 | View Edit Delete | ||||||||||||
| 765664 | 1241850001 | WINREVAIR 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WINREVAIR 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada 1 ml | 45 mg | 80 | 1 | 61 | 1 vial + 1 jeringa precargada 1 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241850001/1241850001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241850001/1241850001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 34945 | 69623 | 2024-09-02 | 1 | 1 | 1 | 2024-09-03 | 2024-09-02 | 1 | 2025-07-08 | View Edit Delete | ||||||||||||
| 765665 | 1241850001 | WINREVAIR 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | WINREVAIR 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 2 viales + 2 jeringas precargadas 1 ml | 45 mg | 80 | 2 | 61 | 2 viales + 2 jeringas precargadas 1 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241850001/1241850001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241850001/1241850001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 34945 | 69623 | 2024-09-02 | 1 | 1 | 1 | 2024-09-03 | 2024-09-02 | 1 | 2025-07-08 | View Edit Delete | ||||||||||||
| 765692 | 1211575011 | BIMZELX 320 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | BIMZELX 320 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 2 ml | 320 mg inyectable 2 ml | 66 | 1 | 49 | 1 pluma precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211575011/1211575011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211575011/1211575011_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2024-09-06 | 1 | 1 | 1 | 2024-09-07 | 2024-09-06 | 1 | 2025-01-07 | View Edit Delete | ||||||||||||
| 765713 | 1241844003 | STEQEYMA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | STEQEYMA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241844003/1241844003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241844003/1241844003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 765714 | 1241844001 | STEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | STEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241844001/1241844001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241844001/1241844001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 765715 | 1241844002 | STEQEYMA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | STEQEYMA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241844002/1241844002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241844002/1241844002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 765725 | 1231780001 | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml | 140 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231780001/1231780001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231780001/1231780001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 8910 | 21333 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-09-16 | 1 | 2025-04-02 | View Edit Delete | ||||||||||||
| 765726 | 1231780001 | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE | RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 4 ml | 140 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231780001/1231780001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231780001/1231780001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 8910 | 21333 | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-09-16 | 1 | 2025-04-02 | View Edit Delete | ||||||||||||
| 765843 | 1241861002 | ITUXREDI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | ITUXREDI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 2 | 34 | 2 viales de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241861002/1241861002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241861002/1241861002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36528 | 27152 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-07-03 | View Edit Delete | ||||||||||||
| 765845 | 1241861003 | ITUXREDI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | ITUXREDI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241861003/1241861003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241861003/1241861003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36528 | 27152 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-07-03 | View Edit Delete | ||||||||||||
| 765851 | LT1983805025IP1 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805025IP1/LT1983805025IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 765861 | 1241863003 | OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863003/1241863003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863003/1241863003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-02-11 | View Edit Delete | ||||||||||||
| 765862 | 1241863001 | OTULFI 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | OTULFI 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863001/1241863001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863001/1241863001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-02-11 | View Edit Delete | ||||||||||||
| 765863 | 1241863002 | OTULFI 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | OTULFI 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863002/1241863002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863002/1241863002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2025-02-11 | View Edit Delete | ||||||||||||
| 765897 | 1241859001 | YUVANCI 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | YUVANCI 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 10 mg/20 mg | 110 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241859001/1241859001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241859001/1241859001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2024-10-03 | 1 | 1 | 1 | 2024-10-04 | 2024-10-03 | 1 | 2025-02-12 | View Edit Delete | ||||||||||||
| 765898 | 1241859002 | YUVANCI 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | YUVANCI 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 10 mg/40 mg | 110 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241859002/1241859002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241859002/1241859002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2024-10-03 | 1 | 1 | 1 | 2024-10-04 | 2024-10-03 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 765941 | 64811 | ZOLPIDEM VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ZOLPIDEM VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64811/64811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64811/64811_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2002-06-03 | 1 | 1 | 1 | 2002-06-03 | 2002-06-03 | 1 | 2011-10-24 | Lista IV | View Edit Delete | |||||||||||
| 765999 | 1231763001 | CATIOLANZE 50 MICROGRAMOS/ML COLIRIO EN EMULSION | CATIOLANZE 50 MICROGRAMOS/ML COLIRIO EN EMULSION, 90 envases unidosis de 0,3 ml | 50 microgramos/ml | 37 | 90 | 16 | 90 envases unidosis de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1231763001/1231763001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231763001/1231763001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2024-02-27 | 1 | 1 | 1 | 2024-02-28 | 2024-10-17 | 1 | 2025-04-24 | View Edit Delete | ||||||||||||
| 766036 | 1201508001IP | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201508001IP/1201508001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201508001IP/1201508001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8400 | 37912 | 2024-10-28 | 1 | 1 | 1 | 2024-10-29 | 2024-10-28 | 1 | 2024-11-19 | View Edit Delete | ||||||||||||
| 766066 | LT1983805025IP2 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805025IP2/LT1983805025IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 26669 | 2024-11-05 | 1 | 1 | 1 | 2024-11-06 | 2024-11-05 | 1 | 2025-01-21 | View Edit Delete | ||||||||||||
| 766122 | 89922 | ATORVASTATINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (BLISTER) | 10 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89922/89922_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89922/89922_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766123 | 89922 | ATORVASTATINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (FRASCO) | 10 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89922/89922_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89922/89922_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766124 | 89923 | ATORVASTATINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (BLISTER) | 20 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89923/89923_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89923/89923_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766125 | 89923 | ATORVASTATINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (FRASCO) | 20 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89923/89923_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89923/89923_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766126 | 89924 | ATORVASTATINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (BLISTER) | 30 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89924/89924_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89924/89924_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766127 | 89924 | ATORVASTATINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (FRASCO) | 30 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89924/89924_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89924/89924_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766128 | 89925 | ATORVASTATINA TEVA-RATIO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (BLISTER) | 40 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89925/89925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89925/89925_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766129 | 89925 | ATORVASTATINA TEVA-RATIO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89925/89925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89925/89925_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 766130 | 89926 | ATORVASTATINA TEVA-RATIO 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA TEVA-RATIO 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (BLISTER) | 60 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89926/89926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89926/89926_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 766131 | 89926 | ATORVASTATINA TEVA-RATIO 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA TEVA-RATIO 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (FRASCO) | 60 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89926/89926_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89926/89926_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-11-14 | View Edit Delete | ||||||||||||
| 766132 | 89927 | ATORVASTATINA TEVA-RATIO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (BLISTER) | 80 mg | 110 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89927/89927_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89927/89927_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 766133 | 89927 | ATORVASTATINA TEVA-RATIO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TEVA-RATIO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (FRASCO) | 80 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89927/89927_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89927/89927_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2024-12-04 | 1 | 1 | 1 | 2024-12-04 | 2024-12-04 | 1 | 2025-08-14 | View Edit Delete | ||||||||||||
| 766169 | LT120001224001IP | AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS | AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT120001224001IP/LT120001224001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 17193 | 2024-11-11 | 1 | 1 | 1 | 2024-11-12 | 2024-11-11 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 766195 | 89940 | ATORVASTATINA DAVURGAMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ATORVASTATINA DAVURGAMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 10 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89940/89940_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89940/89940_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-07-14 | View Edit Delete | ||||||||||||
| 766197 | 89941 | ATORVASTATINA DAVURGAMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ATORVASTATINA DAVURGAMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 20 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89941/89941_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89941/89941_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-09-12 | View Edit Delete | ||||||||||||
| 766198 | 89942 | ATORVASTATINA DAVURGAMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | ATORVASTATINA DAVURGAMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 30 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89942/89942_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89942/89942_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 766199 | 89943 | ATORVASTATINA DAVURGAMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ATORVASTATINA DAVURGAMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 40 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89943/89943_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89943/89943_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-09-12 | View Edit Delete | ||||||||||||
| 766202 | 89944 | ATORVASTATINA DAVURGAMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | ATORVASTATINA DAVURGAMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 60 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89944/89944_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89944/89944_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-09-12 | View Edit Delete | ||||||||||||
| 766203 | 89945 | ATORVASTATINA DAVURGAMA 80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ATORVASTATINA DAVURGAMA 80 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 80 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89945/89945_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89945/89945_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2026-01-15 | View Edit Delete | ||||||||||||
| 766239 | 89958 | DOCETAXEL HIKMA 80 MG/4 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL HIKMA 80 MG/4 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 80 mg inyectable perfusión 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89958/89958_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89958/89958_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | 50666 | 2025-01-07 | 1 | 1 | 1 | 2025-01-07 | 2025-01-07 | 1 | 2026-05-26 | View Edit Delete | ||||||||||||
| 766240 | 89959 | DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 160 mg inyectable perfusión 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89959/89959_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89959/89959_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | 50666 | 2025-01-07 | 1 | 1 | 1 | 2025-01-07 | 2025-01-07 | 1 | 2026-05-19 | View Edit Delete | ||||||||||||
| 766274 | 772991623042018 | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/772991623042018/772991623042018_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38197 | 43579 | 2024-11-20 | 1 | 1 | 1 | 2024-11-21 | 2024-11-20 | 1 | 2025-02-12 | View Edit Delete | ||||||||||||
| 766342 | 1241874002 | HYMPAVZI 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYMPAVZI 150 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 150 mg | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241874002/1241874002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241874002/1241874002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2024-11-22 | 1 | 1 | 1 | 2024-11-23 | 2024-11-22 | 1 | 2026-01-13 | View Edit Delete | ||||||||||||
| 766343 | 1812450 | SLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/1812450/1812450_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 17193 | 2024-11-22 | 1 | 1 | 1 | 2024-11-23 | 2024-11-22 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 766344 | 1812450 | SLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 (3 x 28) comprimidos | 4 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/1812450/1812450_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 17193 | 2024-11-22 | 1 | 1 | 1 | 2024-11-23 | 2024-11-22 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 766358 | 1241878001 | FLUAD SUSPENSION INYECTABLE EN JERINGA PRECARGADA | FLUAD SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas precargadas sin aguja 0,5 ml | N/A (Vacuna) | 33 | 10 | 61 | 10 jeringas precargadas sin aguja 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241878001/1241878001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241878001/1241878001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32240 | 24060 | 2024-11-25 | 1 | 1 | 1 | 2024-11-26 | 2024-11-25 | 1 | 2025-08-11 | View Edit Delete | ||||||||||||
| 766395 | 3400935533951IP1 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935533951IP1/3400935533951IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67217 | 26669 | 2024-12-03 | 1 | 1 | 1 | 2024-12-04 | 2024-12-03 | 1 | 2025-01-21 | View Edit Delete | ||||||||||||
| 766407 | 89990 | NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 500 mg/20 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89990/89990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89990/89990_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2024-12-04 | 1 | 1 | 1 | 2024-12-05 | 2024-12-04 | 1 | 2025-11-13 | View Edit Delete | ||||||||||||
| 766563 | 1241881007 | ALHEMO 300 MG/3 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | ALHEMO 300 MG/3 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 3 ml | 300 mg (100 mg/ml) inyectable 3 ml | 66 | 1 | 49 | 1 pluma precargada de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241881007/1241881007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241881007/1241881007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2025-01-07 | 1 | 1 | 1 | 2025-01-08 | 2025-01-07 | 1 | 2026-03-09 | View Edit Delete | ||||||||||||
| 766564 | 1241881005 | ALHEMO 150 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | ALHEMO 150 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1,5 ml | 150 mg (100 mg/ml) inyectable 1,5 ml | 66 | 1 | 49 | 1 pluma precargada de 1,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241881005/1241881005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241881005/1241881005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2025-01-07 | 1 | 1 | 1 | 2025-01-08 | 2025-01-07 | 1 | 2026-03-09 | View Edit Delete | ||||||||||||
| 766565 | 1241881003 | ALHEMO 60 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA | ALHEMO 60 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1,5 ml | 60 mg (40 mg/ml) inyectable 1,5 ml | 66 | 1 | 49 | 1 pluma precargada de 1,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241881003/1241881003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241881003/1241881003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1974 | 41044 | 2025-01-07 | 1 | 1 | 1 | 2025-01-08 | 2025-01-07 | 1 | 2026-03-09 | View Edit Delete | ||||||||||||
| 766568 | 1241872001 | IMULDOSA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | IMULDOSA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241872001/1241872001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241872001/1241872001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2025-01-10 | 1 | 1 | 1 | 2025-01-11 | 2025-01-10 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 766569 | 1241872002 | IMULDOSA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | IMULDOSA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241872002/1241872002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241872002/1241872002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2025-01-10 | 1 | 1 | 1 | 2025-01-11 | 2025-01-10 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 766570 | 1241872003 | IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241872003/1241872003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241872003/1241872003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2025-01-10 | 1 | 1 | 1 | 2025-01-11 | 2025-01-10 | 1 | 2025-02-14 | View Edit Delete | ||||||||||||
| 766688 | 1983805025IP1 | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/1983805025IP1/1983805025IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 17193 | 2025-01-14 | 1 | 1 | 1 | 2025-01-15 | 2025-01-14 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 766719 | 90078 | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90078/90078_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90078/90078_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | 587 | 2025-01-20 | 1 | 1 | 1 | 2025-01-21 | 2025-01-20 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 766765 | 80572 | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal, 115 dosis | 50 microgramos/dosis | 6 | 115 | 31 | 115 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80572/80572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80572/80572_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2016-01-22 | 1 | 1 | 1 | 2016-01-22 | 2025-01-28 | 1 | 2025-03-31 | View Edit Delete | ||||||||||||
| 766799 | 034972291IP | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972291IP/034972291IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 41972 | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-09 | View Edit Delete | ||||||||||||
| 766800 | 034972442IP | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972442IP/034972442IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 41972 | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-09 | View Edit Delete | ||||||||||||
| 766806 | 88191 | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG, 30 comprimidos (PVC/Al) | 100 mg | 5 | 30 | 10 | 30 comprimidos (PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88191/88191_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88191/88191_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42344 | 9915 | 2023-03-31 | 1 | 1 | 1 | 2023-03-31 | 2025-01-31 | 1 | 2026-05-11 | View Edit Delete | ||||||||||||
| 766815 | 90121 | EZETIMIBA/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90121/90121_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90121/90121_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2025-02-19 | 1 | 1 | 1 | 2025-02-19 | 2025-02-19 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 766829 | 90122 | EZETIMIBA/ATORVASTATINA KRKA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KRKA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90122/90122_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90122/90122_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2025-02-19 | 1 | 1 | 1 | 2025-02-19 | 2025-02-19 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 766842 | 90123 | EZETIMIBA/ATORVASTATINA KRKA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KRKA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90123/90123_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90123/90123_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2025-02-19 | 1 | 1 | 1 | 2025-02-19 | 2025-02-19 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 766854 | 90124 | EZETIMIBA/ATORVASTATINA KRKA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KRKA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90124/90124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90124/90124_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2025-02-19 | 1 | 1 | 1 | 2025-02-19 | 2025-02-19 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 766896 | 08462001IP3 | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 375 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462001IP3/08462001IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462001IP3/08462001IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 23628 | 2025-02-05 | 1 | 1 | 1 | 2025-02-06 | 2025-02-05 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 766909 | 406641022062011 | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/406641022062011/406641022062011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38197 | 41972 | 2025-02-10 | 1 | 1 | 1 | 2025-02-11 | 2025-02-10 | 1 | 2025-04-03 | View Edit Delete | ||||||||||||
| 766932 | 90137 | FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA | FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml + 1 aguja | N/A (Vacuna) | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml + 1 aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90137/90137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90137/90137_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 2025-02-13 | 1 | 1 | 1 | 2025-02-14 | 2025-02-13 | 1 | 2025-07-11 | View Edit Delete | ||||||||||||
| 766943 | 1231736009 | OMVOH 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA + OMVOH 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | OMVOH 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA + OMVOH 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 100 mg + 1 pluma precargada de 200 mg | 100 mg + 200 mg | 66 | 1 | 49 | 1 pluma precargada de 100 mg + 1 pluma precargada de 200 mg | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231736009/1231736009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231736009/1231736009_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 71735 | 1673 | 2025-02-18 | 1 | 1 | 1 | 2025-02-19 | 2025-02-18 | 1 | 2026-01-08 | View Edit Delete | ||||||||||||
| 766974 | 1241801004 | PYZCHIVA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | PYZCHIVA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 66 | 1 | 49 | 1 pluma precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801004/1241801004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801004/1241801004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2025-02-18 | 1 | 1 | 1 | 2025-02-19 | 2025-02-18 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 766975 | 1241801005 | PYZCHIVA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | PYZCHIVA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 90 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801005/1241801005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801005/1241801005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2025-02-18 | 1 | 1 | 1 | 2025-02-19 | 2025-02-18 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 766990 | 90161 | ESOMEPRAZOL SANDOZ CARE 20 MG CÁPSULAS DURAS GASTRORRESISTENTES | ESOMEPRAZOL SANDOZ CARE 20 MG CÁPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90161/90161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90161/90161_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2025-02-20 | 1 | 1 | 1 | 2025-02-21 | 2025-02-20 | 1 | 2026-02-18 | View Edit Delete | ||||||||||||
| 766993 | 161138007IP | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 100 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138007IP/161138007IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138007IP/161138007IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 37912 | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2025-02-25 | View Edit Delete | ||||||||||||
| 767015 | 90165 | ATORVASTATINA COMBIX PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX PHARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90165/90165_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90165/90165_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2026-04-09 | View Edit Delete | ||||||||||||
| 767019 | 90166 | ATORVASTATINA COMBIX PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA COMBIX PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90166/90166_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90166/90166_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767021 | 90167 | ATORVASTATINA COMBIX PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA COMBIX PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90167/90167_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90167/90167_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2026-04-09 | View Edit Delete | ||||||||||||
| 767023 | 90168 | ATORVASTATINA COMBIX PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA COMBIX PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90168/90168_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90168/90168_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767041 | R7164IP1 | OMNIC 0,4 MG CAPSULAS DE LIBERACION MODIFICADA | OMNIC 0,4 MG CAPSULAS DE LIBERACION MODIFICADA, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R7164IP1/R7164IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43818 | 23628 | 2025-02-26 | 1 | 1 | 1 | 2025-02-27 | 2025-02-26 | 1 | 2025-07-12 | View Edit Delete | ||||||||||||
| 767042 | 1241823005 | WEZENLA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | WEZENLA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 66 | 1 | 49 | 1 pluma precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823005/1241823005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823005/1241823005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2025-02-26 | 1 | 1 | 1 | 2025-02-27 | 2025-02-26 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 767043 | 1241823006 | WEZENLA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | WEZENLA 90 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 90 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241823006/1241823006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241823006/1241823006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 24978 | 41943 | 2025-02-26 | 1 | 1 | 1 | 2025-02-27 | 2025-02-26 | 1 | 2025-05-12 | View Edit Delete | ||||||||||||
| 767048 | 1231784005 | UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231784005/1231784005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231784005/1231784005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2787 | 6220 | 2025-02-26 | 1 | 1 | 1 | 2025-02-27 | 2025-02-26 | 1 | 2025-05-06 | View Edit Delete | ||||||||||||
| 767100 | 114931006IP | MEKINIST 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | MEKINIST 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 2 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114931006IP/114931006IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114931006IP/114931006IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | 37912 | 2025-03-03 | 1 | 1 | 1 | 2025-03-04 | 2025-03-03 | 1 | 2025-03-04 | View Edit Delete | ||||||||||||
| 767115 | 118356IP | TRECLINAC 10 MG/G + 0,25 MG/G GEL | TRECLINAC 10 MG/G + 0,25 MG/G GEL, 1 tubo de 30 g | 10 mg/g + 0,25 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/118356IP/118356IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67991 | 17193 | 2025-03-07 | 1 | 1 | 1 | 2025-03-08 | 2025-03-07 | 1 | 2025-08-27 | View Edit Delete | ||||||||||||
| 767219 | 90212 | PLAXOS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PLAXOS 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90212/90212_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90212/90212_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | 1803 | 2025-03-20 | 1 | 1 | 1 | 2025-03-20 | 2025-03-20 | 1 | 2025-07-09 | View Edit Delete | ||||||||||||
| 767220 | 90213 | PLAXOS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PLAXOS 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90213/90213_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90213/90213_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | 1803 | 2025-03-20 | 1 | 1 | 1 | 2025-03-20 | 2025-03-20 | 1 | 2025-07-09 | View Edit Delete | ||||||||||||
| 767221 | 90214 | PLAXOS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PLAXOS 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90214/90214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90214/90214_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | 1803 | 2025-03-20 | 1 | 1 | 1 | 2025-03-20 | 2025-03-20 | 1 | 2025-07-09 | View Edit Delete | ||||||||||||
| 767225 | 90215 | ESOMEPRAZOL ALMUS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALMUS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90215/90215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90215/90215_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2025-06-19 | 1 | 1 | 1 | 2025-06-19 | 2025-06-19 | 1 | 2026-01-30 | View Edit Delete | ||||||||||||
| 767227 | 90215 | ESOMEPRAZOL ALMUS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALMUS 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90215/90215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90215/90215_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2025-06-19 | 1 | 1 | 1 | 2025-06-19 | 2025-06-19 | 1 | 2026-01-30 | View Edit Delete | ||||||||||||
| 767243 | 90216 | ESOMEPRAZOL ALMUS 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALMUS 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90216/90216_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90216/90216_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2025-06-19 | 1 | 1 | 1 | 2025-06-19 | 2025-06-19 | 1 | 2026-01-30 | View Edit Delete | ||||||||||||
| 767244 | 90216 | ESOMEPRAZOL ALMUS 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL ALMUS 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90216/90216_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90216/90216_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | 37937 | 2025-06-19 | 1 | 1 | 1 | 2025-06-19 | 2025-06-19 | 1 | 2026-01-30 | View Edit Delete | ||||||||||||
| 767276 | 1241908001 | PAXNEURY 1 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PAXNEURY 1 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908001/1241908001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908001/1241908001_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767278 | 1241908002 | PAXNEURY 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PAXNEURY 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 2 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908002/1241908002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908002/1241908002_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767279 | 1241908003 | PAXNEURY 3 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PAXNEURY 3 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 3 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908003/1241908003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908003/1241908003_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767280 | 1241908004 | PAXNEURY 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | PAXNEURY 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908004/1241908004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908004/1241908004_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767281 | 1241908005 | PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA | PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908005/1241908005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908005/1241908005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767282 | 1241908006 | PAXNEURY 6 MG COMPRIMIDOS DE LIBERACION PROLONGADA | PAXNEURY 6 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 6 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908006/1241908006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908006/1241908006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767283 | 1241908007 | PAXNEURY 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA | PAXNEURY 7 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 7 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241908007/1241908007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241908007/1241908007_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 43544 | 45332 | 2025-03-19 | 1 | 1 | 1 | 2025-03-20 | 2025-03-19 | 1 | 2025-08-01 | View Edit Delete | ||||||||||||
| 767291 | 90228 | PAZOPANIB DR. REDDYS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB DR. REDDYS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90228/90228_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90228/90228_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2025-04-09 | 1 | 1 | 1 | 2025-04-09 | 2025-04-09 | 1 | 2025-10-22 | View Edit Delete | ||||||||||||
| 767295 | 1241892002 | YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241892002/1241892002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241892002/1241892002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44114 | 44571 | 2025-03-20 | 1 | 1 | 1 | 2025-03-21 | 2025-03-20 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767297 | 90229 | PAZOPANIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90229/90229_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90229/90229_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2025-04-09 | 1 | 1 | 1 | 2025-04-09 | 2025-04-09 | 1 | 2025-10-22 | View Edit Delete | ||||||||||||
| 767300 | 1241892003 | YESINTEK 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | YESINTEK 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241892003/1241892003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241892003/1241892003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44114 | 44571 | 2025-03-20 | 1 | 1 | 1 | 2025-03-21 | 2025-03-20 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767304 | BE318254 | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318254/BE318254_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 23628 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 767305 | BE318272 | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318272/BE318272_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 23628 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 767309 | 1241896010 | AVTOZMA 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AVTOZMA 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,9 ml | 162 mg inyectable 0,9 ml | 66 | 1 | 49 | 1 pluma precargada de 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896010/1241896010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896010/1241896010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767310 | 1241896001 | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896001/1241896001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896001/1241896001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-07-14 | View Edit Delete | ||||||||||||
| 767311 | 1241896001 | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896001/1241896001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896001/1241896001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767312 | 1241896001 | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 20 ml | 20 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896001/1241896001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896001/1241896001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767313 | 1241896007 | AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,9 ml | 162 mg inyectable 0,9 ml | 33 | 1 | 49 | 1 jeringa precargada de 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896007/1241896007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896007/1241896007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-07-14 | View Edit Delete | ||||||||||||
| 767418 | 1241885003 | ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1,2 ml | 200 mg inyectable 1,2 ml | 66 | 1 | 49 | 1 pluma precargada de 1,2 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241885003/1241885003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241885003/1241885003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2026-03-06 | View Edit Delete | ||||||||||||
| 767426 | 90265 | ATORVASTATINA/EZETIMIBA CINFA 20 MG/10 MG CAPSULAS DURAS | ATORVASTATINA/EZETIMIBA CINFA 20 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 20 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90265/90265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90265/90265_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767427 | 90266 | ATORVASTATINA/EZETIMIBA CINFA 40 MG/10 MG CAPSULAS DURAS | ATORVASTATINA/EZETIMIBA CINFA 40 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 40 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90266/90266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90266/90266_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767471 | 1241892004 | YESINTEK 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | YESINTEK 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241892004/1241892004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241892004/1241892004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44114 | 44571 | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 767479 | 1211594002 | RYBREVANT 1600 MG SOLUCION INYECTABLE | RYBREVANT 1600 MG SOLUCION INYECTABLE, 1 vial de 10 ml | 1600 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211594002/1211594002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211594002/1211594002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2025-04-14 | 1 | 1 | 1 | 2025-04-15 | 2025-04-14 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 767480 | 1211594003 | RYBREVANT 2240 MG SOLUCION INYECTABLE | RYBREVANT 2240 MG SOLUCION INYECTABLE, 1 vial de 14 ml | 2240 mg inyectable 14 ml | 45 | 1 | 34 | 1 vial de 14 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211594003/1211594003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211594003/1211594003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2025-04-14 | 1 | 1 | 1 | 2025-04-15 | 2025-04-14 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 767491 | 63908 | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63908/63908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63908/63908_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2001-05-21 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 767503 | 1241870001 | HETRONIFLY 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | HETRONIFLY 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241870001/1241870001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241870001/1241870001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2025-04-22 | 1 | 1 | 1 | 2025-04-23 | 2025-04-22 | 1 | 2026-01-13 | View Edit Delete | ||||||||||||
| 767505 | 90289 | NILOTINIB ZENTIVA 150 MG CAPSULAS DURAS EFG | NILOTINIB ZENTIVA 150 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 150 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90289/90289_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90289/90289_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8183 | 69439 | 2025-06-23 | 1 | 1 | 1 | 2025-06-23 | 2025-06-23 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 767508 | 90290 | NILOTINIB ZENTIVA 200 MG CAPSULAS DURAS EFG | NILOTINIB ZENTIVA 200 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 200 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90290/90290_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90290/90290_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8183 | 69439 | 2025-07-09 | 1 | 1 | 1 | 2025-07-09 | 2025-07-09 | 1 | 2026-01-14 | View Edit Delete | ||||||||||||
| 767509 | 63908 | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL STADA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63908/63908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63908/63908_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2001-05-21 | 1 | 2015-05-14 | View Edit Delete | ||||||||||||
| 767539 | 90298 | AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90298/90298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90298/90298_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2025-04-28 | 1 | 1 | 1 | 2025-04-30 | 2025-04-28 | 1 | 2025-11-13 | View Edit Delete | ||||||||||||
| 767548 | 1171234005 | TREMFYA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | TREMFYA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 20 ml | 200 mg inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171234005/1171234005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171234005/1171234005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2025-05-06 | 1 | 1 | 1 | 2025-05-07 | 2025-05-06 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 767725 | PA2229010002 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/PA2229010002/PA2229010002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34753 | 41972 | 2025-05-26 | 1 | 1 | 1 | 2025-05-27 | 2025-05-26 | 1 | 2025-07-18 | View Edit Delete | ||||||||||||
| 767730 | 1221674003 | VYVGART 1.000 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | VYVGART 1.000 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 5 ml | 1.000 mg inyectable 5 ml | 33 | 1 | 61 | 1 jeringa precargada de 5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221674003/1221674003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221674003/1221674003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41147 | 71016 | 2025-05-26 | 1 | 1 | 1 | 2025-05-27 | 2025-05-26 | 1 | 2025-07-29 | View Edit Delete | ||||||||||||
| 767806 | BE318254IP | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318254IP/BE318254IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 23628 | 2025-05-27 | 1 | 1 | 1 | 2025-05-28 | 2025-05-27 | 1 | 2025-07-12 | View Edit Delete | ||||||||||||
| 767807 | BE318272IP | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318272IP/BE318272IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 23628 | 2025-05-27 | 1 | 1 | 1 | 2025-05-28 | 2025-05-27 | 1 | 2025-07-12 | View Edit Delete | ||||||||||||
| 767875 | 1151024002IP2 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP2/1151024002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP2/1151024002IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 26669 | 2025-05-29 | 1 | 1 | 1 | 2025-05-30 | 2025-05-29 | 1 | 2025-05-30 | View Edit Delete | ||||||||||||
| 767904 | 64004 | OMEPRAZOL TECNIMEDE 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIMEDE 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64004/64004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64004/64004_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-06-20 | 1 | 1 | 1 | 2016-03-16 | 2025-06-04 | 1 | 2025-08-25 | View Edit Delete | ||||||||||||
| 767906 | 64004 | OMEPRAZOL TECNIMEDE 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIMEDE 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 20 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64004/64004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64004/64004_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-06-20 | 1 | 1 | 1 | 2016-03-16 | 2025-06-04 | 1 | 2026-03-30 | View Edit Delete | ||||||||||||
| 767948 | 3811201301814 | ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 37,5 mg/325 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3811201301814/3811201301814_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28217 | 17193 | 2025-06-13 | 1 | 1 | 1 | 2025-06-14 | 2025-06-13 | 1 | 2025-12-01 | View Edit Delete | ||||||||||||
| 767965 | 1241863004 | OTULFI 45 MG SOLUCIÓN INYECTABLE | OTULFI 45 MG SOLUCIÓN INYECTABLE, 1 vial de 0,5 ml | 45 mg inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863004/1241863004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863004/1241863004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | 14285 | 2025-06-16 | 1 | 1 | 1 | 2025-06-17 | 2025-06-16 | 1 | 2025-10-31 | View Edit Delete | ||||||||||||
| 768005 | 96022010IP2 | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96022010IP2/96022010IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96022010IP2/96022010IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44757 | 37912 | 2025-06-30 | 1 | 1 | 1 | 2025-07-01 | 2025-06-30 | 1 | 2025-07-03 | View Edit Delete | ||||||||||||
| 768006 | 96022009IP1 | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS, 28 comprimidos | 10 | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96022009IP1/96022009IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96022009IP1/96022009IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44757 | 37912 | 2025-06-30 | 1 | 1 | 1 | 2025-07-01 | 2025-06-30 | 1 | 2025-07-03 | View Edit Delete | ||||||||||||
| 768112 | 90449 | RISEDRONATO CINFAMED 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISEDRONATO CINFAMED 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 2 comprimidos | 75 mg | 5 | 2 | 10 | 2 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90449/90449_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90449/90449_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2025-07-15 | 1 | 1 | 1 | 2025-07-16 | 2025-07-15 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 768188 | 1171234008 | TREMFYA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | TREMFYA 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 2 ml | 200 mg inyectable 2 ml | 66 | 1 | 49 | 1 pluma precargada de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171234008/1171234008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171234008/1171234008_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2025-07-28 | 1 | 1 | 1 | 2025-07-29 | 2025-07-28 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 768202 | 82182 | FLECTORMED 180 MG APOSITO ADHESIVO MEDICAMENTOSO | FLECTORMED 180 MG APOSITO ADHESIVO MEDICAMENTOSO, 5 apósitos | 180 mg | 35 | 5 | 69 | 5 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82182/82182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82182/82182_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11580 | 44585 | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2025-07-30 | 1 | 2026-04-08 | View Edit Delete | ||||||||||||
| 768285 | 1211538001IP | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 500 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211538001IP/1211538001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211538001IP/1211538001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30289 | 37912 | 2025-08-08 | 1 | 1 | 1 | 2025-08-09 | 2025-08-08 | 1 | 2025-10-30 | View Edit Delete | ||||||||||||
| 768314 | 90515 | EZETIMIBA/ATORVASTATINA NORMOGEN 10 MG/20 MG COMPRIMIDOS EFG | EZETIMIBA/ATORVASTATINA NORMOGEN 10 MG/20 MG COMPRIMIDOS EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90515/90515_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90515/90515_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2025-08-14 | 1 | 1 | 1 | 2025-08-16 | 2025-08-14 | 1 | 2025-10-10 | View Edit Delete | ||||||||||||
| 768315 | 90516 | EZETIMIBA/ATORVASTATINA NORMOGEN 10 MG/40 MG COMPRIMIDOS EFG | EZETIMIBA/ATORVASTATINA NORMOGEN 10 MG/40 MG COMPRIMIDOS EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90516/90516_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90516/90516_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2025-08-14 | 1 | 1 | 1 | 2025-08-16 | 2025-08-14 | 1 | 2025-10-10 | View Edit Delete | ||||||||||||
| 768379 | 1241801007 | PYZCHIVA 45 MG SOLUCION INYECTABLE | PYZCHIVA 45 MG SOLUCION INYECTABLE, 1 vial de 0,5 ml | 45 mg inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241801007/1241801007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241801007/1241801007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 23615 | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 1 | 2026-04-15 | View Edit Delete | ||||||||||||
| 768393 | 1251957002 | USYMRO 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | USYMRO 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | 45 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251957002/1251957002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251957002/1251957002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8334 | 10616 | 2025-09-01 | 1 | 1 | 1 | 2025-09-02 | 2025-09-01 | 1 | 2025-10-29 | View Edit Delete | ||||||||||||
| 768394 | 1251957003 | USYMRO 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | USYMRO 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 90 mg inyectable 1 ml | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251957003/1251957003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251957003/1251957003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8334 | 10616 | 2025-09-01 | 1 | 1 | 1 | 2025-09-02 | 2025-09-01 | 1 | 2025-10-29 | View Edit Delete | ||||||||||||
| 768395 | 1251957004 | USYMRO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | USYMRO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | 130 mg inyectable 26 ml | 45 | 1 | 34 | 1 vial de 26 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251957004/1251957004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251957004/1251957004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8334 | 10616 | 2025-09-01 | 1 | 1 | 1 | 2025-09-02 | 2025-09-01 | 1 | 2025-10-30 | View Edit Delete | ||||||||||||
| 768402 | 1151014002IP2 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP2/1151014002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP2/1151014002IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 70791 | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768403 | 1151014001IP2 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial 4 ml | 10 mg/ml | 45 | 1 | 34 | 1 vial 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014001IP2/1151014001IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014001IP2/1151014001IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 70791 | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768404 | 161138007IP1 | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VENCLYXTO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 100 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/161138007IP1/161138007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/161138007IP1/161138007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | 70791 | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768413 | 1231736014 | OMVOH 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | OMVOH 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 2 ml | 200 mg | 66 | 1 | 49 | 1 pluma precargada de 2 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231736014/1231736014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231736014/1231736014_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 71735 | 1673 | 2025-09-05 | 1 | 1 | 1 | 2025-09-06 | 2025-09-05 | 1 | 2026-01-08 | View Edit Delete | ||||||||||||
| 768423 | 90554 | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90554/90554_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90554/90554_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2025-09-05 | 1 | 1 | 1 | 2025-09-06 | 2025-09-05 | 1 | 2026-03-12 | View Edit Delete | ||||||||||||
| 768425 | 90552 | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 80 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90552/90552_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90552/90552_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2025-09-05 | 1 | 1 | 1 | 2025-09-06 | 2025-09-05 | 1 | 2026-03-12 | View Edit Delete | ||||||||||||
| 768426 | 90555 | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90555/90555_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90555/90555_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2025-09-05 | 1 | 1 | 1 | 2025-09-06 | 2025-09-05 | 1 | 2026-03-12 | View Edit Delete | ||||||||||||
| 768448 | 1151024002IP3 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP3/1151024002IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP3/1151024002IP3_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | 70791 | 2025-09-09 | 1 | 1 | 1 | 2025-09-10 | 2025-09-09 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768457 | 1201508001IP1 | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201508001IP1/1201508001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201508001IP1/1201508001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8400 | 70791 | 2025-09-09 | 1 | 1 | 1 | 2025-09-10 | 2025-09-09 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768526 | 90569 | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90569/90569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90569/90569_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2025-10-14 | 1 | 1 | 1 | 2025-10-14 | 2025-10-14 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768561 | BE215826IP | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215826IP/BE215826IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 26669 | 2025-09-25 | 1 | 1 | 1 | 2025-09-26 | 2025-09-25 | 1 | 2025-10-22 | View Edit Delete | ||||||||||||
| 768562 | BE215887IP | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215887IP/BE215887IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 26669 | 2025-09-25 | 1 | 1 | 1 | 2025-09-26 | 2025-09-25 | 1 | 2025-10-22 | View Edit Delete | ||||||||||||
| 768715 | 63437 | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63437/63437_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63437/63437_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2025-10-06 | 1 | 2026-02-05 | View Edit Delete | ||||||||||||
| 768716 | 63436 | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63436/63436_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63436/63436_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2025-10-06 | 1 | 2026-02-05 | View Edit Delete | ||||||||||||
| 768832 | 90684 | NINTEDANIB DR.REDDYS 100 MG CAPSULAS BLANDAS EFG | NINTEDANIB DR.REDDYS 100 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 100 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90684/90684_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90684/90684_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2025-10-20 | 1 | 1 | 1 | 2025-10-21 | 2025-10-20 | 1 | 2026-02-24 | View Edit Delete | ||||||||||||
| 768833 | 90685 | NINTEDANIB DR.REDDYS 150 MG CAPSULAS BLANDAS EFG | NINTEDANIB DR.REDDYS 150 MG CAPSULAS BLANDAS EFG, 60 cápsulas | 150 mg | 110 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90685/90685_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90685/90685_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2025-10-20 | 1 | 1 | 1 | 2025-10-21 | 2025-10-20 | 1 | 2026-02-24 | View Edit Delete | ||||||||||||
| 768847 | 034972442IP1 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972442IP1/034972442IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 17193 | 2025-10-20 | 1 | 1 | 1 | 2025-10-21 | 2025-10-20 | 1 | 2026-03-12 | View Edit Delete | ||||||||||||
| 768850 | 1241896010 | AVTOZMA 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AVTOZMA 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,9 ml | 162 mg | 66 | 2 | 49 | 2 plumas precargadas de 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896010/1241896010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896010/1241896010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-10-20 | 1 | 2026-03-03 | View Edit Delete | ||||||||||||
| 768851 | 1241896007 | AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,9 ml | 162 mg inyectable 0,9 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,9 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896007/1241896007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896007/1241896007_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32858 | 67335 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-10-20 | 1 | 2026-04-13 | View Edit Delete | ||||||||||||
| 768857 | 96022010IP3 | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96022010IP3/96022010IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96022010IP3/96022010IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44757 | 26669 | 2025-10-21 | 1 | 1 | 1 | 2025-10-22 | 2025-10-21 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 768858 | 96022009IP2 | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS | ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96022009IP2/96022009IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96022009IP2/96022009IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44757 | 26669 | 2025-10-21 | 1 | 1 | 1 | 2025-10-22 | 2025-10-21 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 768932 | BE318254IP1 | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318254IP1/BE318254IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 43579 | 2025-10-23 | 1 | 1 | 1 | 2025-10-24 | 2025-10-23 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 768933 | BE318272IP1 | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318272IP1/BE318272IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 43579 | 2025-10-23 | 1 | 1 | 1 | 2025-10-24 | 2025-10-23 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 768966 | 034972291IP1 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972291IP1/034972291IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 43579 | 2025-10-24 | 1 | 1 | 1 | 2025-10-25 | 2025-10-24 | 1 | 2026-05-13 | View Edit Delete | ||||||||||||
| 768967 | 034972442IP2 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972442IP2/034972442IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | 43579 | 2025-10-24 | 1 | 1 | 1 | 2025-10-25 | 2025-10-24 | 1 | 2026-05-13 | View Edit Delete | ||||||||||||
| 768977 | BE215826IP1 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215826IP1/BE215826IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 43579 | 2025-10-24 | 1 | 1 | 1 | 2025-10-25 | 2025-10-24 | 1 | 2026-01-28 | View Edit Delete | ||||||||||||
| 768978 | BE215887IP1 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215887IP1/BE215887IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | 43579 | 2025-10-24 | 1 | 1 | 1 | 2025-10-25 | 2025-10-24 | 1 | 2026-01-28 | View Edit Delete | ||||||||||||
| 769092 | 90745 | ESOMEPRAZOL STADAFARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL STADAFARMA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (Al/Al) | 20 mg | 5 | 56 | 10 | 56 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90745/90745_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90745/90745_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2025-11-06 | 1 | 1 | 1 | 2025-11-07 | 2025-11-06 | 1 | 2026-05-11 | View Edit Delete | ||||||||||||
| 769096 | 90746 | ESOMEPRAZOL STADAFARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG | ESOMEPRAZOL STADAFARMA 40 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos (Al/Al) | 40 mg | 5 | 56 | 10 | 56 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90746/90746_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90746/90746_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2025-11-06 | 1 | 1 | 1 | 2025-11-07 | 2025-11-06 | 1 | 2026-05-11 | View Edit Delete | ||||||||||||
| 769114 | BE318254IP2 | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318254IP2/BE318254IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 43579 | 2025-11-12 | 1 | 1 | 1 | 2025-11-13 | 2025-11-12 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769115 | BE318272IP2 | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE318272IP2/BE318272IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28767 | 43579 | 2025-11-12 | 1 | 1 | 1 | 2025-11-13 | 2025-11-12 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769124 | BE465822IP2 | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATOZET 10 MG/80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 10 mg/80 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE465822IP2/BE465822IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 37912 | 2025-11-14 | 1 | 1 | 1 | 2025-11-15 | 2025-11-14 | 1 | 2025-11-17 | View Edit Delete | ||||||||||||
| 769235 | 1241853001 | LOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | LOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 6 ml | 240 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial de 6 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241853001/1241853001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241853001/1241853001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71507 | 34965 | 2025-11-24 | 1 | 1 | 1 | 2025-11-25 | 2025-11-24 | 1 | 2026-04-10 | View Edit Delete | ||||||||||||
| 769412 | 77052 | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TECNIGEN 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (blíster) | 30 mg | 5 | 56 | 43 | 56 cápsulas (blíster) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77052/77052_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77052/77052_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2013-01-28 | 1 | 1 | 1 | 2013-01-28 | 2025-12-05 | 1 | 2026-05-02 | View Edit Delete | ||||||||||||
| 769496 | LT1983805025IP3 | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805025IP3/LT1983805025IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 37912 | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769498 | 8194201506 | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/8194201506/8194201506_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 37912 | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769499 | LT1983805063 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805063/LT1983805063_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 37912 | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 1 | 2025-12-15 | View Edit Delete | ||||||||||||
| 769721 | LT1214806001IP | ATORDUO 10 MG/10 MG CAPSULAS DURAS | ATORDUO 10 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 10 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1214806001IP/LT1214806001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 23628 | 2026-01-21 | 1 | 1 | 1 | 2026-01-22 | 2026-01-21 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 769722 | LT1214807001IP | ATORDUO 20 MG/10 MG CAPSULAS DURAS | ATORDUO 20 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 20 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1214807001IP/LT1214807001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 23628 | 2026-01-21 | 1 | 1 | 1 | 2026-01-22 | 2026-01-21 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 769723 | LT1214808001IP | ATORDUO 40 MG/10 MG CAPSULAS DURAS | ATORDUO 40 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 40 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1214808001IP/LT1214808001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | 23628 | 2026-01-21 | 1 | 1 | 1 | 2026-01-22 | 2026-01-21 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 769820 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 100 dosis | 50 microgramos/137 microgramos/dosis | 6 | 100 | 31 | 100 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2026-02-02 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 769821 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 150 dosis | 50 microgramos/137 microgramos/dosis | 6 | 150 | 31 | 150 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2026-02-02 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 769842 | 28600056IP | OPIREN 30 mg CÁPSULAS | OPIREN 30 mg CÁPSULAS, 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/28600056IP/28600056IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71226 | 23628 | 2026-02-05 | 1 | 1 | 1 | 2026-02-06 | 2026-02-05 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 769846 | LT1983805044IP | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805044IP/LT1983805044IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 41972 | 2026-02-05 | 1 | 1 | 1 | 2026-02-06 | 2026-02-05 | 1 | 2026-05-07 | View Edit Delete | ||||||||||||
| 769847 | LT1983805025IP4 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT1983805025IP4/LT1983805025IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | 41972 | 2026-02-05 | 1 | 1 | 1 | 2026-02-06 | 2026-02-05 | 1 | 2026-05-07 | View Edit Delete | ||||||||||||
| 769874 | 1251927002 | WINLEVI 10 MG/G CREMA | WINLEVI 10 MG/G CREMA, 60 gramos | 10 mg/g | 44 | 60 | 21 | 60 gramos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251927002/1251927002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251927002/1251927002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 71596 | 71079 | 2026-02-09 | 1 | 1 | 1 | 2026-02-10 | 2026-02-09 | 1 | 2026-03-30 | View Edit Delete | ||||||||||||
| 769875 | 1251927002 | WINLEVI 10 MG/G CREMA | WINLEVI 10 MG/G CREMA, 30 gramos | 10 mg/g | 44 | 30 | 21 | 30 gramos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251927002/1251927002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251927002/1251927002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 71596 | 71079 | 2026-02-09 | 1 | 1 | 1 | 2026-02-10 | 2026-02-09 | 1 | 2026-03-30 | View Edit Delete | ||||||||||||
| 769878 | 1211623004 | SAPHNELO 120 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | SAPHNELO 120 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 4 plumas precargadas de 0,8 ml | 120 mg inyectable 0,8 ml | 66 | 4 | 49 | 4 plumas precargadas de 0,8 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211623004/1211623004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211623004/1211623004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34774 | 41965 | 2026-02-09 | 1 | 1 | 1 | 2026-02-10 | 2026-02-09 | 1 | 2026-05-14 | View Edit Delete | ||||||||||||
| 769932 | 2346204042012IP | LOBIVON 5 MG COMPRIMIDOS | LOBIVON 5 MG COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/2346204042012IP/2346204042012IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | 23628 | 2026-02-17 | 1 | 1 | 1 | 2026-02-18 | 2026-02-17 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 769954 | 3400937412865 | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400937412865/3400937412865_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29137 | 43579 | 2026-02-18 | 1 | 1 | 1 | 2026-02-19 | 2026-02-18 | 1 | 2026-03-27 | View Edit Delete | ||||||||||||
| 770273 | 113853018 | REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2,5 ml | 100 mg | 45 | 1 | 34 | 1 vial de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113853018/113853018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113853018/113853018_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2026-04-13 | 1 | 1 | 1 | 2026-04-14 | 2026-04-13 | 1 | 2026-05-15 | View Edit Delete | ||||||||||||
| 770274 | 113853018 | REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8,75 ml | 350 mg | 45 | 1 | 34 | 1 vial de 8,75 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113853018/113853018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113853018/113853018_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | 1534 | 2026-04-13 | 1 | 1 | 1 | 2026-04-14 | 2026-04-13 | 1 | 2026-05-15 | View Edit Delete | ||||||||||||
| 774547 | 44000 | HIDROPOLIVIT GOTAS ORALES EN SOLUCION | HIDROPOLIVIT GOTAS ORALES EN SOLUCION , 1 frasco de 20 ml | N/A (más de 4 PA) | 56 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/44000/44000_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/44000/44000_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | 1803 | 1967-02-01 | 1 | 1 | 1 | 1967-02-01 | 2003-11-12 | 1 | 2011-10-13 | 769265 | View Edit Delete | |||||||||||
| 776344 | 62578 | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 20 mg COMPRIMIDOS GASTRORRESISTENTES , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62578/62578_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62578/62578_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 70973 | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2011-09-05 | View Edit Delete | ||||||||||||
| 776435 | 62580 | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62580/62580_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62580/62580_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 70973 | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2011-09-05 | View Edit Delete | ||||||||||||
| 778324 | 64882 | VEJICUR POLVO Y DISOLVENTE PARA SUSPENSION INTRAVESICAL | VEJICUR POLVO Y DISOLVENTE PARA SUSPENSION INTRAVESICAL, 1 vial (catéter adaptador Luer-Lock) | N/A | 3 | 1 | 54 | 1 vial (catéter adaptador Luer-Lock) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64882/64882_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64882/64882_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11137 | 10255 | 2002-07-05 | 1 | 1 | 1 | 2002-07-05 | 2002-07-05 | 1 | 2023-09-13 | View Edit Delete | ||||||||||||
| 778894 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2001-05-22 | 1 | 2015-08-11 | View Edit Delete | ||||||||||||
| 781211 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2001-05-22 | 1 | 2016-04-07 | View Edit Delete | ||||||||||||
| 792143 | 25489 | NEO-HUBBER GOTAS | NEO-HUBBER GOTAS, 1 frasco de 5 ml | 5 mg/ml + 3,5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2896 | 2896 | 1956-03-01 | 1 | 1 | 1 | 1956-03-01 | 1956-03-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 794370 | 54529 | BECLO-RINO 50 MICROGRAMOS APLICACIÓN SUSPENSIÓN PARA PULVERIZACIÓN NASAL | BECLO-RINO 50 MICROGRAMOS APLICACIÓN SUSPENSIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 200 dosis | 50 microgramos/dosis | 27 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54529/54529_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54529/54529_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 1979-02-01 | 1 | 1 | 1 | 1979-02-01 | 1999-04-01 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 798959 | 59717 | BESITRAN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BESITRAN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59717/59717_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59717/59717_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 1993-03-01 | 1 | 1 | 1 | 1993-03-01 | 1993-03-01 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 806836 | 59778 | LACIPIL 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LACIPIL 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59778/59778_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59778/59778_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | 3732 | 1993-04-01 | 1 | 1 | 1 | 1993-04-01 | 1993-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 807404 | 97055002 | VIRAMUNE 50 mg/5 ml SUSPENSION ORAL | VIRAMUNE 50 mg/5 ml SUSPENSION ORAL, 1 frasco de 240 ml | 10 mg/ml | 6 | 240 | 26 | 1 frasco de 240 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97055002/97055002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97055002/97055002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5126 | 470 | 2000-06-27 | 1 | 1 | 1 | 2000-06-27 | 2000-06-27 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 811869 | 99112001 | ZIAGEN 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZIAGEN 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99112001/99112001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99112001/99112001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34670 | 3776 | 1999-09-01 | 1 | 1 | 1 | 1999-09-01 | 1999-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 812107 | 99116001 | REMICADE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | REMICADE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99116001/99116001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99116001/99116001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | 71027 | 1999-09-01 | 1 | 1 | 1 | 1999-09-01 | 1999-09-01 | 1 | 2011-02-28 | View Edit Delete | ||||||||||||
| 817445 | 99114001 | ZEFFIX 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZEFFIX 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99114001/99114001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99114001/99114001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2000-01-11 | 1 | 1 | 1 | 2000-01-11 | 2000-01-11 | 1 | 2011-09-19 | View Edit Delete | ||||||||||||
| 817791 | 66092 | LANSOPRAZOL ALTER 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL ALTER 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66092/66092_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66092/66092_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2004-05-20 | 1 | 1 | 1 | 2004-05-20 | 2004-05-20 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 817866 | 46028 | RIFALDIN 20 mg/ml SUSPENSION ORAL | RIFALDIN 20 mg/ml SUSPENSION ORAL , 1 frasco de 120 ml | 20 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/46028/46028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/46028/46028_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40842 | 40842 | 1968-06-01 | 1 | 1 | 1 | 1968-06-01 | 1968-06-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 823211 | 48671 | SEPTRIN PEDIATRICO 8 mg/40 mg/ml SUSPENSION ORAL | SEPTRIN PEDIATRICO 8 mg/40 mg/ml SUSPENSION ORAL , 1 frasco de 100 ml | 40 mg/ml + 8 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48671/48671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48671/48671_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2896 | 2896 | 1969-10-01 | 1 | 1 | 1 | 1969-10-01 | 1969-10-01 | 1 | 2011-05-04 | View Edit Delete | ||||||||||||
| 823997 | 64571 | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64571/64571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64571/64571_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2002-02-21 | 1 | 1 | 1 | 2002-02-21 | 2002-02-21 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 825711 | 64578 | FUTURAN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FUTURAN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 600 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64578/64578_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64578/64578_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2002-02-22 | 1 | 1 | 1 | 2002-02-22 | 2002-02-22 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 835371 | 03260003 | STALEVO 50 mg/12,5 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 50 mg/12,5 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 50 mg/12,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260003/03260003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260003/03260003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2004-05-20 | 1 | 1 | 1 | 2004-05-20 | 2004-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 836163 | 03260007 | STALEVO 100 mg/25 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 100 mg/25 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 100 mg/25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260007/03260007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260007/03260007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2004-05-20 | 1 | 1 | 1 | 2004-05-20 | 2004-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 836833 | 03260011 | STALEVO 150 mg/37,5 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 150 mg/37,5 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 150 mg/37,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260011/03260011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260011/03260011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | 43535 | 2004-05-20 | 1 | 1 | 1 | 2004-05-20 | 2004-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 845826 | 59102 | NEUPOGEN 30 MU (0,3 mg/ml) SOLUCION INYECTABLE | NEUPOGEN 30 MU (0,3 mg/ml) SOLUCION INYECTABLE , 5 viales de 1 ml | 30 millones U | 45 | 5 | 34 | 5 viales de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59102/59102_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59102/59102_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 1991-09-01 | 1 | 1 | 1 | 1991-09-01 | 1991-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 849604 | 03253001 | ALDURAZYME, 100 U/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ALDURAZYME, 100 U/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 100 U/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03253001/03253001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03253001/03253001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42448 | 40842 | 2003-06-24 | 1 | 1 | 1 | 2003-06-24 | 2003-06-24 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 851154 | 64642 | PREVENCOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64642/64642_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64642/64642_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 2002-03-14 | 1 | 1 | 1 | 2002-03-14 | 2002-03-14 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 852616 | 62925 | TRAMADOL VIATRIS 100 MG/ML GOTAS ORALES EN SOLUCIÓN EFG | TRAMADOL VIATRIS 100 MG/ML GOTAS ORALES EN SOLUCIÓN EFG, 1 frasco de 10 ml | 100 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62925/62925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62925/62925_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 44524 | 2000-02-02 | 1 | 1 | 1 | 2000-02-02 | 2000-02-02 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 852665 | 63940 | AXIAGO 20 mg COMPRIMIDOS GASTRORRESISTENTES | AXIAGO 20 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63940/63940_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63940/63940_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2001-05-29 | 1 | 1 | 1 | 2001-05-29 | 2001-05-29 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 852673 | 62925 | TRAMADOL VIATRIS 100 MG/ML GOTAS ORALES EN SOLUCIÓN EFG | TRAMADOL VIATRIS 100 MG/ML GOTAS ORALES EN SOLUCIÓN EFG, 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62925/62925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62925/62925_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 44524 | 2000-02-02 | 1 | 1 | 1 | 2000-02-02 | 2000-02-02 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 853218 | 63944 | AXIAGO 40 mg COMPRIMIDOS GASTRORRESISTENTES | AXIAGO 40 mg COMPRIMIDOS GASTRORRESISTENTES , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63944/63944_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63944/63944_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2001-05-29 | 1 | 1 | 1 | 2001-05-29 | 2001-05-29 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 858506 | 62984 | PRO ULCO 15 mg CAPSULAS GASTRORRESISTENTES | PRO ULCO 15 mg CAPSULAS GASTRORRESISTENTES , 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62984/62984_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62984/62984_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2000-04-11 | 1 | 1 | 1 | 2000-04-11 | 2000-04-11 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 864058 | 97053003 | CEREZYME 400 UNIDADES POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | CEREZYME 400 UNIDADES POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 400 U | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97053003/97053003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97053003/97053003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42448 | 40842 | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 866905 | 59468 | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEROXAT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59468/59468_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59468/59468_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 2002-03-25 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 867465 | 64315 | NEUPOGEN 48 MU (0,96 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA | NEUPOGEN 48 MU (0,96 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml | 48 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64315/64315_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64315/64315_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2001-10-24 | 1 | 1 | 1 | 2001-10-24 | 2001-10-24 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 870261 | 65471 | FERRO SANOL 100 mg CAPSULAS GASTRORRESISTENTES | FERRO SANOL 100 mg CAPSULAS GASTRORRESISTENTES , 50 cápsulas | 100 mg | 5 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65471/65471_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65471/65471_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2896 | 2896 | 2003-07-01 | 1 | 1 | 1 | 2003-07-02 | 2003-07-01 | 1 | 2011-05-04 | View Edit Delete | ||||||||||||
| 870519 | 65474 | OPIREN FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES , 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65474/65474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65474/65474_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 2003-07-21 | 1 | 1 | 1 | 2003-07-22 | 2003-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 872622 | 65475 | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES | OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65475/65475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65475/65475_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | 70973 | 2003-07-21 | 1 | 1 | 1 | 2003-07-22 | 2003-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 876029 | 01171001 | RAPAMUNE 1 mg/ml SOLUCION ORAL | RAPAMUNE 1 mg/ml SOLUCION ORAL, 1 frasco de 60 ml | 1 mg/ml | 71 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01171001/01171001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01171001/01171001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2001-05-22 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 881102 | 58786 | AULCER 20 mg CAPSULAS DURAS GASTRORRESISTENTES. | AULCER 20 mg CAPSULAS DURAS GASTRORRESISTENTES., 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58786/58786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58786/58786_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | 587 | 1990-11-01 | 1 | 1 | 1 | 1990-11-01 | 2001-07-18 | 1 | 2011-10-04 | View Edit Delete | ||||||||||||
| 884858 | 58787 | ULCESEP 20 mg cápsulas duras gastrorresistentes | ULCESEP 20 mg cápsulas duras gastrorresistentes, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58787/58787_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58787/58787_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | 587 | 1990-11-01 | 1 | 1 | 1 | 1990-11-01 | 2001-07-18 | 1 | 2011-10-04 | View Edit Delete | ||||||||||||
| 886077 | 64315 | NEUPOGEN 48 MU (0,96 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA | NEUPOGEN 48 MU (0,96 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA , 5 jeringas precargadas de 0,5 ml | 48 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64315/64315_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64315/64315_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2001-10-24 | 1 | 1 | 1 | 2001-10-24 | 2001-10-24 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 887836 | 60484 | NUCLOSINA 20 mg CAPSULAS DURAS GASTRORRESISTENTES | NUCLOSINA 20 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60484/60484_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60484/60484_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32514 | 32514 | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2001-07-18 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 889006 | 58466 | PARIZAC 20 mg, CAPSULAS DURAS GASTRORRESISTENTES | PARIZAC 20 mg, CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58466/58466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58466/58466_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | 4840 | 1989-10-01 | 1 | 1 | 1 | 1989-10-01 | 2001-07-18 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 890038 | 59466 | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FROSINOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59466/59466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59466/59466_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 2002-11-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 890897 | 66021 | IBUPROFENO KERN PHARMA 20 mg/ml SUSPENSION ORAL EFG | IBUPROFENO KERN PHARMA 20 mg/ml SUSPENSION ORAL EFG, 1 frasco de 200 ml | 20 mg/ml | 88 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66021/66021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66021/66021_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2004-04-06 | 1 | 1 | 1 | 2004-04-06 | 2004-04-06 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 893974 | 66127 | LANSOPRAZOL SANDOZ 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL SANDOZ 15 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66127/66127_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66127/66127_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2004-05-28 | 1 | 1 | 1 | 2004-05-28 | 2004-05-28 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 894006 | 58382 | OMAPREN 20 mg CAPSULAS DURAS GASTRORRESISTENTES | OMAPREN 20 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 20 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58382/58382_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58382/58382_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | 45332 | 1989-10-01 | 1 | 1 | 1 | 1989-10-01 | 2001-07-18 | 1 | 2011-10-07 | 755645 | View Edit Delete | |||||||||||
| 895102 | 66128 | LANSOPRAZOL SANDOZ 30 MG CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL SANDOZ 30 MG CAPSULAS GASTRORRESISTENTES EFG , 28 cápsulas | 30 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66128/66128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66128/66128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2004-05-28 | 1 | 1 | 1 | 2004-05-28 | 2004-05-28 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 895219 | 64137 | IBLASIN 20 MG/ML SUSPENSION ORAL | IBLASIN 20 MG/ML SUSPENSION ORAL , 1 frasco de 100 ml | 20 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64137/64137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64137/64137_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 2001-07-27 | 1 | 1 | 1 | 2022-10-21 | 2022-10-21 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 895847 | 66028 | IBLASIN 40 MG/ML SUSPENSION ORAL | IBLASIN 40 MG/ML SUSPENSION ORAL , 1 frasco de 100 ml | 40 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66028/66028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66028/66028_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 2004-04-15 | 1 | 1 | 1 | 2022-10-21 | 2022-10-21 | 1 | 2025-08-29 | View Edit Delete | ||||||||||||
| 901082 | 59297 | PULMICORT 0,50 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR | PULMICORT 0,50 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR, 5 ampollas de 2 ml | 1 mg | 1 | 5 | 40 | 5 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59297/59297_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59297/59297_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41965 | 41965 | 1992-04-01 | 1 | 1 | 1 | 1992-04-01 | 1992-04-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 901199 | 59298 | PULMICORT 0,25 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR | PULMICORT 0,25 mg/ml SUSPENSION PARA INHALACION POR NEBULIZADOR, 5 ampollas de 2 ml | 0,5 mg | 1 | 5 | 40 | 5 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59298/59298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59298/59298_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41965 | 41965 | 1992-04-01 | 1 | 1 | 1 | 1992-04-01 | 1992-04-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 907089 | 61001 | PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES | PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61001/61001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61001/61001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 70973 | 1996-03-01 | 1 | 1 | 1 | 1996-03-01 | 2000-10-02 | 1 | 2011-09-05 | View Edit Delete | ||||||||||||
| 918706 | 64264 | GEMFIBROZILO TARBIS 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | GEMFIBROZILO TARBIS 900 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 900 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64264/64264_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64264/64264_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2876 | 2876 | 2001-09-28 | 1 | 1 | 1 | 2001-09-28 | 2001-09-28 | 1 | 2015-01-13 | View Edit Delete | ||||||||||||
| 926519 | 61002 | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES | ANAGASTRA 40 mg COMPRIMIDOS GASTRORRESISTENTES , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61002/61002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61002/61002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14147 | 70973 | 1996-01-01 | 1 | 1 | 1 | 1996-01-01 | 2000-10-20 | 1 | 2011-09-05 | View Edit Delete | ||||||||||||
| 932822 | 61742 | PREVENCOR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | PREVENCOR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61742/61742_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61742/61742_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 38815 | 1997-10-01 | 1 | 1 | 1 | 1997-10-01 | 2001-05-03 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 933572 | 60897 | VINCIGRIP FORTE GRANULADO PARA SOLUCION ORAL SABOR CACAO | VINCIGRIP FORTE GRANULADO PARA SOLUCION ORAL SABOR CACAO , 10 sobres | 650 mg/4 mg/30 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60897/60897_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60897/60897_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 1995-11-01 | 1 | 1 | 1 | 1995-11-01 | 2001-09-05 | 1 | 2011-07-04 | 682401 | View Edit Delete | |||||||||||
| 935270 | 63436 | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63436/63436_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63436/63436_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2000-11-15 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 935353 | 63437 | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 mg COMPRIMIDOS GASTRORRESISTENTES , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63437/63437_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63437/63437_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | 10103 | 2000-11-15 | 1 | 1 | 1 | 2000-11-15 | 2000-11-15 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 941682 | 01185002 | ARANESP 10 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA | ARANESP 10 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 0,4 ml | 10 microgramos | 33 | 4 | 61 | 4 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01185002/01185002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01185002/01185002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2001-07-17 | 1 | 1 | 1 | 2001-07-17 | 2001-07-17 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 957878 | 56132 | ISOPTO FLUCON 1 MG/ML COLIRIO EN SUSPENSION | ISOPTO FLUCON 1 MG/ML COLIRIO EN SUSPENSION 1 frasco de 5 ml | 1 mg/ml | 56 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56132/56132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56132/56132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41362 | 41362 | 1984-01-01 | 1 | 1 | 1 | 1984-01-01 | 1984-01-01 | 1 | 2011-11-08 | View Edit Delete | ||||||||||||
| 971408 | 57150 | EULITOP RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA | EULITOP RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57150/57150_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57150/57150_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | 16109 | 1986-10-01 | 1 | 1 | 1 | 1986-10-01 | 1986-10-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 977314 | 57595 | FUNGAREST 20 mg/g crema | FUNGAREST 20 mg/g crema , 1 tubo de 30 g | 20 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57595/57595_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57595/57595_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 1988-01-01 | 1 | 1 | 1 | 1988-01-01 | 1988-01-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 978528 | 57684 | KETOISDIN 20mg/g CREMA | KETOISDIN 20mg/g CREMA , 1 tubo de 30 g | 20 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57684/57684_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57684/57684_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-03-01 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 985937 | 59494 | ACTILYSE POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION | ACTILYSE POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial 20 mg + vial de disolvente | 20 mg | 45 | 1 | 34 | 1 vial 20 mg + vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59494/59494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59494/59494_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5126 | 470 | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 985945 | 59494 | ACTILYSE POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION | ACTILYSE POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial 50 mg + vial de disolvente | 50 mg | 45 | 1 | 34 | 1 vial 50 mg + vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59494/59494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59494/59494_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5126 | 470 | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 987313 | 49391 | BALSOPRIM 26,6MG/ML+5,4MG/ML+0,5MG/ML SUSPENSIÓN ORAL | BALSOPRIM 26,6MG/ML+5,4MG/ML+0,5MG/ML SUSPENSIÓN ORAL, 1 frasco de 150 ml | 26,6 mg/ml + 5,4 mg/ml + 0,5 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49391/49391_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49391/49391_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67189 | 67189 | 1971-06-01 | 1 | 1 | 1 | 1971-06-01 | 1971-06-01 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 990325 | 58404 | DECAPEPTYL MENSUAL 3,75 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | DECAPEPTYL MENSUAL 3,75 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE, 1 vial + 1 ampolla de disolvente | 3,75 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58404/58404_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58404/58404_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68629 | 68629 | 1990-04-01 | 1 | 1 | 1 | 1990-04-01 | 1990-04-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 997015 | 58832 | LOPID 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOPID 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 600 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58832/58832_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58832/58832_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11622 | 11622 | 1991-02-01 | 1 | 1 | 1 | 1991-02-01 | 1991-02-01 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 997106 | 58839 | TRIALMIN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TRIALMIN 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 600 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58839/58839_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58839/58839_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1803 | 1803 | 1991-02-01 | 1 | 1 | 1 | 1991-02-01 | 1991-02-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 998427 | 64314 | NEUPOGEN 30 MU (0,6 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA | NEUPOGEN 30 MU (0,6 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml | 30 millones U | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64314/64314_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64314/64314_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2001-10-24 | 1 | 1 | 1 | 2001-10-24 | 2001-10-24 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 998443 | 64314 | NEUPOGEN 30 MU (0,6 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA | NEUPOGEN 30 MU (0,6 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA , 5 jeringas precargadas de 0,5 ml | 30 millones U | 33 | 5 | 61 | 5 jeringas precargadas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64314/64314_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64314/64314_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7884 | 41943 | 2001-10-24 | 1 | 1 | 1 | 2001-10-24 | 2001-10-24 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 999730 | 65582 | CARBOCAL D 600 MG/400 UI COMPRIMIDOS MASTICABLES | CARBOCAL D 600 MG/400 UI COMPRIMIDOS MASTICABLES , 60 comprimidos | 1.500 mg (600 mg Ca)/400 UI | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65582/65582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65582/65582_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | 5478 | 2003-08-29 | 1 | 1 | 1 | 2003-09-04 | 2005-05-06 | 1 | 2012-01-02 | 714378 | View Edit Delete |